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ABSTRACT 
Soyeon Guh: THREE ESSAYS ON INTRA-HOUSEHOLD RESOURCE ALLOCATION, 
THE COST OF ILLNESS MEASURE, AND IMMUNIZATION POLICY 
(Under the direction of Richard N.L. Andrews) 
 
The dissertation comprises three chapters, ranging from health economics to 
immunization policy analysis. In the first and second chapters I focus mainly on establishing 
theoretically correct measures of welfare benefit, while in the third chapter I aim to 
determine which kind of immunization program is best by using better measures of both 
benefits and costs associated with one episode of typhoid fever. 
The objective of the first chapter is to separately derive a mother’s versus a father’s 
willingness to spend money and time to save her child from one day of sickness. In order to 
accomplish this goal, I extend the existing theories of household decision-making by 
integrating Chiappori (1988)’s household decision-making model and Grossman (1972)’s 
health production model. All illnesses have financial and time consequences. When a child is 
sick, the mother and the father may respond differently to the health shock. They may have 
different preferences toward risk and they may not fully pool their income. They may thus 
want to allocate different amounts of money and time for improving their children’s health. I 
take account of these differences using an interdisciplinary approach. The novelty of my 
approach, thus, is in its departure from the unitary household framework on which health 
valuation studies have relied until now. Finally, I find that maternal/paternal willingness to 
pay for the child’s health is determined by six factors: the income share, the non-labor 
income, the price of medical care, an individual time value (i.e., wage), and the household’s 
and individual technology for producing the child’s health. 
In the second chapter, I compare measures estimating the benefits of reduced 
morbidity in order to answer several questions: what would be the theoretically correct 
benefit measure for reduced morbidity?  How much would the true measure differ from 
others? What are the determinants of the differences between the true measure and others? In 
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order to answer these basic questions, I begin with Bockstael and McConnell (2007)’s model, 
which derives welfare measures for non-marginal changes of morbidity, and then incorporate 
insurance into it, based on the proposition that insurance may have a significant effect on the 
magnitude of the discrepancies between the cost-of-illness (COI) and willingness-to-pay 
measures. Next, I incorporate uncertainty into the model, since an individual does not know 
what her health will be with certainty (Berger et al., 1987). In doing so, I derive ex ante COI 
and ex ante compensating variation measures. Theoretically they are unlikely to be the same. 
Based on the findings of this study, the COI estimates are not reliable and do not give clear 
guidance as to the lower bound on the theoretically true estimates in measuring the benefits 
of reduced morbidity. Therefore, the value of COI estimates in decision-making may be 
limited. 
The third chapter examines school-based immunization against typhoid fever in North 
Jakarta in order to assess the merits of such a program. Decisions about optimal vaccination 
programs involve tensions between efficiency and equity (Levy et al., 2007), especially in the 
developing world. Most vaccination policy analysis, however, mainly takes efficiency into 
account in order to find the lowest-cost program or the one providing maximum net benefits. 
Equality in the distribution of benefits is often overlooked (Yitzhaki, 2003) because of lack 
of data or interest. The absence of a systematic framework to consider both efficiency and 
equity results in a one-sided immunization policy that disregards or, at worst, enlarges the 
gap of inequality in children’s immunization rate. In order to address this limitation, I 
incorporate efficiency measures and equity indicators within one framework. I believe that 
using quantitative indicators of inequality based on parents’ level of education will help 
avoid immunization options that are dominated by efficiency at the expense of equity. The 
results of the analysis suggest that to strike a fair balance between efficiency and equity, 
policy makers would be best advised to adopt a school-based typhoid fever immunization 
program, partially funded by donors (and with plans for sustaining it in the future), in which 
the typhoid vaccine was simultaneously delivered with the TT booster vaccines. Even this 
solution, however, leaves unsolved the equity problem of immunizations for children not in 
school and the question of how such programs would be sustained after the end of the donor 
funding period (typically five years).  
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 Chapter I 
DOES A MOTHER’S WILLINGNESS TO PAY FOR CHILDREN’S HEALTH 
DIFFER FROM A FATHER’S? 
 
1. Introduction 
All illnesses have financial and time consequences. When a child is sick, the mother 
and the father may respond differently to the health shock. They may have different 
preferences toward risk and they may not fully pool their income. They may thus want to 
allocate different amounts of money and time for improving their children’s health. I take 
account of these differences by combining the health production model with the collective 
household model, one of the non-unitary household decision-making models. The unitary 
household model has been most commonly used to estimate parents’ willingness to pay for 
their children’s health, but it is limited in its ability to address the differences between the 
mother and the father because of its restrictive assumptions. First, it assumes the household is 
a single unit with homogenous preferences. Second, it assumes that all of the household 
members pool their resources and maximize a single utility subject to the household’s pooled 
budgetary constraint. In order to counter these restrictive assumptions, non-unitary models 
take each family member as the unit of analysis and treat household decisions as the 
outcomes of interactions among family members. They are flexible enough to account for 
potentially different resource allocations for children’s health between a mother and a father.  
Non-unitary models, however, are still theoretically and empirically under 
development, which makes it hard, for example, to include household production of a family 
public good1 within their frameworks.  First, there are increasing theoretical complexities in 
deriving both individual preferences and a bargaining-power mechanism with regard to the 
household production of public goods, here children’s health.  And second, there is a lack of 
such data as money and time costs associated with children’s illness, as well as sufficiently 
                                                 
1
 “Family public goods” are defined as goods consumed together by all family members and do not necessarily 
exclude such public goods as education, health, security, housing, and cultural services. 
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rich socioeconomic data essential to reveal a bargaining power mechanism for empirical 
analysis. 
More recently, however, non-unitary studies have made some promising theoretical 
progress in extending the framework to include family public goods, and this development 
may shed some light on the nexus between non-unitary household decision-making models 
and children’s health valuation studies. In particular, Blundell, Chiappori, and Meghir (2005) 
theoretically extend the collective household model to include family public goods-children’s 
wellbeing- and to identify from observed behavior how much the mother and the father is 
separately willing to pay for their children’s health. While I rely substantially on Blundell, 
Chiappori and Meghir (2005), I depart from them insofar as I apply their framework to the 
health production model and I separately derive a mother’s willingness to pay to save her 
child from one day of sickness from a father’s.  
The novelty of my approach, then, is in its departure from the unitary household 
framework on which health valuation studies have relied until now. The theoretical 
implications of intra-household resource allocations for maternal versus paternal willingness 
to pay have never been explored. This essay introduces three theoretical innovations. First, it 
expands the health production model within the collective household. Second, it includes a 
shadow value of health production time in health valuation under an assumption that the 
resources of the parent are constrained by both money and time. Third, it consistently 
incorporates two constraints, money and time, in the health-production model as well as in 
the intra-household bargaining model. As a result of these innovations, I am able to derive 
maternal willingness to pay for improving children’s health separately from paternal 
willingness to pay.  
In section 2 below I review the literature on household decision-making models, both 
unitary and non-unitary, as well as the empirical findings from children’s health valuation 
studies based on non-unitary models. In section 3, I explain the theoretical framework for 
separately deriving maternal and paternal willingness to pay for children’s health. 
 
2. Literature Review 
2.1. Unitary Model 
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Children’s health valuation studies have typically adopted a unitary approach. 
Assume there are two decision makers in a household.  A couple cares about their own 
consumption of private goods and their own health, as well as the wellbeing of their child. 
The health of their child is considered a “family public good,” which is valued by the mother 
and the father, denoted m and f, respectively. The individual utility of either the mother or 
father is represented by  
 
)),(,,( kkkiiii HXvHXUU =                                i= m or f         (1-1) 
 
where Xi denotes consumption of private goods consumed by i; Hi denotes healthy time of i; 
and  vk denotes a sub-utility of their child, composed of his/her own consumption and healthy 
time of child k. 
The household welfare is a function of the individual sub-utilities: 
 
))),(,,()),,(,,(( kkkmmmkkkfffhh HXvHXUHXvHXUUU =               (1-2) 
 
The unitary model assumes that family members have the same preferences. They 
pool their incomes and maximize the household welfare function ( hU ), subject to the 
household budget constraint. Under these assumptions the sub-utility function of i (Ui) is 
identical between the mother and the father. Thus in the unitary model either the household is 
treated as a single unit or there is one family member, a benevolent dictator, who makes all 
decisions regarding resource allocation. If the unitary model is correct, then children’s health 
outcomes depend not on parents’ individual share of resources, but simply on pooled 
household income (Xu, 2005).  
Before discussing the limits of the unitary model, I will summarize the findings from 
several unitary studies with regard to children’s health valuation. First, Salkever (1982) 
examines the impact of children’s health on household medical expenditures for the child, 
and in particular, the time mothers and fathers spend caring for the sick child. He finds that 
the production of child health is more time-intensive for mothers than for fathers and that 
children’s chronic health problems have a more pronounced negative effect on both the labor 
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supply and earnings of mothers than of fathers. Pitt and Rosenzweig (1990) examine gender 
differences in the intra-family allocation of caring time when an infant is sick in Indonesia 
and find significant inequalities in household care activities by sex. Consistently, Salkever 
(1990), Ettner (1995), Wolfe and Hill (1995), and Powers (2001) find that mothers with a 
disabled child in the household are less likely to enter the labor market.  
Second, Dickie and Salois (2003) compare mothers’ willingness to pay (WTP) for 
avoiding one symptom day for their nine-year-old child to fathers’ willingness to pay in 
U.S.A. Though the measures are not from the same couples, they find that married fathers’ 
willingness to pay for their child’s health is approximately 1.6 times greater than married 
mothers’ ( )(6.1)( mf HWTPHWTP ×= ). However, the marginal rate of substitution of a 
mother’s illness for her child’s illness is approximately 1.3 times larger than the MRS of a 
father’s illness for his child’s illness 







×= )(
)(3.1)(
)(
f
k
m
k
HWTP
HWTP
HWTP
HWTP
. In other words, though 
a mother’s WTP is lower than a father’s, probably because of her limited ability to pay, she is 
more willing to substitute her child’s illness with her own than a father is. 
Third, Dickie and Salois (2003) report an interesting link between behaviors and 
perceptions with regard to caring responsibility for sick children by gender in a household. 
They assume that the spouse with the lower wage will spend more time caring for the child 
because that would be financially more efficient. However, they find that wives assume the 
primary responsibility for staying with a sick child and taking the child to the doctor 
regardless of employment or wage. In marriages where both spouses are employed, the 
allocation of time caring for the child depends not on wages but on gender. This result 
suggests that gender disparities in time spent caring for sick children are determined not by 
concern for efficiency so much as by the contemporary social norm regarding gender roles.  
Despite the simple theoretical framework and some successful empirical applications 
of the unitary approach, the key assumptions of the model— income pooling and 
homogenous preferences—have proven to be mistaken when tested. The income-pooling 
assumption is consistently rejected in studies that can be categorized by types of resources in 
a household:  
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(1) Non-labor incomes: one group of studies has tested the hypothesis that non-labor incomes 
of husbands and wives are pooled and has rejected it. Thomas (1994) shows that children 
with more powerful mothers—that is, mothers who have more non-labor income—are more 
likely to have less morbidity in Brazil. Schultz (1990) finds that for wives in Thailand an 
increase in non-labor income reduces fertility. 
(2) Labor incomes: Qian (2005) in China finds that the more the mother’s income increases 
as a result of post-Mao reform, the higher children’s survival rates are. 
 (3) Premarital assets: another group of studies uses premarital assets to test the resource 
pooling assumption. Thomas et al. (2002) show that assets, brought to a marriage by the 
husband, have a different effect on children’s health from assets brought by the wife in 
Indonesia. Quisumbing and Maluccio (2003) also find that the impact of assets on the health 
outcome of children in Bangladesh, Indonesia, Ethiopia, and South Africa differs by gender. 
In summary, who controls resources in a family matters for children’s health  
Second, while the unitary model assumes that family members have homogenous 
preferences, many studies find that there are different preferences between spouses regarding 
health risks. Mothers tend to be more concerned about risk than fathers (Flynn, Slovic, and 
Mertz, 1994; Davidson and Freudenburg, 1996; Byrnes et al., 1999; Finucane et al., 2000). 
Since risk attitudes affect the form of an individual’s utility function, gender differences in 
risk attitudes could lead to different responses to questions about WTP to reduce risk to 
children’s health (Bostrom, et al., 2006).  
 
Willingness to pay using the revealed preference method 
Most of the revealed-preference studies estimating willingness to pay for an 
additional healthy day for a child (Dickie, 2005; Freeman, 2003) can be summarized as 
follows: (1) the health production function is a function of medical care use, but not the 
caring time spent by parents ( ),( •= kk MfH ); (2) caring time is determined by the time a 
child is sick ( )( kH HfT = ); and (3) at the optimal provision, the household WTP for an 
additional healthy day for the child is equal to the marginal cost of producing health, 
weighted by household technology in producing health. Only the marginal cost of medical 
care use is considered.  
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The WTP estimates derived according to the unitary household model assumption 
have four potential limits: (1) they may not be accurate measures since unitary household 
assumptions have been rejected by many non-unitary studies; (2) model specifications under 
the unitary household model are different from those under non-unitary models and 
potentially wrong if non-unitary models are assumed to be correct; (3) they neglect the active 
bargaining mechanism in a household; and (4) time input in producing children’s health is 
totally disregarded. Among children’s health production studies, only two (Pitt and 
Rosenzweig, 1990; and Salkever, 1982) consider that time is a scarce and valuable resource 
and include caring time in the health production function as one of the inputs. However, 
neither study goes further and estimates willingness to pay.  
Recently, there have been improvements in children’s health production studies in 
that researchers have begun to include shadow values of time in WTP estimates, relying on 
theoretical progress in home production and shadow wage estimation by Mincer (1962), 
Becker (1965), DeSerpa (1971), Gronau (1973a, b, 1980), Jacoby (1993). Propper (1990) 
used stated preference techniques to estimate the value of reducing patients’ waiting times in 
a health care facility. Dalenberg, Fitzgerald, Schuck, and Wicks (2004) have used the same 
approach to obtain WTP estimates for leisure time. Eom and Larson (2006) assess the value 
of home production time based on willingness to spend time and money in order to obtain 
environmental improvements. They develop a new approach to show that WTP can be 
defined with respect to either time or money when the choices people make are constrained 
by time as well as money. They prove their joint estimation is consistent with the utility 
structure. 
 
2.2. Non-unitary models 
Non-unitary household models commonly argue that it is not realistic to aggregate 
individual preferences into one household unit on the assumption that they are homogenous 
or altruistic (Chiappori, 1997). Non-unitary frameworks relax the restrictions that the 
traditional unitary model imposes and consider an individual as a unit of study. Non-unitary 
studies have taken three different directions based on different assumptions of efficient 
outcomes and bargaining processes (Xu, 2005): (1) the collective household model; (2) the 
Nash bargaining model; and recently (3) the non-cooperative bargaining model.  
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A key distinction among these household models lies in how a couple makes 
resource-allocation decisions. The unitary household model assumes one spouse to have 
dictatorial power over the allocations, whereas the two bargaining models (i.e., the Nash 
cooperative and the non-cooperative models) assume that decisions are made through the 
bargaining process. The collective model assumes that a couple builds fair decision rules for 
each other and that the final decisions of consumption on goods and times are Pareto 
efficient. By contrast, the two bargaining models do not assume efficient outcomes within a 
household. However, in the Nash model a couple finally achieves efficient outcomes through 
the bargaining process, whereas the non-cooperative model does not necessarily lead to 
efficient outcomes (Xu, 2005).  The assumption of Pareto efficiency can easily be tested 
empirically for the collective model, but not for the two bargaining models. 
 
 
Table 1.1 Characteristics of non-unitary models2 
Model Bargaining Efficient Outcomes 
Testable 
hypotheses 
Collective Model No Assumed Yes 
Nash Bargaining Model Yes Yes No 
Non-cooperative bargaining 
model Yes Not necessarily No 
 
 
2.2.1. The collective model 
Chiappori (1988, 1992) takes the lead in developing an intra-household decision-
making model in which family members reach Pareto efficient allocations. A household 
maximizes the weighted individual utility below: 
 
)),(,,()1()),(,,( kkkfffkkkmmmh HXvHXUHXvHXUU ππ −+=  ,                (1-3) 
 
where π  is the power coefficient or Pareto weight. Chiappori’s equation explains how a 
household allocates the resources within a couple. Greater π  means more weight on the 
mother’s utility than the father’s utility. Suppose accepted rules of fairness result in weights 
                                                 
2
 Modified from Xu (2005). 
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based on relative wages (wm, wf), non-labor income, and distribution factors. There is no 
reason to think π =1/2 is more “fair” (Bergström, 2003). The person who earns more may 
have more decision-making power in a household. Or if females are scarcer in a remarriage 
market, a wife’s bargaining position within a household could increase.  
The core problem of the collective model is how to reveal both individual preferences 
and the Pareto weight from observing labor supplies and the household expenditures. In this 
model, the household decision regarding resource allocation is made by a two-stage 
procedure. In the first stage, all family members pool their income and allocate total 
household income to savings, expenditures on family public goods, and expenditures on 
private goods for each family member according to the sharing rule (Chaippori, Fortin, and 
Lacroix, 2002). The income-sharing rule is equivalent to the weights. The more powerful an 
individual, the bigger the person’s share of the pie in the first stage (Thomas et al., 2002). In 
the second stage family members maximize their own utility given their income share.  
To estimate the mother’s WTP for children’s health separately from the father’s, the 
collective model needs to include home production since parents produce children’s health 
together at home and children’s health is a family public good. Earlier studies incorporating 
the collective model with home production (Apps and Rees, 1996, 1997; Chiappori, 1997) 
investigate whether the presence of home production changes the results obtained in the 
collective household model and whether it is possible to derive a sharing rule when the 
collective model includes home production. They conclude that the sharing-rule parameters 
can be recovered with certain restrictions. Apps and Rees (1997)’s restrictions are (1) 
household production is linear and homogenous and (2) demands for leisure are independent 
of the price of the domestic good. Chiappori (1997)’s restriction is (1) a good produced in a 
household is assumed to be tradable in the market and (2) the production function exhibits 
constant returns to scale.  
Although children’s health-valuation studies have been interested in intra-family 
resource allocation, the difficulties in identifying the model and in recovering the sharing rule 
have hindered the integration of the collective approach with health-valuation studies. 
However, recent theoretical (Blundell, Chiappori, and Meghir, 2005) and empirical progress 
(Fortin and Lacroix, 1997; Aronsson, Daunfeldt and Wikstrom, 2001; Chiappori, Fortin and 
Lacroix, 2002) has been made within the collective framework. In particular, Blundell, 
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Chiappori, and Meghir (2005) extend the collective model to include a family public good, 
which is necessary for separately estimating a mother’s and a father’s valuation of children’s 
health in a household.  First, they introduce the collective indirect utility function and derive 
marginal WTP of the mother and the father, separately, for children’s good by using 
Samuelson’s Pareto optimality condition. They show that if individual consumption of time 
and money are separable from expenditure on children, then individual preferences on family 
public goods, as well as Pareto weights, are identifiable. However, while they say it is 
possible to expand their model to measure time consumption for children, they focus only on 
the expenditure on children’s good. Their study also is purely theoretical.  
 
2.2.2. The Nash cooperative and the non-cooperative bargaining models 
Manser and Brown (1980) and McElroy and Horney (1981) establish the Nash 
bargaining approach. The Nash model bargaining in a marriage is similar to that between a 
firm and a union in a labor market. People choose to get married (employed) and stay in a 
marriage (a job) as long as their utility in a marriage (their wage rate in a job) is greater than 
the utility of staying single (the possible wage in another job), which is called the fall-back 
utility (Ti); otherwise they dissolve their marriage (Xu, 2005). In the bargaining process, just 
as the possibility of an alternative job plays the role of the threat point to the firm when a 
firm and a worker do not agree on wage rates, so the high fall-back utility of one partner 
being single is the “threat point” to the other partner. A household chooses allocations of 
resources to maximize the Nash maximand (N) 
 
)]);,())(,,()][;,())(,,([ ffffkfffmmmmkmmm ywTvHXUywTvHXUN αα −•−•= ,  (1-4) 
 
where Ti  is the threat points of i. Ti is a function of wage rates (wi) and non-labor income 
(yi), as well as the extra-household environmental parameters ( iα , EEPs), for example, the 
male/female ratio in a remarriage market.  
However, bargaining within a marriage also is different from bargaining in a labor 
market. Unlike a firm and a union in a labor market, a couple in a marriage bargains every 
day, and during their day-to-day marital bargaining they do not usually consider a divorce. 
 10 
The divorce threat point of the Nash cooperative model therefore may be unrealistic in a 
marital bargaining situation.  
At this point the non-cooperative bargaining model (Rubinstein, 1982; Ulph, 1988; 
Woolley, 1988; Lundberg and Pollak, 1993; Konrad and Lommerud, 1995, 2000; and Chen 
and Woolley, 2001) departs from the Nash cooperative model. There are broadly two 
structures of non-cooperative household models according to an assumption of threat points: 
an empty (Equation (1-5) below) and a non-empty bargaining set (Equation (1-6) below).  
Rubinstein (1982) specifies the generalized Nash product without a threat point in a 
repeated game of two agents across time periods, i.e., the empty bargaining set, below: 
 
ββ −••= 1))(,,())(,,( kfffkmmm vHXUvHXUN ,                            (1-5) 
 
where β  is the weight for each agent. In a repeated game, α  is determined by each agent’s 
time preference, a function of property rights, institutional practices (e.g. child-support 
awards or enforcement), or cultural norms that affect individual bargaining power (Xu, 
2005).  
On the other hand, Binmore, Rubinstein and Wolinsky (1986), Lundberg and Pollak 
(1993), and Chen and Woolley (2001) propose a non-cooperative model with a threat point 
(Tm, Tf), i.e., non-empty bargaining set. The definitions of their threat points are various, but 
they have a common characteristic in the sense that fall-back utilities are interpreted as 
“utilities during conflict” rather than utilities of divorce (Xu, 2005), as shown below:   
 
)];,())(,,()][;,())(,,([ ffffkfffmmmmkmmm ywTvHXUywTvHXUN ββ −•−•=     (1-6) 
 
where  iβ  is the extra-household environmental parameters.   
In determining how families allocate resources when children are sick, the 
assumption of threat points in the non-cooperative bargaining model is more appropriate than 
in the Nash model, since there is little evidence of divorce occurring because of children’s 
illness.  
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Although non-unitary models are still under theoretic development, several empirical 
analyses of these models provide several insights for children’s health valuation. First, the 
mother’s WTP for improving children’s health may not be the same as the father’s for two 
possible reasons: (1) mothers’ marginal rate of substitution between her child’s health and 
her own health is larger than fathers’ (Dickie and Salois, 2003); and (2) WTP for a child per 
the share of non-labor income ( iiWTP Φ/ ) differs between the mother and the father 
(Blundell, Chiappori and Meghir, 2005). 
Second, it is feasible to extend the non-unitary model to include household 
production, but extensive data covering both household expenditures and individual time use 
is required. Blundell, Chiappori, and Meghir (2005) impose restrictions for identifying the 
collective model with a family public good, specifying that data on individual labor supply, 
aggregate household consumption, expenditure on the family public good, and relative 
wages, as well as time use data of inputs for household production are required. Most studies 
within the collective framework, however, rely either on data on expenditure or on time-use 
data but not on both. Those that focus on the intra-family allocation of expenditures rather 
than time use ususally show the impact of different levels of power by gender on such  
outcomes as children’s health (Thomas, 1994; Thomas et al., 2002), children’s nutrition 
intake (Breunig and Dasgupta, 2000; Duflo, 2000; Jacoby, 2002), or children’s education 
(Quisumbing and Maluccio, 2003; Xu, 2005; Park, 2006). Other studies focus on the intra-
family allocation of time, such as time spent with child (Bourguignon, 1999; Chiuri, 1999) 
and individual labor-supply decisions (Chiappori, 1988, 1997; Bourguignon and Chiappori, 
1992; Aronsson, Daunfeldt, and Wikstrom, 2001; Chiappori, Fortin, and Lacroix, 2002; 
Blundell, Chiappori, Magnac, and Meghir, 2005). Only one published study (Browning and 
Görtz, 2006) covers both time use and expenditures within a household using the collective 
household model.  
Third, gender inequalities in terms of who spends time caring for sick children may 
result not from a concern for efficiency in household decisions of resource allocation, but 
from social norms. Becker (1981) interprets the customary gender-based division of labor as 
an efficient response to differences in father and mother endowments. Within the unitary 
approach, any unequal allocation of resources can be justified on efficiency grounds (Xu, 
2005). Norms, however, are almost always more efficient for some groups than for others 
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(Ullmann, 1977). Several recent studies within non-unitary frameworks shift focus from 
efficiency to gender ideology (Brines, 1994; Pitt and Khandker, 1994; Kabeer, 1995; 
Greenstein, 2000; Iyigun, 2002; Bittman et al., 2003; Lundberg and Pollak, 2003; Lundberg 
2005) or to developing a dynamic model to explain an endogenous relation between 
household decision and power which  is identified by “gender-specific environmental 
parameters” (GEPs, introduced by Folbre, 1997: Iyigun, 2002, 2005; Peters and Siow, 2002; 
Basu, 2004).  
 
2.2.3. Bargaining Power 
Proxies for bargaining power have included (1) labor income (Apps and Rees, 1996, 
1997; Chiappori, 1997; Chiappori, Fortin and Lacroix, 2002); (2) non-labor  income (Schultz, 
1990; Thomas, 1990); (3) assets at marriage (Quisumbing, 1994; Guyer, 1997; Thomas, 
Contreras, and Frankenberg, 1997; Frankenberg and Thomas, 1998; Quisumbing and 
Maluccio, 2000); (4) remarriage market parameters, such as sex ratio or divorce law (Adam, 
Hoddinott, and Ligon, 2003; Carlin, 1991; Chiappori, Fortin, and Lacroix, 2002; Folbre, 
1997); or (5) welfare benefits (Duflo, 2000; Lundberg, Pollak, and Wales, 1997; Lundberg, 
2002; Rubalcava and Thomas, 2000; Ward-Batts, 2003; Zimmermann, 2006).  
 
Economic power             
As Lundberg, Pollack, and Wales (1997) have shown, non-unitary models assume 
that the determinants of the power function are exogenous. However, the most common 
proxy, labor income, is clearly problematic because it is confounded with time allocation and 
labor-force participation decisions. Non-labor income may not be independent of time 
preferences and labor market conditions if much of it comes from unemployment benefits or 
savings over the life cycle. Current assets may also depend on preferences within a marriage, 
i.e., asset accumulation decisions. Also, since assets acquired within a marriage may be joint 
properties, they cannot be clearly assigned to either the husband or the wife. Property rights 
to assets brought to a marriage are also ambiguous. They may be endogenous to the marriage 
market (Foster, 1996), but they may be exogenous to decisions made within the marriage.3 
                                                 
3
 See Lundberg, Pollack, and Wales (1997) for further details on the endogenous nature of the various economic 
proxies. 
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Extra-household environmental parameters                          
Characteristics of the environment or the institution are also proxies for bargaining 
power. For example, Chiappori, Fortin, and Lacroix (2002) include divorce law in bargaining 
power parameters: mutual consent vs. unilateral divorce law, property division, enforcement 
of support orders, and whether to treat professional degrees or licenses as divisible property 
at divorce. Lundberg, Pollak, and Wales (1997) look at the effects of child welfare policy on 
bargaining power. They find that after the British government transferred the child benefit 
from fathers to mothers in two-parent families in the late 1970s, household expenditures on 
children’s clothing increased. Similarly, after rigorously controlling for changes in relative 
prices of the goods examined, Ward-Batts (2003) finds that expenditures on children (i.e., for 
toys and pocket money) increased, while expenditures on men’s tobacco declined, after the 
child benefit policy change in the U.K. took effect.  
 
2.3. Empirical applications of the non-unitary model to children’s health valuation 
The few health valuation studies that adopt a non-unitary framework can be divided 
into three categories: (1) models that apply the bargaining framework to the health 
production model; (2) models that extend the collective household model to include the 
health production function; and (3) empirical studies that compare individual WTP with 
household WTP.  
 
The Nash cooperative or the non-cooperative bargaining model with health production  
By combining the Nash cooperative model with the health production framework, 
Bolin, Jacobson, and Lindgren (2001) develop a basic dynamic model of the demand for 
“lifetime health” in which the spouses bargain for the allocation of the family’s total 
resources. They show theoretically how Nash threat points shift Pareto optimality and WTP. 
By contrast, Strand (2003, 2004) uses the non-cooperative model with the empty bargaining 
set to compare household members’ WTP for a (pure) public good on behalf of the 
household with WTP for the same good on behalf of oneself. Strand (2003) argues that WTP 
on behalf of the household is on average a correct representation of the sum of individual 
willingness to pay estimates (i.e., WTPf  + WTPm) if one member does not have a higher or 
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lower marginal public-good value than another member. In another paper, Strand (2004) 
specifically focuses on both the individual and the household value of mortality reduction. 
However, his analysis requires the restrictive assumption that marginal utilities obtained in 
consuming family public good are equal across family members. Based on that assumption, 
Strand calculates the marginal rates of substitution between the family public good and 
private goods (equations (6) and (7) in Strand, 2003) and finds that this ratio is the same as 
the ratio between household WTP and individual WTP (equation (10) in Strand, 2003). By 
contrast, several other non-unitary household studies adopt Samuelson (1954)’s condition in 
order to derive individual WTP for family public good within a couple (Bergstrom, 1996, 
2002; Chiuri and Simmons, 1997; and Donni, 2004). Samuelson’s condition avoids the 
condition imposed by Strand, which is more restrictive.  
Mount et al. (2001) also develop a model of the value of reduced fatality risk for 
adults and children in a family using a Nash cooperative bargaining model. They show that 
the value of a statistical life (VSL) in a Nash model is the same as the VSL in a unitary 
model. As Dickie and Salois (2003) point out, however, their result hinges on the assumption 
that the threat points are independent of risk and exogenous factors in the model. Recently, 
Zimmerman (2006) finds that marriage market factors, especially state divorce laws, 
significantly contribute to the decision for a child’s mental health treatment, as well as the 
degree of conflict within the marriage. With regard to mental health care, children do best 
when mothers have relatively more decision-making power, a finding that is consistent with 
the existing literature based on non-unitary models.  
 
The collective model with health production 
Smith and van Houtven (1998) further extend the collective model to consider 
measurement of Hicksian consumer surplus. They show how two measures of compensating 
variation can be derived from the model, depending on whether the spouses’ shares of 
income are held constant. Blundell, Chiappori, and Meghir (2005) introduce a family public 
good (i.e., children) within the collective model and identify how much each parent is willing 
to pay for their children. They argue that it is not clear that the mother’s WTP for children is 
greater than the father’s, but they find that if her WTP is more sensitive to child goods then 
the demand for expenditure on children in the household increases when her power increases. 
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Using survey data on family health and nutrition in Brazil, Thomas (1994) empirically tests 
that households pool their income and maximize household welfare. He finds that who 
controls the resources within a household matters. The effect of non-labor income in the 
hands of a mother on child survival probabilities is almost twenty times greater than the 
effect of non-labor income under the control of a father. Thomas et al. (2002) examine 
whether in Indonesia parents’ assets brought to the marriage have a different effect on a 
child’s health depending on the gender of the child. They find different preferences between 
mothers and fathers in Java and Sumartra: mothers who are more powerful allocate resources 
disproportionately towards their sons and so sons have fewer episodes of cough and fever 
than daughters.  
In sum, Smith and van Houtven (1998), Thomas (1994), and Thomas et al. (2002) do 
not specifically consider the mother’s WTP for children’s health or safety separately from the 
father’s. Blundell, Chiappori, and Meghir (2005) identify maternal versus paternal WTP, but 
they focus primarily on expenditures on children, not the mother’s and the father’s time 
inputs for children. However, they open up the possibility of extending their theoretical 
model to include time inputs in household production as well as monetary inputs. 
 
The contingent-valuation method  
Direct, stated-preference methods can avoid many of the empirical problems of 
revealed-preference methods in separately eliciting a mother’s WTP for children from a 
fathers (Bateman and Munro, 2006; Bostrom et al., 2006; and Cockerill et al., 2006), 
although stated-preference methods are subject to hypothetical bias. Several contingent-
valuation studies have elicited separate mothers’ and fathers’ WTP for child safety in the 
same household. However, empirical results often are contradictory. Several studies find no 
significant difference between the mother and the father in the same household in WTP for 
reduced child injuries (Cockerill, Chilton, and Hutchinson, 2006) or for improved 
environment in a local harbor (Dupont, 2001). On the other hand, Bateman and Munro 
(2006) argue that the identity of the respondent does matter for calculating WTP and cast 
doubt on the assumption that household WTP is the same for all family members. Lampietti 
et al (1999) test the income-pooling hypothesis of the unitary model in Ethiopia and argue 
that the nature of the good matters in intra-household resource allocation. They cannot reject 
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the hypothesis that husbands and wives pool resources to purchase bed nets (a non-exclusive 
good), but reject the income pooling hypothesis for the hypothetical malaria vaccine (an 
exclusive private good). It is thus unclear at present whether respondents are providing their 
own preferences or their appraisal of the outcome of the household decision process 
(Bostrom et al., 2006), or whether maternal WTP is different from paternal WTP. 
 
The travel-cost method  
While not related to health-valuation studies, Dosman and Adamowicz (2006)’s study 
applying the travel-cost method within non-unitary frameworks provides some insight on 
time value. Dosman and Adamowicz (2006) combine stated and revealed preference data to 
examine the impact of family members’ relative power on household vacation decisions and 
find that relative income is a significant determinant and the unitary model is not valid. In 
addition, they find the value of time is important in decision-making, as well as ideological 
beliefs and education. Interestingly, the partner with the lower value of time has more 
influence in the vacation decision because she invests more time in gathering information 
regarding vacation, which runs counter to the common assumption that the individual with 
the higher value of time would have more power in family decision-making.  
 
3. The cooperative health production model  
The purpose of this study is to explain how the mother and the father separately 
allocate resources for their sick child within the collective household model. To do so, I 
extend the existing literature on household decision making by integrating Chiappori 
(1988)’s household decision-making model and Grossman (1972)’s health-production model.  
To my knowledge, this is the first attempt to apply the non-unitary, collective model of 
household decision making to intra-household health production.  My analysis includes 
refinements to the Grossman health-production model, but not the household decision model. 
Unless otherwise specified, the model specifications described below are mine.  
For my model, which I call the cooperative health-production model, I take one 
episode of illness as the unit for study. As a result of this assumption, the resource allocations 
within a family influence the number of sick days, not the stock of health (Dickie, 2005). I 
assume there are two decision-makers in a conventional household. The mother and the 
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father each care about her/his own consumption of private goods iX  and her/his own health 
iH . For the sake of simplicity I assume the mother and the father are egoistic or self-
interested in their relationship. Both the mother and the father also care about the wellbeing 
of their child kv . The health of their child kH  is considered a “family public good” that is 
valued by the mother and the father. However, the utility the child derives from kH  enters 
the parent’s utility function, not kH   itself. Thus, they are purely altruistic for their child. To 
simplify the analysis, I have assumed that the parents are egoistic in regard to both the utility 
and consumption of each other.4  
To simplify the analysis further, I also assume that the mother and the father have a 
single child. The single-child model avoids the complication of modeling competition for 
resources among multiple children. Mothers and fathers have their own utility based on their 
preference, as follows: 
 
)),(,,( kkkiiii HXvHXUU =                              i= m or f         (1-7) 
 
Since they are married, they also have a household welfare function. A household 
welfare function hU  is assumed to be a linear increasing function of individual utilities: 
 
( )( ) ( )( )fkkkffffmkkkmmmmh ;H,Xv,H,XU;H,Xv,H,XUUMax τπτπ +=       (1-8) 
 
where iτ  is a vector of preference factors, such as age and education of either the mother or 
the father and iπ
5
 is Pareto weight of i. In Chiappori (1988) π  is a relative measure of 
decision-making power between a mother and a father and the sum of Pareto weights is 
necessarily unity. iπ departs from Chiappori (1988) in that it avoids having to assume 
cardinal utility.  
                                                 
4
 Chiappori (1988) demonstrates that disregarding caring preferences or altruism within the couple has no effect 
on the conclusions of the egoistic model. 
 
5
 I am grateful to Reed Johnson for the idea of using iπ , insead of π  for a mother and π−1  for a father. 
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The weight indicates how utility is aggregated in the household welfare function. iπ  
is influenced by wages and non-labor income, as well as by extra-household environmental 
parameters (EEPs), which Chiappori, Fortin and Lacroix (2002) call distributional factors. 
Empirically, EEPs have included divorce laws, sex ratios in remarriage markets, assets 
brought to the marriage, and welfare-program features.   
The household budget constraint is: 
 
kM
j
j
i
i
H
ii
i
i MpXwTyTwI ++≥+= ∑∑∑ ,       i = m and f and j = m, f, and k,     (1-9) 
 
where full income (I) is composed of total time (T) evaluated at wage rates (wi) and any non-
labor income (y). Full income is spent on consumption of private goods (X) at the price of 
unity, as well as on medical care for the child (Mk) at a price Mp . HiT  is time spent caring 
for a sick child by either the mother or the father. 
I assume that jX , kM , and private time consumption ( HiT , WiT , and LiT ) are 
directly observable. The total time of either the mother or the father is divided between 
healthy time (H) and time spent sick (S). Healthy time is allocated among three activities, 
paid work ( WT ), time spent caring for a sick family member ( HT ), and leisure ( LT ). The 
time constraint for either the mother or the father is written as follows: 
  
i
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i
W
i
H
iiii STTTSHT +++=+=                                 i = m or f.        (1-10) 
 
Combining these elements, the household maximization problem can be written as 
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   (1-11) 
 
where hλ  denotes the marginal utility of household full income.  
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3.1. Two-stage procedures 
The collective household model assumes that the mother and the father employ a two-
stage procedure to maximize their utility. In the first stage, the mother and the father agree on 
the allocation of total household income to savings, expenditures on family public goods 
such as any expenditure for the child, and private expenditures for either the mother or the 
father. The more powerful an individual, the bigger the person’s share of the pie in the first 
stage (Thomas et al., 2002). In the second stage, the mother and the father each maximizes 
her/his own utility given her/his income share. 
In the first stage the expenditure for family public goods is paid from non-labor 
income. Either partner can contribute lump-sum transfers out of their own labor income for 
family public-good expenditures. To avoid distorting incentives, these contributions cannot 
be linked to the labor-leisure choice of the other partner, and thus are treated as non-labor 
income. 6 Rearranging Equation (1-9), we get: 
 
( ) kkM
i
iiii
H
i XMpywTXwT −−=−+∑                                   (1-12) 
 
The right side of Equation (1-12), residual non-labor income after paying for the 
expenditures of family public goods, is used for private expenditures of the parent. This 
income, if any remains, is divided between the mother and the father. The mother and the 
father develop a consensus about how to cooperate with each other. Chiappori calls it the 
sharing rule. The income share of the mother or the father, iΦ , is decided as a function of 
wages, non-labor income, and extra-household environmental parameters (EEPs), which is 
written below:  
 
( )imfii ;P,y,w,w τΦ=Φ ,                                                          (1-13) 
 
where P denotes extra-household environmental parameters.  
                                                 
6
 It is from a personal communication with Chiappori. 
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To account for lump-sum transfers out of wage income, the sharing rule iΦ  need not 
be bounded between 0 and y. If non-labor income is less than the expenditure for the child’s 
health, either the mother or the father would decrease her/his private consumption to pay for 
the health care treatment for their child. Thus, iΦ , can be negative or larger than total non 
labor income.7 This negative iΦ  reflects the private resources for family public goods—that 
is, how much she/he is willing to give up her private consumption for the child’s health.  
In my cooperative health-production model, then, the child’s health is produced by a 
health production function as follows: 
 
( )kHmHfkikk TTMHH µ,,,,Φ= ,                                            (1-14) 
 
where kµ  is the child's long-term health status, including such exogenous factors as the 
presence of pre-existing chronic diseases (Dickie, 2005).  
My model departs from the unitary household framework by including iΦ  in the 
conventional health production model. The unitary household model is limited in its ability to 
include the potential impact of a married couple’s power distribution on children’s health. 
When the child is sick, the mother and the father adjust to the health shock by allocating 
money and time to the sick child. The mother, for example, may be more concerned than the 
father about the health of their child, in which case she would be willing to allocate more 
resources than he would. The mother’s resource-allocation decisions are made based on the 
resources she has at her discretion, mΦ . Equation (1-14) helps account for the empirical 
evidence that children with more powerful mothers are likely to have less mortality or 
morbidity (Quian, 2005; Quisumbing and Maluccio, 2003; Schultz, 1990; Thomas, 1994; 
Thomas et al., 2002).   
There are two different kinds of inputs committed to the child’s health: medical care 
expenditures and caring time. Expenditures on medical care for the sick child are paid from 
                                                 
7
 For a transfer only non-labor income is used because a transfer related to labor income would distorts the 
time-consumption decisions (at Equation (1-49), (1-50) and (1-52), shown later) and violates the efficiency 
properties of the model. Assume a mother receives 30% of a father’s labor income and then his labor supply 
decision would be made at an inefficient point because it is like taxation on his labor supply. This insight is 
provided by Chiappori.  
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income that is treated as a public-input resource, while caring time is an exclusive private 
input.  I propose that the decision on medical care is made in the first stage of the collective 
household model’s process for maximizing the household utility and the one on caring time 
in the second stage.  
The level of the child’s medical-care expenditures kM  thus is decided in the first 
stage where: 
 
( )kimfkk ,,w,wMM µΦ= .                                                         (1-15) 
 
In the second stage, the mother or the father maximizes her/his own utility, given the 
individual income share, iΦ : 
 
( )( )[ ]iHikkkkiii
T,X
;T,MH,Xv,H,XUMax
H
ii
τ                                     (1-16)  
 
                                        subject to ( )LiHiiiii TTHwX −−−=Φ .         
 
In the second stage while the mother and the father individually maximize her/his 
own utility, their individual decisions on consumption or time are Pareto efficient because 
spouses know each other’s preferences well and interact very often (Chiappori, Fortin and 
Lacroix, 2002). Indeed, the collective household model requires only this one assumption 
and it can be tested empirically, as will be discussed in the section on empirical strategy.  
In other words, the collective household model does not recognize free-riding 
behaviors where the mother or the father has an incentive not to contribute toward their 
child’s health because she/he benefits from the spouse’s contributions without spending any 
money or time. The non-cooperative model (Rubinstein, 1982; Ulph, 1988; Woolley, 1988; 
Lundberg and Pollak, 1993; Konrad and Lommerud, 1995, 2000; and Chen and Woolley, 
2001), by contrast, has room to take into account such free-riding behaviors within a 
household. It is beyond the scope of this study to examine such limitations of the collective 
household model.  
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As a result of Equation (1-16), the derived supply function for caring time spent by 
the mother or the father i for their child is defined as follows: 
 
( )iMimfHiHi ;p,,w,wTT τΦ= .                                                  (1-17) 
 
One of the innovations in my model is that the supply of parents’ time depends on the 
parent’s share of income. Without taking into account the division of decision-making power 
between the mother and the father, the caring-time function within the collective household 
model is identical with the unitary model. For example, Pitt and Rosenzweig (1990), who 
conducted the only study of caring time for children’s health, set up linear equations for 
caring time. In their unitary model, the individual decision regarding caring time depends on 
the decision-maker’s own wage, her/his spouse’s wage, and the price of medical care, which 
is below: 
  
( )iMmfHiHi ;p,w,wTT τ= .                                                       (1-18) 
 
Pitt and Rosenzweig’s study therefore does not account for the effect of the decision-making 
power on her/his caring time decisions.  
 
3.2. Willingness to pay for child health 
Because previous studies of willingness to pay (WTP) for the child’s health have 
concentrated primarily on money, they have essentially been limited to Chiappori’s first 
stage, in which a married couple decides how to allocate total household resources. Time, 
like money, is a scarce resource, however, and parents cannot produce their child’s health 
with money alone. The two-stage model explains how the mother and the father each 
determine her/his WTP in terms of both money and time. I thus take the two-stage logic one 
step further and use it to estimate willingness to pay: willingness to spend money in the first 
stage and willingness to spend time in the second stage.  
To derive the household WTP ( $hWTP ), I apply the logic of Freeman (2003) and 
Dickie (2003, 2005) to Equation (1-11). The household WTP for one extra healthy day for 
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the child is given by totally differentiating the indirect household utility function hV  in terms 
of full household income as follows: 
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For calculating the numerator of Equation (1-19), take partial derivatives of the 
household maximization equation (Equation (1-11)) in terms of the medical care and healthy 
time of the child: 
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A simple adjustment of Equation (1-20) gives 
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Substituting the left side of Equation (1-21) into the left side of Equation (1-22) gives 
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Finally, incorporating Equation (1-23) into Equation (1-19) gives a household WTP of 
medical care inputs for a marginal reduction in child sick time 
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Equation (1-24) indicates that a household would be willing to pay for the child’s 
medical care up to the point where the household benefit of an additional healthy child day is 
equal to the marginal cost (MC) weighted by a household marginal product of medical care 
input (MP). The productivity of household technologies measured by MP — the marginal 
output for given inputs — are important in the household WTP for medical care use. Low 
marginal household product in producing child’s health (e.g., if the child has a chronic 
disease as opposed to a cold), results in households being willing to pay more for their 
child’s health.  
Equations (1-19) to (1-25) for household WTP in the cooperative health production 
model look similar to the unitary model. I am interested, however, in separating a mother’s 
WTP from a father’s WTP. If the two WTPs are derived separately, Equation (1-24) in the 
collective household model should be different from the one in the unitary model. To 
separately derive a mother’s WTP from a father’s, Samuelson (1954)’s condition for the 
Pareto optimal allocation of public-good expenditures is a good starting point.8 Samuelson 
derives the optimal level of public-good provision by summing across beneficiaries’ 
willingness to pay. Several non-unitary household studies adopt Samuelson’s logic to obtain 
optimal expenditure shares for a family public good between a couple (Bergstrom, 1996, 
2002; Chiuri and Simmons, 1997; and Donni, 2004). I follow their strategy here since the 
child’s health is a family public good and I want to know how much each beneficiary (the 
mother and the father) would be willing to pay for their child’s health.  
Assuming an interior solution, a Pareto optimum can be obtained by taking the partial 
derivatives of Equation (1-11).  
                                                 
8
  For the basic concept of the Pareto efficient allocation of public goods, see Starrett (1988).  
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Rearranging Equations (1-26) to (1-28) gives the following: 
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Incorporating Equations (1-29) and (1-30) into Equation (1-31) gives 
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Equation (1-32) is the standard result that expenditures on health care should be 
undertaken to the point where the marginal cost equals the sum of the marginal rates of 
substitution between medical care and private consumption. Specifically, the first term of the 
left side in Equation (1-32) represents how much private consumption the mother would be 
willing to give up in order to add one extra healthy day for her sick child. This is the 
mother’s benefit from a household’s supply of the medical care to her child. The second term 
is the father’s benefit. The right side of Equation (1-32) shows the marginal cost of medical 
care, the numerator of the household WTP (Equation (1-24)). Combining all together, the 
sum of the benefits the mother and the father each would obtain per her/his giving up private 
consumption for one extra healthy day of their sick child is equal to the marginal cost of 
medical care input that the mother and the father would spend together. At this point the 
mother cannot be made better off without making the father worse off.  
Incorporating Equation (1-32) into Equation (1-24) gives maternal ( $mWTP ) and 
paternal WTP ( $fWTP ) of the medical care input for their sick child, 
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The total household willingness to spend money for medical care for their sick child 
is the sum of the mother’s WTP and the father’s WTP. The mother’s WTP for medical care 
use, i.e., the first term of Equation (1-33), is the amount of private consumption the mother 
would be willing to give up in order to prevent one day of symptoms weighted by marginal 
household product in producing health. The father’s WTP is derived similarly. This appears 
to be a new result not previously reported. Here the marginal household product of medical-
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care input is not divided between the mother and the father. That is beyond the scope of this 
study.9 
Based on the direct utility function, however, Equation (1-33) does not clearly show 
the role of decision-making power in the collective household model. Thus, I introduce an 
indirect utility function in order to show the significant impact that the decision-making 
power has in deciding the mother’s or the father’s willingness to pay. An indirect utility 
function of i (Vi) can be deduced from Ui as follows: 
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After rearrangement, the left side of Equation (1-32) can be rewritten as follows: 
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From Equation (1-34) the partial derivative of the indirect utility function in terms of 
non-labor income can be written as follows: 
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Incorporating Equation (1-36) into Equation (1-35) gives  
  
                                                 
9
 Using a household marginal product, instead of individual marginal product, may result in overestimation of a 
mother’s WTP and underestimation of a father’s WTP. Assume a mother is more productive in medical-care 
input decision-making when a child is sick, i.e., the maternal marginal product is higher than the paternal 
product. Then, a mother’s WTP using her marginal product, which is higher than the household marginal 
product, could be lower than a mother’s WTP using a household marginal product. The opposite could be true 
for a father’s WTP.  
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Finally, Equation (1-33) is rewritten using the indirect utility function as follows: 
 
$
f
$
m WTPWTP +














∂
∂
Φ∂
∂
∂
∂
+
∂
∂
Φ∂
∂
∂
∂
−=
k
k
f
f
M
f
k
k
m
m
M
m
M
H
V
p
V
M
H
V
p
V
                                      (1-38) 
 












∂
∂
∂
∂
∂
∂
∂
Φ∂
+
∂
∂
∂
∂
∂
∂
∂
Φ∂
−=
k
k
f
M
f
f
k
k
m
M
m
m
M
H
y
V
p
V
y
M
H
y
V
p
V
y
.                      (1-39) 
 
Equation (1-38) clearly reveals the characteristics of the collective household model 
in deriving the mother’s WTP and the father’s WTP. Parents’ WTP for their child’s medical 
care is determined by three factors: (1) the income share (Φ ); (2) the price of medical care; 
and (3) the household’s technology in producing a child’s health. In other words, the more 
resources the mother has under her control, the higher her willingness to pay. The lower the 
marginal product of a household in producing the child’s health, the higher both parents’ 
WTP. In addition, Equation (1-39) shows the route by which the individual share affects 
WTP. For one-dollar increases in non-labor income, the marginal change in an individual 
share that results from this increase may be different for the mother than for the father. If the 
mother’s share is more sensitive to non-labor income, her WTP is more sensitive when non-
labor income changes than the father’s WTP.      
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Next, the mother’s or father’s WTP in terms of caring time is decided in the second 
stage. The individual utility maximization problem can be rewritten from Equation (1-16) as 
follows: 
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where iλ denotes the individual marginal utility of the individual share of i ( iΦ ).  
The first order conditions of Equation (1-40) are 
 
                         i
i
i
X
U
λ=
∂
∂
,                                                                             (1-41) 
 
iiH
i
k
k
k
k
i w
T
H
H
v
v
U
λ=
∂
∂
∂
∂
∂
∂
.                                                        (1-42) 
 
Since like money, time is a scarce resource, one can define the standard Hicksian 
compensating surplus measures with respect to time. If producing a household good takes a 
significant amount of time, omission of the time cost would produce bias in the demand 
estimation, which would then lead to an underestimation of consumer surplus (Bockstael and 
McConnell, 2007). However, the health/environmental valuation studies generally have not 
accounted for time. Larson and Shaikh (2001) and Eom and Larson (2006) have developed 
new approaches to deriving willingness to spend time, as well as willingness to spend money, 
but they do so in the context of the unitary household model. This is the first study to derive 
willingness to spend time for the child’s health within the collective household model.  
When child health is improved from an initial level 0kH  to a subsequent level 
1
kH , the 
Hicksian compensating surplus of  TiWTP
 
is implicitly defined as  
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where 0iV  is the  initial utility level of i.  
In other words, TiWTP
 
is estimated by totally differentiating the individual utility 
function in terms of individual share ( iΦ ), as follows 
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Here I apply the basic logic of willingness to spend money to that of willingness to 
spend time. To estimate the numerator of Equation (1-44), differentiate the Lagrangian 
(Equation (1-40)) in terms of kH : 
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Finally, after incorporating Equation (1-45) into Equation (1-42) and then into 
Equation (1-44), an individual TiWTP  for a marginal reduction in the child’s sick time is 
obtained as 
 
i
i
H
ik
i
i
kiT
i MP
MC
TH
wHVWTP −=
∂∂
−=
∂
∂∂
−=
λ
.                              (1-46) 
 
Equation (1-46) shows that an individual benefit of an additional day available for 
non-caring activities equals the marginal time cost of producing an additional healthy day of 
the child, i.e., the market time value of the mother or the father (wi) weighted by the 
individual marginal product of each one’s caring time input. There are two factors to bear in 
mind here. First, the caring-time decision of either the mother or the father is made based on 
the individual share ( iΦ ), which is different from the unitary model. Second, an individual 
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caring-time decision is made at the Pareto-efficient point between the mother and the father, 
the central assumption of the collective household model.  
Combining WTP for medical care usage ( $iWTP ) with WTP for caring time ( TiWTP ) 
gives us the WTP of the mother and the father for the child’s health ( kiWTP ), as shown 
below:  
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In sum, by enabling us to separate a mother’s WTP in terms of time and money from 
a father’s WTP, the cooperative health-production model that I develop here yields the 
following results: 
 
(1) There are two kinds of inputs to produce the child’s health based on whether the 
input is exclusive: time inputs, which are exclusive, and monetary inputs, which 
are not. 
(2) There are two different types of technology in producing a child’s health: 
producing one extra healthy day of the child at a household level and one extra 
day at an individual level.   
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(3) The willingness to pay for the child’s health is the sum of the willingness to pay 
of the mother or the father for medical care and for caring time. 
(4) WTP in terms of each input (i.e., time and money) is determined at its marginal 
cost weighted by producing one additional healthy day for the child. 
(5) Since medical expenditures are expenditures on a family public good, their 
optimal allocation between the mother and the father is decided at the point at 
which the sum of the marginal rates of substitution between a family public good 
and private goods is the same as the marginal cost of medical inputs.  
(6) Most importantly, parental WTP for the child’s medical care is determined by 
four factors: income share (Φ ), non-labor income, the price of medical care, and 
the household’s technology for producing the child’s health. 
(7) Parental WTP of caring time is determined by three factors: an individual time 
value (i.e., wage), an individual technology for caring for the sick child, and 
income share (since HiT  is a function of iΦ ).  
 
3.3. The Empirical Strategy 
3.3.1. From caring-time supply function to income-sharing rule 
The goal of this study, as stated, is to derive the mother’s WTP for the child’s health 
separately from the father’s WTP. In order to accomplish the goal, Equation (1-47) shows 
that it is necessary to know the individual indirect utility functions (the numerator of the first 
term in each bracket), the household health production function (the denominator of the first 
term in each bracket), and the individual caring-time function (the denominator of the second 
term in each bracket). Also, the assumption of the collective model — that the decisions of 
the mother and the father are Pareto efficient — needs to be tested. In these procedures, it is 
crucial to reveal the income-sharing rule since it is included in all of the functions and is not 
directly observable.  
Non-unitary household studies have taken two approaches to identify the individual 
share. One is to specify a functional form of the direct or indirect utility and then to derive 
individual supply equations. Burtless and Hausman (1978) warn that this approach imposes 
strong restrictions on the utility function. The other is to specify individual supply equations 
and then to derive the indirect utility function. Chiappori, Fortin, and Lacroix (2002) take the 
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second approach within the collective household framework. I follow their procedures, but I 
augment their empirical equations with family public goods. Chiappori, Fortin, and Lacroix 
(2002) begin with a semi-log functional form for HiT : 
 
m
'
Mmfmf
H
m mpmPmPmwlogwlogmymwlogmwlogmmT τ87261543210 ++++++++=  
(1-49) 
 
,fpfPfPfwlogwlogfyfwlogfwlogffT f'MmfmfHf τ87261543210 ++++++++=          
 (1-50) 
 
The collective framework assumes the mother and the father make a joint decision on 
caring time under Pareto-efficient conditions (Chiappori, Fortin, and Lacroix, 2002): 
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These proportionality restrictions — that the mother and the father jointly decide at 
the same ratio of influence from the distributional factor — are important since they show 
which point is chosen on the Pareto frontier. They are also important for testing the collective 
household model. The constraints are testable by using a joint Wald test after estimating 
Equations (1-49) and (1-50). If this proportionality restriction holds, the collective household 
model holds. Furthermore, the constraints play a critical role in identifying the individual 
shares. The income-sharing rule parameters (Equation (1-13)) are estimated by imposing the 
proportionality constraints on Equation (1-49) and (1-50). After several mathematical steps,10 
Chiappori, Fortin, and Lacroix (2002) derive the income-sharing rule equation as follows: 
 
                                                 
10
 I do not show the technical steps here because I find that the income-sharing rule is the same when family 
public good is included in Equation (1-49) and (1-50) (see Equation (1-13)) as when it is not included in 
Chiappori, Fortin, and Lacroix (2002)’s equations. For more mathematical details, see appendix in Chiappori, 
Fortin, and Lacroix (2002).  
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( )264154434442411 PmfPmfyfmwlogwlogfmwlogfmwlogmf mffmm +++++∆=Φ , 
(1-52) 
 
where 3443 fmfm −=∆ , conditional on 3535 mmff ≠ .  
Each parent’s caring time then can be rewritten as follows: 
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( ) ( )fMmkkMfHf pXMpywlogT τββββ 4321 ++Φ−−−+= ,                   (1-54) 
 
 
where 414411 f/)fmfm( −=α , 42 f/∆=α , 442241 m/)fmfm( −=β , and 42 m/∆−=β . 
1α and 2α  are derived by equalizing the derivatives of Equation (1-52) with respect to wages 
to those of Equation (1-49). Following the same logic, 1β and 2β  are derived, too. 
 
3.3.2. Indirect utility functions 
To estimate each parent’s WTP, it is necessary to derive individual indirect utility 
functions from the caring-time functions (Equation (1-49) and (1-50)). Stern (1986) 
summarizes various studies that derive indirect utility functions from various functional 
forms for supply equations and provides a convenient table linking utility and demand 
functions. The semi-log functional form is commonly used in empirical models. Following 
Stern (1986), the functional form of the indirect utility functions can be obtained from semi-
log caring-time functions as follows: 
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Equations (1-53) to (1-56) differ from Chiappori, Fortin, and Lacroix (2002) in that 
they take into account family public goods. 
 
3.3.3. Willingness to pay of the mother and the father 
A combination of Equations (1-55) and (1-47) gives, finally, a mother’s willingness 
to spend money and time as follows:  
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Using the same logic, a father’s willingness to spend money and time is:  
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Equation (1-57) shows that a mother’s willingness to spend money is obtained by 
dividing the optimal amount a mother would spend on her child’s medical care ( 23 αα ) 
divided by a household marginal product of medical inputs ( )( kMMP ). Parents’ willingness 
to spend time to avoid one day of school loss for their child is equal to their time value spent 
for caring for the sick child, divided by the individual marginal product of time ( ( )HiTMP ). 
These two marginal products can be obtained from the health production functions 
(Equations (1-14) and (1-15)).  
 
Next, in Equations (1-57) and (1-58), 2α  and 2β  show the characteristics of the 
collective household model. They are the coefficients of individual shares in the indirect 
utility functions.  The individual share is a function of a parent’s own wage, her/his spouse’s 
wage, non-labor income, and EEPs (Equation (1-52)). The individual share is determined at 
the Pareto efficient point (Equation (1-51)). Thus, 2α  and 2β  are affected by the ratio of 
distributional factors (f4, f5, f6, m4, m5, m6), as well as non-labor income (f3, m3). In other 
words, the magnitude of the difference between a mother’s and a father’s WTP is partially 
determined by distributional factors. If the ratio of distributional factors is unity, it is possible 
that a mother’s WTP is close to a father’s WTP. 
 
4. Conclusion 
The objective of this essay is to separately derive a mother’s willingness to spend 
money and time to save her child from one day of sickness from a father’s. In order to 
accomplish the goal, I use the collective household model to shed light on the health 
production model and in so doing advance a theoretical model of my own, which I call the 
cooperative health production model. To identify both the collective model and the health 
production model, empirically, one must have the rich data in six categories: (1) individual 
characteristics such as wage, educational attainment, age, race, etc.; (2) individual time use 
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for producing the child’s health, or if that is not available, individual time use for work in the 
market ; (3) medical care expenditures for the child; (4) family characteristics such as non-
labor income, number of children, etc.; (5) children’s health; and (6) extra-household 
environmental parameters.   
The full analysis would take the following four steps: (1) test the assumption of the 
collective model; (2) estimate the caring time supply model and the income-sharing rule in 
order to check whether the assumption of the collective model holds; (3) estimate marginal 
products of medical care and caring time using a health production function; and finally (4) 
estimate WTP of mothers and fathers. 
Therefore, several hypotheses can be tested in the empirical analysis: (1) extra-
household environmental parameters have an impact on the distribution of decision-making 
power between the mother and the father; (2) EEPs have an impact on the consumption 
decisions of time and money for improving the child’s health; (3) children with more 
powerful mothers have fewer days of school loss due to illness or injury; and (4) a mother’s 
willingness to pay for an additional healthy day of a child is greater than a father’s.  
In this essay I expanded the health production model by reframing it along the lines 
of a promising intra-household model, the collective household model. I begin with the two-
stage procedure in the collective household model and consistently use it to estimate 
willingness to pay, that is, willingness to spend money in the first stage and willingness to 
spend time in the second stage. Finally, I find that maternal/paternal WTP for the child’s 
health is determined by six factors: the income share (Φ ), the non-labor income, the price of 
medical care, an individual time value (i.e., wage), and the household’s and individual 
technology for producing the child’s health. 
For the last two decades, health/environmental valuation studies have questioned 
whether to combine the two models, as well as how much a mother’s WTP differs from a 
father’s, if any. Here an inter-disciplinary approach such as mine opens up the possibility of a 
separate estimation of a mother’s WTP from a father’s. This possibility in turn raises several 
important issues. If a mother’s WTP is different from a father’s WTP, does it mean that a 
household WTP is not an accurate welfare measure for saving a child from one extra day of a 
symptom? What are the policy implications of these separate estimates?  
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At the very least, separate estimates would have implications on targeting policies. 
Since non-unitary models include various extra-household environmental parameters in the 
models themselves, they suggest various policy tools. For example, several studies use the 
characteristics of welfare programs or health insurance programs as extra-household 
environmental parameters and show the impact of EEPs on consumption for child goods, 
child’s health, or child’s nutritional status. Since non-unitary models also make agents 
(mothers and fathers) in a household visible, they are able to specify which parent is more 
sensitive between mothers and fathers to children’s welfare. Such findings would be valuable 
to the framers of a targeting policy. Understanding the mechanism of intra-household 
bargaining may lead to accurate benefit estimates and better prediction about the impact of 
public programs for children. If a mother showed more concern than a father for their 
children’s welfare and her WTP for that health were greater than his WTP—information that 
is obtainable from the cooperative health-production model proposed here— then a 
government considering a program for improving children’s health, nutrition, or educational 
attainment would be well advised to target the program toward mothers as recipients of the 
subsidies, rather than fathers.  
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CHAPTER II 
A SKEPTICAL VIEW OF THE COST-OF-ILLNESS MEASURE 
 
1. Introduction 
Diarrhea is a leading cause of disease and death from communicable disease in 
developing countries. Diarrheal diseases are a global problem, but they are especially 
prevalent in developing countries, which are more likely to have poor environmental 
sanitation, inadequate water supplies, poverty, and limited public health education (Kosek, 
Bern, and Guerrant, 2003). In areas where basic interventions to combat these problems 
cannot be implemented in the near future, efforts have been directed towards disease 
prevention through vaccines. If immunization programs are to be subjected to close analysis, 
it is necessary to have accurate benefit measures of reduced morbidity.  
The most widely used measure for estimating the benefits of reduced morbidity is the 
cost-of-illness (COI) approach11, which measures the sum of medical expenses and 
opportunity costs in terms of lost wages.12 Another is the willingness-to-pay measure, which 
determines individual welfare change associated with a disease by measuring the maximum 
amount of income that an individual would be willing to give up to be healthy. Although 
there is little basis in economic theory for the cost-of-illness measure, it has been commonly 
used in policy analysis13 because of Harrington and Portney’s (1987) result that COI  
 
                                                 
11
 Numerous cost-of-illness studies have been conducted (Segal, 2006) since the work of Rice (1966) 40 years 
ago. A 2001 systematic literature review of cost-of-illness studies identified a total of 1,725 publications 
(Bloom, Bruno, Maman, et al., 2001).   
 
12
 The COI approach may be used to estimate the “public” costs to a community or society of treating infected 
individuals, or “private” (out-of-pocket) costs to individuals, or both. The present study is concerned 
exclusively with private costs (Guh et al., 2008). 
 
13
 For example, the 1996 Amendments to the Safe Drinking Water Act require the US Environmental Protection 
Agency and the Centers for Disease Control and Prevention to develop a national estimate of waterborne 
infectious disease cases that are attributable to public drinking water systems (US EPA 1996 [see Section I458 
(d)]). Such disease-burden estimates usually rely on the cost-of-illness measure (Rice, Heberling, et al., 2006).  
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estimates are lower bounds on theoretically correct measures of willingness to pay (WTP).  
Harrington and Portney (1987) show that the marginal WTP to avoid one unit of illness is the 
sum of monetized pain or suffering from illness and defensive expenditures, as well as 
medical expenses and lost opportunity costs due to illness. In other words, WTP estimates are 
more comprehensive than COI.   
Several empirical studies support Harrington and Portney’s argument by reporting 
that WTP is 1.6 to 8.0 times higher than COI (Rowe and Chestnut, 1985; Chestnut et al., 
1988, 1996; Dickie and Gerking, 1991; Alberini and Krupnick, 2000; and Cropper et al, 
2004). These theoretical and empirical studies have played a role in justifying the use of COI 
measures in policy analysis. If the conservative benefit estimates (COI) exceed the cost of a 
program, the program is guaranteed to pass the benefit-cost test using a comprehensive 
benefit measure (WTP). Policy makers also prefer COI estimates because of their interest in 
the budgetary effects of health policy interventions, their lack of understanding of welfare-
based estimates of economic benefits, and their skepticism about the accuracy of stated 
preference techniques (Guh et al., 2008).  
One limitation of Harrington and Portney’s study is that it pertains to marginal 
changes, while it is non-marginal changes that we are most often interested in evaluating. 
However, recently Bockstael and McConnell (2007) have clarified the confusion in 
interpreting Harrington and Portney’s study by distinguishing a welfare measure for non-
marginal changes from a measure for marginal changes. Bockstael and McConnell show that 
COI estimates can either overstate or understate non-marginal WTP estimates. Thus, I revisit 
the comparisons between private COI and WTP estimates for diarrhea diseases in the context 
of developing countries in order to answer several questions: what would be the theoretically 
correct benefit measure for reduced morbidity?  How much would the true measure differ 
from others? What are the determinants of the differences between the true measure and 
others?  
I begin with Bockstael and McConnell (2007)’s model and articulate the underlying 
factors that create potential differences between the true and other benefit measures in 
developing country contexts. In developing countries, people lack health insurance and 
public expenditure on health is low. Thus, most illnesses impose great financial burdens on 
poor households. I therefore incorporate insurance into Bockstael and McConnell’s model, 
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because I propose that insurance may have a significant effect on the magnitude of the 
discrepancies between the COI and WTP measures. Medical insurance could either shift the 
marginal cost of treatment away from the sick individual (Freeman, 2003) or alter 
individuals’ choices of averting activities and days of illness (Harrington and Portney, 1987). 
For example, a 100% coverage insurance plan reduces the price of medical treatment to zero 
(Freeman, 2003). In other words, the social risk pooling system, insurance, is a key factor in 
determining the magnitude of the difference between COI and WTP measures. By 
incorporating insurance into Bockstael and McConnell’s model, I show that ex post COI 
tends to overstate ex post WTP because of income effects in developing countries, which are 
different from those in developed countries.  
Next, I incorporate uncertainty into the model, since an individual does not know 
what her health will be with certainty (Berger et al., 1987). In doing so, I derive ex ante COI 
and ex ante compensating variation (CV) measures. The ex ante COI measures how much a 
program prevents in terms of the expected value of the loss from an adverse event. The loss 
is calculated as the actual loss (ex post COI) multiplied by the probability of the occurrence 
of an adverse event. The ex ante CV, on the other hand, measures expected changes in an 
individual’s utility as the result of a public program and assumes that an individual 
maximizes her expected utility. Thus, the difference between ex ante COI and ex ante WTP 
lies in the difference between expected utility and expected value. Theoretically they are 
unlikely to be the same unless an individual is risk neutral (Freeman, 1989; and Johannesson, 
1996). The literature on decision-making under uncertainty shows that the difference 
between expected utility and expected value is a risk premium. That is, a risk averse 
individual is likely to pay more than the expected loss (here ex ante COI) in order to avoid a 
risk (Friedman, 2002). 
In section 3, I compare the four different measures of the economic benefits of 
avoiding one episode of diarrhea diseases. I base my empirical comparison on a combined 
epidemiological and economic study conducted in China, Indonesia, Vietnam, Bangladesh, 
and Thailand between 2001 and 2005 by the Diseases of the Most Impoverished (DOMI) 
program. The epidemiological component of the study had been previously conducted 
through a population-based surveillance study. In the economic part of the study, patients 
with laboratory-confirmed illness (or their caregivers) were asked to answer questions about 
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their out-of-pocket expenditures and lost earnings associated with diarrhea and the results 
were used to calculate ex post COI. In order to measure ex post WTP, the study asked 
respondents about their willingness to pay to avoid another, similar episode of diarrhea. Next, 
the ex ante COI was calculated by multiplying the incidence rate by ex post COI estimates. 
Ex ante WTP estimates were also obtained from another contingent valuation study 
measuring the benefit of avoiding one episode of diarrhea by a hypothetical vaccine.  
To the best of my knowledge, all four measures (ex post COI and WTP, and ex ante 
COI and WTP) have been neither theoretically discussed together nor empirically assessed 
using consistent methods across multiple countries. In this study I find that there is no clear 
evidence that ex post COI is a lower bound on ex post WTP. The ex post COI associated with 
one episode of diarrheal diseases is close to, lower than, or higher than ex post WTP in the 
Asian countries. On the other hand, ex ante COI measures understate the benefits of reduced 
morbidity in developing countries because of their disregard for risk premiums. Furthermore, 
the discrepancy between ex ante measures is not within a reasonable range. In sum, COI 
measures are unreliable proxies for true WTP measures, especially in developing countries. 
Therefore, the value of COI estimates as welfare benefit measures may be limited in a policy 
analysis.  
 
2. Theoretical basis for comparing cost-of-illness and willingness-to-pay measures 
Knowledge of the economic burden of a disease can help policy makers to decide 
which diseases need to be addressed first with public health interventions (Segel, 2006). In 
this section, I extend Bockstael and McConnell (2007)’s model for comparing ex post COI 
and ex post WTP measures for one avoided episode of illness by incorporating the effects of 
insurance and uncertainty.  
 
2.1. Ex post CV versus ex post COI  
The health S is produced as a function of the effect of pollution, averting activity (Ai), 
and medical treatment (Mi): 
 
);,,( iiii MAbsS µ= ,                                                             (2-1) 
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where health is measured by the number of sick days S. b is the quality of public bad and iµ  
is the genetic endowment of an individual i. 
Utility depends on the consumption of a numeraire (X), the leisure time ( LT ), and the 
amount of time spent ill with diarrhea diseases (S) of an individual i, conditional on the 
quality of public bad:  
 
 ( )bSTXuU iLiii ;,,= .                                                           (2-2) 
 
An individual maximizes her utility subject to her budget constraint,  
 
( ) iMiAiiLiiii MpApXSTTwIy ++=−−+= ,                      (2-3) 
 
where I is non-labor income and T is the total time available. This budget constraint indicates 
that the expenditures on the numeraire, averting activity, and medical treatment cannot 
exceed the sum of her unearned and earned income. Ap  and Mp  are price of preventive 
goods and medical care, respectively. 
The utility maximization model can be written as  
 
( )[ ]iMiAiiLiiiiLiii MpApXSTTwISTXu −−−−−++ λ),,(max .                      (2-4) 
 
Restating the model for expenditure minimization yields 
 
( )iMAii u,T,p,p,w,be  
 
= ( ) [ ]),,(min
,,,
i
L
iiiiiiiMiAii
L
ii
MATX
STXuuTwMpApXSTw
L
−+−++++ τ .                (2-5) 
 
Using the expenditure function in equation (2-5), the welfare measure for a non-
marginal increase in the public bad from an initial level 0b  to a subsequent level 1b , while 
holding the utility constant, is 
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                    ex post CVi ( ) ( )0100 ,,,,,,,,,, iMAiiiMAii uTppwbeuTppwbe −=  
 
= 
H
iM
H
ii
H
iA
H
i MpSwApX +++ ,                                                   (2-6) 
 
where a superscript H represents the Hicksian demand.  
Equation (2-6) is just a simple version of Bockstael and McConnell’s equation (8.52). 
The compensating variation is the total amount of income required to keep the utility 
constant once the quality of the environment degrades. Equation (2-6) allows for four 
behavioral responses to one episode of illness. An individual actively responds to changes in 
public bad by either altering consumptions of other goods (X) or leisure ( LT ) or purchasing 
preventive goods (Ai , e.g., bottled water or vaccines), while taking days (S) off and seeking 
medical treatment (Mi). All are decisions made to maintain the same level of well-being at 
the occurrence of environmental degradation. For example, a person might buy bottled water 
at the announcement of water pollution or get a flu vaccine. She might reduce or increase 
consumptions of other goods based on her ability to pay for health costs for an episode of 
illness. 
On the other hand, the cost of illness can be simply written as follows: 
 
ex post COIi MiM
M
ii MpSw += ,                                                         (2-7) 
 
where a superscript M represents the Marshallian demand.  
It is worth noting that Equation (2-7) makes no allowance for individuals to have 
control over their health by actively adjusting consumptions of other goods or leisure to 
changes in public bad. Equation (2-7) also makes no allowance for any preventive behaviors 
that would produce better health, by definition (Bockstael and McConnell, 2007). In other 
words, health status is not a choice variable, but exogenous in COI estimates.  
 
2.1.1. A model without insurance 
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Equations (2-6) and (2-7) are used to calculate the difference between the 
compensating variation and the cost of illness estimate below: 
 
ex post CVi−ex post COIi ( ) ( )44342144 344 2143421
SinDifference
SSw
MinDifference
MMp
CVinonly
ApX Mi
H
ii
M
i
H
iM
H
iA
H
i −+−++=  .       (2-8) 
 
The difference between non-marginal willingness to pay (CV) for an improvement in 
health outcomes and actual loss due to illness (COI) is composed of four elements in 
Equation (2-8): consumption of other goods (the first term of the left side), averting 
expenditures (the second), and the differences between expenditures on Marshallian and 
Hicksian medical (the third) and health demand (the fourth). The first two terms are included 
only in the CV measure. 
Bockstael and McConnell (2007) assume that an individual would consume more 
X and adopt more preventive activities after experiencing degradation in the environment. 
However, this is not always true. Especially in developing countries, the responses of the 
poor to health shocks may differ from those expected by Bockstael and McConnell. For 
example, poor households may cut their consumption of other goods in the market ( X ) when 
the treatment cost for a sick family member places a heavy burden on their tight household 
budgets.14 The poor often live on a daily wage that is barely enough to provide for minimum 
health care expenditures (Russell, 2003). Even minor illness can have a great impact on their 
budgets. In order to cope with this financial shock, the poor would reduce consumption first 
of non-essential and then essential items. Thus, the first term of equation (2-8) could be more 
often negative in developing countries.  
The third and fourth terms are the difference between the Marshallian and the 
Hicksian cost of illness. As the public bad changes, the Hicksian and Marshallian demand 
functions diverge. The difference between Marshallian demand and Hicksian demand is 
commonly explained by income effect. Willig (1976) shows that the magnitude of 
differences between Marshallian and Hicksian demands depends on income elasticity, as well 
as the budget share of a good relative to income. The smaller the income elasticity or the 
                                                 
14
 The empirical evidence of decreasing consumption associated with illness in developing countries is well 
documented in the consumption against illness literature (Gertler and Gruber, 2002; Morduch, 1995, 1999; 
Townsend, 1995; and World Bank, 1993, 1995). 
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smaller the budget share of a good (here medical care expenditures and lost wages) relative 
to income, the closer the demand curve of the compensated (i.e., Hicksian) to the 
uncompensated (i.e., Marshallian). Therefore, the third and fourth terms of equation (2-8) 
could be negative or positive. The magnitude of discrepancies between the two measures can 
be explained by income effects.  
The second term, preventive expenditures, is important in explaining the disparity 
between COI measures and WTP measures (Dickie, 2003; Dickie and Gerking, 1991; and 
Harrington et al., 1989). However, this term raises a measurement issue. It is not clear how to 
measure the cost(s) of averting a single episode of diarrhea. Activities to prevent diarrhea 
might include personal hygiene (careful hand-washing after using the toilet, or washing 
hands with soap), safe food preparation, boiling drinking and cooking water, protecting 
sources of food and water from contamination, and practicing hygienic disposal of household 
wastes (Guh et al., 2008). Computing such expenditures is problematic because preventive 
actions have joint products (see Dickie and Gerking, 1991). For instance, hand washing 
reduces the risk of more than one diarrheal disease. The cleanliness and freshness that come 
from hand washing also increase individual utility. It is not possible, therefore, to measure 
preventive expenditures separately for only one episode of diarrhea diseases.  
The third terms of Equation (2-8), ( )MHM MMp − , raises an additional measurement 
issue. In COI estimation researchers typically use average costs rather than marginal costs 
(Byford, Torgerson, and Raftery, 2000; and Songer et al., 1998). Moreover, costs are not 
determined in competitive markets.15 Thus, the average costs estimated by cost-of-illness 
studies are likely to be higher than the marginal costs. In other words, typical COI estimation 
may cause overestimations of MM Mp  in the third term of Equation (2-8). 
In summary, given the signs of the first term, the third and fourth terms in Equation 
(2-7), ex post CV may be close to, lower than, or higher than ex post COI under a wide range 
of circumstances, while the second term is assumed as indeterminable. In addition, income 
effect could be one of the key factors in the difference between ex post COI and ex post CV. 
 
2.1.2. A model with insurance 
                                                 
15
 I am grateful to Reed Johnson for this observation. 
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In this section I incorporate insurance into Equation (2-8) and explore whether the 
availability of health insurance decreases the magnitude of the difference between the 
Marshallian and the Hicksian demand in Equation (2-8), and subsequently decreases the gap 
between CV and COI.   
Assume that everyone in a society has identical preferences toward risk and a 
monthly income of USD200.16 The probability that each would become ill (π ) is 1/100. 
Without insurance, if an individual became ill, s/he would pay USD100 for medical care. For 
those who are insured, the insurance is assumed as fair, so PMpM =×π [1/100×100=1], 
where P is the insurance premium. The individual who is insured and becomes ill pays the 
fair premium of USD1 and receives USD100 of medical care (K), paid for entirely by 
insurance. K is the insurance payoff. 
Since the probability of illness is 1 in 100, for each person who becomes ill, there are 
ninety-nine others who transfer USD1 to the person who becomes ill (Newhouse and Phelps, 
1976). As a result, this transfer decreases the out-of-pocket expenditures for treatment paid 
by the patient. This is incorporated into Equations (2-6) and (2-7), putting π  aside,17 and 
mathematically written below:  
 
Ex post CVi = i
H
i
H
iM
H
ii
H
iA
H
i KPMpSwApX −++++ ,                                      (2-9) 
 
Ex post COIi = i
M
i
M
iM
M
ii KPMpSw −++ .                                                         (2-10) 
 
It should be noted that Equation (2-9) measures the welfare benefit in non-marginal 
changes in public bad using Bartik’s bound (1988) (for further details, see Bockstael and 
McConnell, 2007). 
If an individual purchases full insurance coverage that pays the entire medical 
expenditure for treatment K, then KMpM = . Equation (2-8) can be rewritten below: 
 
                                                 
16
 Adapted from Newhouse and Phelps (1976). 
 
17
 A discussion of ex ante measures takes into account π  in the next section.  
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ex post CVi - ex post COIi  = ( ) ( )4434214342143421
SinDifference
SSw
PinDifference
PP
CVinonly
ApX Mi
H
ii
M
i
H
i
H
iA
H
i −+−++ .      (2-11) 
 
Equation (2-11) with insurance shows that the difference in M is different from 
Equation (2-8) without insurance. The difference in premiums ( MH PP − ) would be much 
smaller than the difference in the actual medical care expenditures ( )( MHM MMp − ). 
Therefore, from an individual perspective,18 being insured decreases a patient’s out-of-pocket 
expenses in the event of illness and also decreases income effects. Finally, the gap between 
ex post COI and CV decreases.  
Instead of a simple illustration explaining the effect of insurance on the difference 
between ex post CV and ex post COI, Willig’s approximation equation can be used below:   
 






−≈
y
CS
CV
CS
2
11 η  ,                                                          (2-12) 
 
where η  is income elasticity and CS is consumer surplus.  
Assume consumer surplus as a direct cost of illness and income elasticity as 1.4.  If 
the budget share of medical care relative to income ( y/CS ) is 0.8 without insurance, then 
the consumer surplus overstates CV [CS/CV = ( )( )8024111 ././ ×− =2.5]. However, at the 
same income elasticity, if the budget share of medical care decreases to 0.2 with insurance, 
then CS is 116% of CV [CS/CV = ( )( )2024111 ././ ×− =1.16]. Therefore, the differences in M 
in Equation (2-11) decrease from 150% (without risk pooling) to 16% (with risk pooling).  
In summary, the difference between ex post CV and ex post COI is at some level 
determined by the extent of medical insurance coverage.  
 
2.2. Ex ante CV versus ex ante COI 
Both ex post COI and ex post WTP measures, discussed in the previous section, 
assume certainty in estimating the benefit of health improvement. However, an individual 
does not know what her health will be with certainty (Berger et al., 1987). In this section, I 
                                                 
18
 The aggregate societal perspective in taking insurance into account is out of scope of this study.  
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incorporate uncertainties into ex post COI and ex post WTP expressions. To my knowledge, 
this is the first attempt to compare ex ante CV to ex ante COI for non-marginal change in 
public bad.  
 
2.2.1. A model without insurance 
An individual faces illness with probability π  and good health with probability 1-π . 
She seeks to maximize an expected utility function as  
 
),,(),,()1max( sLsshLhh STXuSTXu ππ +− ,                                       (2-13) 
 
where the subscripts h and s represent a healthy and an ill state, respectively. π  is a function 
of preventive actions and the level of public good given individual genetic endowment 
( )( )µπ ;,bA= .  
Anyone in the population j could be sick or healthy and anyone could also be the 
beneficiary of the reduction of illness through a public intervention. The ex ante 
compensating variation for the reduction in probability of illness corresponds to Equation (2-
6) and is written below: 
 
          Ex ante CVj  
= ( )( ) ( )
444444 3444444 21444444 3444444 21
s
H
jsM
H
jsj
H
jsA
H
js
h
H
jhM
H
jhj
H
jhA
H
jh
CV
MpSwApX
CV
MpSwApX +++++++− ππ1      (2-14)  
 
   = ( )( ) ( )HjsMHjsjHjsAHjsHjhAHjh MpSwApXApX +++++− ππ1                                    (2-15) 
 
where hCV  and sCV  are the ex post compensating variation in a health and an ill state, 
respectively. For the sake of simplicity, it is assumed that hS =0 and hM =0 in a healthy state 
in Equation (2-14). Equation (2-15) means that an individual’s willingness to pay is 
determined as the sum of the utility in a healthy state and in an ill state multiplied by the 
probabilities of each state.   
Ex ante COI of patients i can also be simply written as follows: 
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            Ex ante COIi = ( )( ) ( )MisMMisiMihMMihi MpSwMpSw +++− ππ1                              (2-16) 
 
= ( )MisMMisi MpSw +π ,                                                                      (2-17) 
 
Here assume that hS =0 and hM =0, too. Ex ante COI is calculated as the ex post COI 
in the ill state multiplied by the probability of illness.  
The difference between ex ante CV and ex ante COI recalls Equation (2-8) and can be 
written as follows: 
 
Ex ante CVj - Ex ante COIi 
 
( )( ) ( ) ( )
444 344 21444444 3444444 2144 344 21
COIinonly
MpSw
CV
MpSwApX
CV
ApX MisM
M
isi
s
H
jsM
H
jsj
H
jsA
H
js
h
H
jhA
H
jh +−+++++−= πππ1           (2-18) 
 
( )( ) ( ) ( ) ( )










−+−++++−=
44 344 21443421
SinDifference
SwSw
MinDifference
MMpApXApX Misi
H
jsj
M
is
H
jsM
H
jsA
H
js
H
jhA
H
jh ππ1         (2-19) 
 
Equation (2-19) shows that the sign and the magnitude of the difference between ex 
ante COI and ex ante CV depend on:  
(1) the difference in socioeconomic characteristics between the general  
population and the patient population ( jw , iw , jM , iM ); 
(2) the impact of illness on consumption of other goods and averting  
expenditures; and 
(3) the curvature of utility with respect to income. 
 
First, if there is a relationship between an incidence of an illness and socioeconomic 
status, there will be a difference in wages and medical care expenditures between the general 
and patient population. In other words, if there is a higher incidence rate of an illness in the 
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poor than in the rich, then jw  and jM  in Equation (2-19) would be different from iw  and 
iM , respectively.
19
 
The second terms, ( )HjsAHjs ApX +π , are explained in the previous section.  
Finally, an obvious difference between Equation (2-8) and Equation (2-18) lies in the 
first terms in Equation (2-19), which are related to the expected utility theory. In comparing 
ex ante CV and ex ante COI, the key factor is the shape of utility function associated with 
risk preferences. Several studies (Arrow, 1971; Freeman, 1989; and Johannesson, 1996) 
provide a clear distinction between ex ante CV and ex ante COI: the logic of converting ex 
post COI to ex ante COI corresponds to the concept of the expected value of a risky situation, 
while ex ante CV reflects the expected utility function. 
Figure 2.1 draws  ex ante CV and ex ante COI assuming risk averse preference. 
 
 
 
Figure 2.1 Ex ante CV vs. ex ante COI, assuming risk averse preference 20 
                                                 
19
 For example, Mackillop et al. (2000) find out a relationship between socioeconomic status and the incidence 
of cancer in the U.S. There are moderately strong, inverse relationships between income level and the incidence 
of carcinomas of the cervix, the head and neck region, the lung, and the gastrointestinal tract. Several of these 
diseases are twice as common in the bottom income decile as they are in the top decile.  
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In Figure 2.1, the x-axis shows an individual’s income in a healthy state and in an ill 
state as yh and ys, respectively. If she were infected by diarrhea diseases, she would lose her 
income, yh−ys  [=ex post COI]. Assume 3.0=π . Her ex ante COI is yh−ys multiplied by the 
probability of contacting typhoid fever, i.e., one third of yh−ys.20  
By contrast, the curve in Figure 2.1 shows the individual’s utility as a function of 
income. The y-axis shows her utility in a healthy state and in an ill state as U(h) and U(s), 
respectively. Assume an individual is risk averse with respect to income, i.e., a concave 
curvature of utility function with respect to income (for further details, see Friedman, 2002). 
If a government considers introducing a vaccination program against typhoid fever, an 
individual’s ex post willingness to pay would be the maximum income she would be willing 
to give up to be healthy (Johannesson, 1996), which is equal to yh−ys in Figure 2.1. Her ex 
ante WTP is decided at the point A [= yh−yA], at which she maximizes her expected utility.21 
Therefore, ex ante COI is lower than ex ante CV in this case, because she is risk averse. The 
difference between ex ante CV and ex ante COI (i.e., AB ) is a conventional risk premium — 
someone averse to risk will pay more than the expected value of the loss in order to avoid a 
risk (Friedman, 2002).   
If one allows different risk preferences, more deviations can be considered. So far it is 
assumed that people are risk averse. Figure 2.2 illustrates different curvatures of the utility 
function that reflect different attitudes toward risk.  
 
 
                                                 
20
 Adapted from Johannesson (1996) and Friedman (2002).   
 
21
 If one adopts non-linear probability weighting (Tversky and Kahneman, 1992; Bleichrodt and Pinto, 2000;  
Starmer, 2000; and Johnson, Houtvan, and Hauber, 2008), instead of the linear weighting of expected utility 
theory, the discrepancy [= yh−yA] would be greater with small probabilities of getting sick, since people tend to 
overweight small probabilities and underweight large probabilities. I am grateful to Reed Johnson for this 
insight.    
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Figure 2.2 Ex ante CV vs. ex ante COI by different risk attitudes 
 
 
If the utility function with respect to income is concave, the individual is risk averse 
and the slope of the curve A is diminishing. If she is risk neutral, her utility function is a 
straight line, N (i.e., constant marginal utility), and her ex ante CV is the same as the ex ante 
COI. Finally, if she is risk taker, her utility function T is convex, i.e., increasing the marginal 
utility of income (Friedman, 2002). In this case, her ex ante CV is lower than the ex ante 
COI. Thus, it is theoretically impossible to generalize the relationship between ex ante CV 
and ex ante COI without knowing the curvature of the utility.  
In summary, ex ante cost-of-illness estimates and the ex ante compensating variation 
are likely to be different. Ex ante COI may either overstate or understate ex ante CV. 
However, if one assumes that people are risk averse, ex ante COI tends to understate ex ante 
CV because of the significant role that the probability of illness plays. The terms in the 
square bracket of Equation (2-19) are exactly the same as those in Equation (2-8). As 
discussed in the section on ex post COI versus ex post CV, the bracket in Equation (2-19) can 
be positive or negative. However, here I am interested in the sum of the weighted value at 
two states (ill and healthy). Assuming the probability of illness is 0.01, then π−1  is 0.99. 
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Finally, it is possible that the first terms of Equation (2-19), if any exists, determine the sign 
of Equation (2-19). 
 
In section 2.2.1, I mainly focus on the probability term and the curvature of the 
expected utility function because they are the key differences between ex ante measures and 
ex post measures. Otherwise, everything is the same, as explained in the section 2.1.1. In the 
equation of ex ante CV, health status is a choice variable, while in the ex ante COI equation, 
S is not. In other words, the ex ante CV equation allows for behavioral responses to illness, 
but in the ex ante COI equation S is exogenously determined.   
 
2.2.2. A model with insurance 
The difference between ex ante COI and ex ante CV with insurance can be written by 
incorporating insurance into Equation (2-18):  
 
            Ex ante CVj - Ex ante COIi 
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If an individual purchases full insurance coverage, then Equation (2-20) can be 
rewritten as follows: 
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Again, the difference in premium ( ij PP − ) would be smaller than the weighted 
medical care expenditures by π ( )( )( )HisHjsM MMp −π . Therefore, with insurance income 
effects in medical care expenditures decrease and then the gap between ex ante CV and ex 
ante COI decreases, too.  
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3. Study design 
In order to measure the economic benefits of preventing diarrheal diseases (e.g., 
typhoid fever, cholera, and shigellosis), the DOMI program conducted three different studies 
(of ex post COI using the cost of illness method, and of ex post WTP and ex ante WTP using 
the contingent valuation method) in seven study sites in China, Vietnam, Bangladesh, 
Indonesia, and Thailand.  
First, the data on private costs of illness were collected in the course of a combined 
epidemiological and economic study. Laboratory-confirmed patients (or their caregivers) 
were asked to answer questions about their out-of-pocket expenditures and lost earnings 
associated with one of the diarrhea diseases 7, 14, and 90 days after onset of illness.  
Second, at the end of the follow-up COI interview (on the 14th or 90th day after onset), 
respondents were asked about their willingness to pay to avoid another episode of the disease 
like the one they had just experienced. The respondents were asked to mark two prices on a 
sliding-scale payment card, a lower bound on WTP (WTPL), and an upper bound on WTP 
(WTPU).22 This measures ex post WTP.  
There are two aspects of this interviewing method that are important to mention. 
First, the responses to open-ended questions, if truthful, are direct expressions of value and 
would be interpreted as measures of compensating surplus (Freeman, 2003) or compensating 
variation. Second, the WTP estimates from the sliding-scale questions are ex post measures. 
Therefore, these two studies offer a chance to explore the relationship between ex post COI 
and ex post CV for morbidity reduction from the perspective of one set of individuals able to 
offer insight on both measures.  
Third, at the same study or neighborhood sites as the above, another contingent 
valuation study was conducted using the discrete choice question format. People were asked 
directly via in-person interviews whether they would purchase a hypothetical vaccine (e.g., 
the typhoid vaccine or the cholera vaccine23) for themselves and for other members of their 
household if it were available to them at a specified price. Descriptions of vaccines with 
different levels of efficacy and duration and with different prices were randomly assigned to 
respondents in order to investigate how private individual or household demand for a 
                                                 
22
 For further details, see Guh et al. (2008). 
23
 Since the development of a shigellosis vaccine is under study, the contingent valuation study for investigating 
shigellosis vaccine demand was not conducted. 
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hypothetical vaccine changes with variations in these vaccine characteristics (Malik et al., 
2005). The responses to this discrete choice question were used to derive ex ante willingness-
to-pay estimates for a hypothetical vaccine. 
 
   
4. Results 
4.1. Sample size and characteristics 
In the economic study, a total of 1,786 patients (or caretakers) completed several 
rounds of face-to-face interviews in seven study sites in Thailand, China, Vietnam, 
Indonesia, and Bangladesh between 2001 and 2005 (see Table 2.1).  
 
 
Table 2.1 Comparisons of ex post COI and ex post WTP in China, Indonesia, Vietnam, 
Thailand, and Bangladesh for shigellosis, cholera, or typhoid fever (2005US Dollars) 
Study site 
(Sample size) COI† WTP
U
 
Monthly 
wagea 
WTPL/ 
COI 
COI > 
WTPU t-value
b
 
Shigellosis 
Kaengkhoi, Thailand 
(N=127) 
3 14 92 1.9 29% -2.27 
(p=0.99) 
Zhengding, China  
(N=307) 
6 6 55 0.5 52% -0.07 
(p=0.53) 
Nha Trang, Vietnam 
(N=279*) 
7 14 37 1.3 43% 0.07 
(p=0.47) 
N. Jakarta, Indonesia 
(N=425) 
23 11 73 0.4 59% 5.54 
(p=0.00) 
Cholera 
Matlab, Bangladesh 
(N=234**) 
12 1 46 0.001 98% 15.09 
(p=0.00) 
N. Jakarta, Indonesia 
(N=176) 
40 16 99 0.4 61% 4.41 
(p=0.00) 
Typhoid fever 
Hue, Vietnam  
(N=17) 
38 11 31 0.1 88% 3.52 
(p=0.00) 
Hechi, China  
(N=49***) 
141 49 68 0.3 75% 3.08 
(p=0.00) 
N. Jakarta, Indonesia 
(N=107) 
106 17 81 0.2 80% 5.40 
(p=0.00) 
Note: † denotes the average COI for hospitalized and non-hospitalized cases, weighted by hospitalization rate. 
*279 out of 291, **234 out of 278, and ***49 out of 58 adult patients and caretakers answered willingness-to-
pay questions.  a. Some adult patients, mostly wage earners, provided information on their wages.   
b. The null hypothesis is that the mean private cost of illness is equal to the mean upper bound on WTP. The 
alternative hypothesis is that COI > upper bound on WTP, on average.  
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Out of the sample, 65 observations were unusable for the comparison between ex post COI 
and ex post WTP because they were incomplete for ex post WTP questions. Due to the 
limited socioeconomic information on the sample, an illustrative empirical analysis is 
conducted below. 
 
4.2. Ex post CV versus ex post COI  
Table 2.1 shows the mean estimates of ex post WTP and COI for three diseases in 
seven different study sites. It immediately reveals several tendencies:  
1. The COI estimates for shigellosis tend to be lower than those for both cholera and typhoid 
fever.  
2. The upper bound on WTP estimates on average show a narrower range (USD1-1724) 
regardless of disease or country (except for one extreme case [typhoid fever in Hechi]), while 
the ex post COI estimates have a wider range (USD3-106).  
3. Contrary to other empirical results, ex post WTPL estimates are 0.001 to 0.5 times lower 
than ex post COI estimates, except for Kaengkhoi (the fifth column). 
4. The high percentage of cases (43-98%) indicates that ex post COI estimates exceed the 
upper bound on WTP, except for Kaengkhoi (the sixth column).  
 
The sixth column of the first panel shows that of the total 1138 WTPU-COI pairs 
[=127+307+279+425], around 30 to 60% of patients (or caretakers) gave an upper bound on 
willingness to pay that was lower than their actual losses. Berger et al. (1987) investigate 
WTP-COI pairs and report strikingly different results: in the United States, (1) less than 25% 
of their WTP-COI pairs indicate higher COI than WTP for light symptoms, and (2) the ratio 
of WTP to COI ranges from 3 to 79.  
In the DOMI studies, only Thailand shows the same tendency as reported by Berger 
et al. (1987). The lower bound on WTP in Thailand is around twice as much as COI on 
average, and 30% of patients indicated higher WTPs than COIs. This result probably reflects 
the fact that the public expenditure on health in Thailand covers 60% of the total expenditure 
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 In this study the currency is 2005US dollars. 
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on health, whereas the other countries in the study have low health insurance coverage, from 
less than 10% of the population in Vietnam and Indonesia to 30% in China. Thus, for 29-
59% of the sample, the actual expenses associated with shigellosis are higher than the upper 
bound on WTP.  
However, the one-sided t-test (H0: COI = WTPU; and H1: COI > WTPU) shows that 
the difference between the upper bound on WTP and COI for shigellosis is not statistically 
significant in China, Vietnam, and Thailand. In these countries ex post COI on average is 
lower (< USD10) than in Indonesia. In Indonesia, with a higher COI (USD23) for shigellosis, 
the average COI estimates are higher than the upper bound on WTP. The difference is 
statistically significant (p <.001). Thus, one tentative conclusion at this point is that 
statistically ex post WTP may be close to ex post COI when ex post COI is lower. However, 
when ex post COI increases, ex post WTP does not increase at the same rate, because of more 
restrictive budget constraints on WTP, and so ex post WTP is lower than ex post COI. In ex 
post COI estimates, medical care expenditures, especially for hospitalized cases, tend to 
exceed individual income, while ex post WTP estimates show that people are not likely to 
pay more than their incomes regardless of hospitalization. 
The second panel shows the same comparisons for cholera. In North Jakarta, the 
average COI estimates are high (USD40). One episode of cholera costs patients almost 40% 
of their monthly income (USD99). Almost 60% of cases express their upper bounds on WTP 
as lower than the private COI. In Bangladesh all patients were hospitalized for cholera. They 
lost USD12 on average, but they would be willing to pay only USD1 in order to avoid one 
episode of cholera. Even more strikingly, almost all patients in Bangladesh answered that 
their upper bounds on willingness-to-pay measures were lower than their cost-of-illness 
estimates (p <.001).  
In the third panel of Table 2.1, the COI estimates for typhoid fever are much higher, 
on average, than those estimates for shigellosis and cholera. When COI estimates are higher, 
one can see that WTP estimates do not proportionally increase. Then, the ratio of the lower 
bound on WTP to COI ranges only from 0.1 to 0.3, which is opposite to the results from 
other empirical studies.  
WTP-COI pairs for typhoid fever show similar results to those for cholera. Of the 172 
WTP-COI pairs in Vietnam, China, and Indonesia, more than 75% of patients or caretakers 
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gave an upper bound on WTP that was lower than their actual losses due to typhoid fever. 
These comparisons of the paired estimates are statistically significant at a .001 level.   
From the broad comparisons, one can see that ex post COI estimates are equal to, 
lower than, or higher than the upper bound on WTP, on average, as predicted in the theory 
section. COI estimates are also out of proportion in relation to WTP estimates. These results 
vary by disease as well as by country, specifically, by the insurance mechanisms in the 
different countries.  
Recent studies—macro-level (Preker et al., 2002) and micro-level multi-country 
studies (Doorslaer, et al., 2007; O’Donnell et al., 2008; and Xu, et al., 2003)—give empirical 
support to the hypothesis that risk-sharing in health financing affects the level and 
distribution of financial protection against the cost of illness. In other words, national health 
financing systems can have a significant impact on the magnitude of private burden resulting 
from illness. There are also clear differences in financing health care between developed and 
developing countries. Out-of-pocket payments are the principal means of financing health 
care in Asia (Doorslaer, et al., 2007), while a combination of general taxation, insurance, and 
limited out-of-pocket user charges is the preferred instrument for health financing in middle- 
and high-income countries (Schieber and Maeda, 1997).  
Given the effect of insurance on the discrepancies between COI and CV measures, 
shown in Equation (2-11), how health care is financed at the national level may reduce the 
magnitude of the difference between CV and COI estimates. However, insurance is not the 
only important determinant of discrepancies between the two measures across countries. 
Others include different levels of health-service delivery and use as well as differences in 
healthcare markets, healthcare technologies, and basic socioeconomic development between 
developing and developed countries. Nonetheless, I propose that the discrepancies between 
COI and CV are likely to be much more pronounced in countries where the provision of a 
public health financing system is weak. There is no study that examines the impact of macro-
economic factors on the discrepancies between COI and CV. This study is the first attempt to 
introduce the variation in insurance mechanisms across countries, a macro-economic factor, 
as an explanatory variable in comparing COI to WTP estimates.      
Table 2.2 shows the national health care financing systems of the five Asian countries 
by main source.  
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Table 2.2 Private expenditure on health and national health care system* 
% of total health expenditure  
Public Private 
Country 
Private 
expenditure on 
health per capita 
per month 
(2005 USD) 
General 
government  
Prepaid & risk-
pooling plans 
Out-of-pocket 
payment 
Bangladesh  0.6 37 6 56 
China  4.3 42 4 54 
Indonesia  1.6 35 4 49 
Thailand 3.2 64 6 27 
Vietnam 2.4 32 2 61 
*Sources: National Healthcare Account-World Health Organization (http://www.who.int/nha/country/en/) 
 
 
Public health care financing coverage is low for most of these countries. 
Governments cover approximately 32-42% of the total health expenditure. Only Thailand’s 
government provides wider public coverage on health (64%). In other countries out-of-
pocket expenses play a significant role, while pooling instruments contribute a negligible 
share (2-6%) of the total expenditure on health.  
Without a social risk-pooling system, people with low incomes face serious financial 
hardship when a family member falls ill. The first column of Table 2.2 summarizes average 
private expenditures on health per capita per month. For example, in Indonesia an individual 
spends USD1.6 on health per month, but one episode of typhoid fever costs seventy times as 
much (USD106). People can therefore fall into an illness-poverty trap due to only one 
episode of typhoid fever. Poor households may be pushed down to a poverty level when 
faced with severe typhoid fever symptoms that require hospitalization.  
At the same time, a poor household’s willingness to pay is constrained by its limited 
budget. When a significant portion of the financial burdens associated with diarrhea is 
imposed on the poor, the difference between ex post COI and ex post WTP increases. The 
patients from Matlab, Bangladesh, who had had cholera, for example, lost USD12 but said 
that they would be willing to pay only USD1. This gap makes sense when one considers that 
people in Matlab spend an average of 60 cents per month on health care.  
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For a close examination of the financial burdens associated with one episode of 
diarrheal disease, Table 2.3 presents the budget share of ex post direct COI and WTP out of 
the monthly income of adult patients. Out of a total of 828 adult cases, only 229 patients 
reported their earned income.25 Table 2.3 refers only to these 229 cases. Thus, the analysis 
using 229 patients is not representative of the total number of patients in the study sites. 
 
 
Table 2.3 Budget share of direct COI and WTP out of income, and percentage of families 
 borrowing money or selling items in order to cover the treatment cost of diarrhea diseases* 
Study site (sample size) Budget share 
of direct COI 
Budget share 
of WTPU 
Families that adopted 
coping strategies 
shigellosis 
Kaengkhoi, Thailand (n=54) 1% 7% 0% 
Nha Trang, Vietnam (n=44) 38% 26% 4% 
N. Jakarta, Indonesia (n=81) 13% 22% 14% 
cholera 
Matlab, Bangladesh (n=32) 19% 1% 13% 
N. Jakarta, Indonesia (n=43) 35% 36% 14% 
typhoid fever 
Hechi, China (n=27) 169% 120% 14% 
N. Jakarta, Indonesia (n=18) 224% 11% 24% 
 *Sources: The DOMI cost-of-illness studies in each country.   
 
 
The budget share of income spent on direct COI varies by disease and country, 
between 1% for shigellosis in Kaengkhoi and 224% for typhoid fever in N. Jakarta. By 
comparison, the budget share of ex post WTP seems reasonable, between 1% and 36%, 
except for the cases of typhoid fever in Hechi (120%).  
In order to cope with the private financial burden of treating diarrhea diseases, some 
families borrowed money or sold items. On average, an episode of typhoid fever imposed the 
heaviest burden on families in North Jakarta, Indonesia. Twenty-four percent of adult 
patients adopted coping strategies because of typhoid fever. In other countries, approximately 
                                                 
25
 Almost 75% of adult patients did not report their wages, mostly because they were not employed in the labor 
market (e.g., housewives). 
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14% of patient families reduced their consumption of other goods or borrowed money 
because of diarrhea diseases. These percentages may reflect the national health care 
financing system in each case. In Thailand, with wider public health care financing coverage, 
no one borrowed or sold items because of shigellosis. In order to hold the household utility 
constant, the first strategy for meeting treatment costs would be to reduce consumption of 
other goods, followed by selling items or borrowing money. From the figures presented in 
Table 2.3, it is safe to say that in developing countries people tend to decrease consumption 
of other goods when a family member contracts diarrhea disease, contrary to the expectation 
of Bockstael and McConnell for the consumption of other goods (the first term) in Equation 
(2-8). According to the consumption against illness studies (Gertler and Gruber, 2002; 
Morduch, 1995, 1999; Townsend, 1995; and World Bank, 1993, 1995), in developing 
countries families with sick members do not insure their consumptions because of the lack of 
insurance. Those who are better off are more likely to spend a large fraction of total 
household resources on health care (Doorslaer, et al., 2007) in developing countries where 
few individuals are covered by formal health insurance. Even small costs for common 
illnesses can be financially disastrous for poor households with no insurance coverage (Xu et 
al., 2003). Spending a large fraction of household resources on health care means that current 
consumption of other goods and services must be sacrificed (Doorslaer et al., 2007). 
After the analysis of the first component in Equation (2-8), the next step is to examine 
the third and fourth components, income effects, by using Willig’s approximation equation 
(Equation (2-12)). The data on income elasticity of health care is necessary for Willig’s 
equation. Studies on income elasticities of health care yield two contradictory results. The 
one using cross-section data shows that income elasticities of health care are less than one 
(Di Matteo & Di Matteo, 1998; and Hitiris & Posnett, 1992), which means that medical care 
is a necessity. Income elasticities vary from country to country. In the United Sates, they are 
very low, ranging from below 0.1 to 0.4.26 In urban China, on the other hand, the estimated 
income elasticity ranges from 0.44 to 0.52, according to a recent study by Mocan, Tekin and 
Zax (2004) of the determinants of the demand for medical care in urban households of China.  
The studies using cross-country data, on the other hand, report that income elasticities 
of health care are greater than one (Gerdtham, Søgaard, Andersson, & Jönsson, 1992; 
                                                 
26
 For further details see Andersen and Benham, 1970; Newhouse and Phelps, 1976; and Phelps, 1975.  
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Kleiman, 1974; Newhouse, 1977; Parkin et al., 1987), ranging from 1.15 to 1.31. This result 
means that medical care is a luxury good, in stark contrast to the result from the cross-
sectional data. One possible explanation is that in developing countries equity in health care 
has not been achieved and so medical care may indeed be a luxury (Gerdtham, Søgaard, 
Andersson, & Jönsson, 1992). Newhouse (1977) also finds that estimated income elasticities 
tend to be higher in countries with lower per capita GDP. While the income elasticity of 
health care is still under debate, it is safe to say that it ranges from 0.4 to 1.4 in developing 
countries.   
I set income elasticities equal to 0.4, 0.6, 0.8, 1.0, and 1.4 and apply Willig’s 
approximation equation to the observations including wage information. Figure 2.3 shows 
that the ratio of direct COI (a measure of CS) to CV is a function of the budget share of direct 
medical care expenditures out of income, especially when income elasticity is greater. The 
reference line shows the acceptable range of using CS instead of CV, which is 10% of the 
range.  
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Figure 2.3 Consumer surplus over compensating variation related to the budget share of 
direct COI by various income elasticities 
 
*For the purpose of presentation, this figure excludes 27 observations with high budget share (>150%) or the 
larger ratio of ex post direct COI to CV (> 4). 
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If the errors from using CS, instead of CV, are within the 10%, the results are considered 
reasonable because there are also errors involved in estimating the Hicksian demand and CV. 
In Figure 2.3, if income elasticity is 0.6 (i.e., η =0.6), COI falls within a reasonable 
range (90% of WTP-110% of WTP) only for the cases in which the budget share of direct 
COI is less than 15% of income. If income elasticities increase from 0.4 to 1.4, the budget 
share decreases within Willig’s acceptable range. Except for the cases in which the patients 
spent a small portion of income on medical treatment for diarrhea, the gap between direct 
COI and CV is not negligible. More specifically, when both income elasticity and budget 
shares of medical treatment are not small, the consumer surplus of medical care demands 
tends to overstate CV by factors of 45 at maximum.  
In order to summarize the results of this study, Table 2.4 shows the simple 
comparisons between ex post COI and ex post WTP.  
 
 
Table 2.4 Ex post COI vs. ex post WTP in the DOMI studies 
 shigellosis cholera typhoid fever 
China COI = WTPu n.a. COI > WTPu 
Vietnam COI < WTPu n.a. COI > WTPu 
Thailand COI < WTPu n.a. n.a. 
Bangladesh n.a. COI > WTPu n.a. 
Indonesia COI > WTPu COI > WTPu COI > WTPu 
 
 
A quick look at Table 2.4 reveals that there is no clear indication that COI is the 
lower bound on WTP. When a consistent method is used in estimating ex post COI and ex 
post WTP associated with diarrhea diseases across several Asian countries, COI estimates are 
equal to, lower than, or higher than the upper bound on WTP, on average. The results using 
multi-country data are inconsistent with those of empirical studies based on single-country 
data, which tend to disregard macroeconomic factors. This study suggests that future research 
should consider macroeconomic factors as one explanation for the discrepancies between 
COI and CV estimates. 
 
4.3. Ex ante COI versus ex ante CV 
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The comparisons between ex ante COI and ex ante WTP are conducted only for 
cholera cases. In order to estimate ex ante COI, the incidence rate is multiplied by ex post 
COI. Ex ante WTP estimates are obtained from contingent valuation studies (Islam et al., 
2007; Malik et al., 2005; and Whittington et al., 2007).  
As shown in Table 2.5, the incidence rate of cholera is between 0.3 and 9 per 1000 
persons per year. Multiplying that rate by ex post COI gives an estimated ex ante COI 
ranging from 1 cents to 7 cents in 2005US dollars.  
 
 
Table 2.5 Ex post/ex ante COI and ex ante WTP estimates for cholera 
Estimates 
(2005 USD) 
                 Incidence ratec               e   
Ratio (=ex ante WTP/ex ante COI) Site Parameters 
Children Adults Children Adults 
ex post COIa 24 33 0.003 0.001 
ex ante COI 0.07 0.03 
Matlab, 
Bangladesh 
ex ante WTPb 0.7 1.2 
10 35 
ex post COIa 56 62 0.0009 0.0003 
ex ante COI 0.05 0.02 
N. Jakarta, 
Indonesia 
ex ante WTPb 1.2 0.5 
25 30 
ex post COIa 20 12 0.004 0.009 
ex ante COI 0.07 0.01 
Kolkata, 
India 
ex ante WTPb 1.9 1.0 
27 84 
Sources: a the DOMI cost-of-illness studies; b the DOMI contingent valuation studies; c the DOMI epidemiology  
studies  
 
 
The healthy respondents were willing to pay from 50 cents to 1.9 U.S. dollars for 
hypothetical cholera vaccines in order to be protected from cholera for one year. Ex ante 
WTP is 10 to 84 times higher than ex ante COI for cholera, which is consistent with the 
experimental results of Freeman (1989). Freeman (1989) simulates comparisons for a range 
of each parameter and finds that ex ante CV for risk reduction can exceed ex ante CS by 
factors of 0.1 to over 50. However, it is not certain whether most of the ratios (i.e., 10-84) in 
this study are inherited from risk premium ( AB  of Figure 2.1) or income effect.  Further 
interrogation is required with appropriate socioeconomic information about the patients. For 
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example, in examining income effect or deciding the shape of utility function it is critical to 
obtain data on income and medical care expenditures associated with a given illness, as well 
as socioeconomic information about patients. 
 
5. Conclusion 
Although the problems of a cost-of-illness approach are well known, there continues 
to be theoretical confusion about whether the cost-of-illness estimate is the lower bound on 
the compensating variation.  
However, Bockstael and McConnell (2007) have recently clarified the source of 
confusion and explained the possible disparities within the context of non-marginal changes. 
Though they shed light on the comparisons, their lack of macroeconomic perspective makes 
their explanations relevant specifically to the context of developed countries. In order to 
apply their logic to developing countries, I incorporate insurance into Bockstael and 
McConnell’s model and then I empirically find that when ex post COI estimates are higher 
compared to income, ex post WTP estimates for diarrhea diseases are more likely to be 
constrained by income. Thus, the magnitude of discrepancy between the two measures 
increases with higher ex post COI. This result due to income effect tends to be significant in 
developing countries because of their lack of a risk-pooling system. 
The responses to one episode of diarrheal disease in developed countries are different 
from those in developing countries, where people lack health insurance and the coverage of 
public expenditures on health is lower, between approximately 12% and 35% of the total 
expenditures on health. These macroeconomic factors determine the share of direct COI out 
of household income. With a larger budget share of direct COI relative to income, the income 
effects in explaining the difference between ex post COI and CV tend to be greater. In that 
case, the differences between COI and WTP do not look negligible. In developing countries, 
the income effects result in higher ex post COI estimates relative to ex post WTP estimates.  
When incorporating uncertainty, ex ante COI estimates (=ex post COI ×  incidence 
rate) substantially underestimate the true individual benefits of reduced morbidity. It is 
mostly because the ex ante compensating variation reflects the expected utility, while the ex 
ante cost of illness corresponds to the expected value of adverse events. Thus, healthy and 
risk-averse people are more likely to be willing to pay more for a hypothetical vaccine than 
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their expected COI because of the curvature of the utility function. Empirically, ex ante cost-
of-illness estimates tend to be 3 to 84 times lower than ex ante WTP. The observed 
discrepancy between the two measures in the empirical studies is far too wide for COI to be 
used as a lower bound on WTP estimates.    
Based on the findings of this study in developing country contexts, the COI estimates 
are not reliable and do not give any guidance as to the lower bound on the theoretically true 
estimates in measuring the benefits of reduced morbidity. Therefore, the value of COI 
estimates in decision-making may be limited (Freeman, 1989; Rice, 1994; and Wiseman and 
Mooney, 1998).  
These findings are, of course, preliminary due to lack of information, especially on 
household income. In order for these findings to be definitive, the following 
recommendations are made. Future studies need to collect information on household income, 
changes in household consumption of other goods, and any preventive expenditures 
associated with illnesses, as well as macroeconomic data from several sources on national 
health insurance coverage and the percentage of public expenditure on health out of the total 
expenditure. Researchers should also look to macroeconomic cross-country regressions for 
valuable insight into the discrepancies between COI and WTP measures derived from 
microeconomic studies, since, as this study has shown, macroeconomic factors may be one of 
the explanations for these differences. 
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CHAPTER III 
TRADE-OFF BETWEEN EFFICIENCY AND EQUALITY IN SCHOOL-BASED TYPHOID 
VACCINATION PROGRAMS IN NORTH JAKARTA, INDONESIA 
 
1. Introduction    
Typhoid fever has caused more than 21 million illnesses and more than 200,000 deaths in 
the year 2000 (Crump et al., 2004). The incidence rates are highest in South and Southeast Asia, 
which account for an estimated 91% of the global typhoid fever disease burden (Crump et al., 
2004). Children living in endemic areas are at particularly high risk (Sinha et al., 1999; Saha et 
al., 2001). 
In Indonesia, there are an estimated 1.08 million new cases of typhoid fever every year, 
causing up to 20,000 deaths (Punjabi, 1998). Typhoid fever imposes an economic burden on a 
society through subsidized treatments in public health care facilities as well as the private 
medical care paid by individuals or families. Typhoid fever is also responsible for lost 
productivity from those who are sick or are taking care of ill family members. 
In the absence of public interventions to improve water and sanitation in the near future 
in developing countries, efforts have been directed towards disease prevention through vaccines. 
The WHO recommends routinely immunizing school-aged children with available new-
generation vaccines in areas where the disease burden is high (WHO, 2003a). The Indonesian 
National Institute of Health Research and Development (NIHRD) is considering immunization 
for the most impoverished children living in typhoid fever-endemic areas (e.g., Jakarta) with the 
Vi polysaccharide vaccine (Agtini et al., 2006), one of the new-generation vaccines against 
typhoid fever.  
This paper examines school-based immunization against typhoid fever in North Jakarta in 
order to assess the merits of such a program. Two vaccine delivery modes and three financing 
schemes are examined. The typhoid vaccines would be administered either as a single injection 
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or together with the tetanus toxoid (TT) booster that is currently administered in Indonesia under 
the schoolchildren immunization program (BIAS).27 The BIAS program has been conducted in 
primary schools for the past 11 years. Each November, health workers visit all schools 
nationwide to administer one dose of diphtheria-tetanus toxoid (Td) or tetanus toxoid vaccine. 
The safety and immunogenicity of Vi polysaccharide, when given simultaneously with TT 
vaccine booster, is under study (Agtini et al., 2006). In this paper I compare two administration 
modes under an assumption that administering the typhoid vaccines along with the TT booster 
vaccines is safe. I also examine three financing schemes for the immunization: the government 
scheme in which the Indonesian government pays all of the immunization costs, the procurement 
assistance scheme financed by external donors, and a user fee scheme.  
Decisions about optimal vaccination programs involve tensions between efficiency and 
equity (Levy et al., 2007), especially in the developing world. Immunization is one of the most 
cost-effective interventions to prevent a series of major illnesses (World Bank, 1993). 
Immunization in developing countries, however, does not equally cover children from all 
socioeconomic strata of society. Children in the poorest quintile are less likely to be fully 
immunized than those in the wealthiest quintile. Given the fact that immunization services are 
largely the domain of the public sector and that immunization services tend to favor the wealthy 
at the expense of the poor, finding ways to improve access to immunization services for the poor 
is a significant policy challenge, especially in developing countries (Nichter, 1995; Pande and 
Yazbek, 2002; Bonu, Rani, and Baker, 2003; and Schwartz and Bhushan, 2004).  
Most vaccination policy analysis, however, mainly takes efficiency into account in order 
to find the lowest-cost program or the one providing maximum net benefits. Equality in the 
distribution of benefits is often overlooked (Yitzhaki, 2003) because of lack of data or interest. 
The absence of a systematic framework to consider both efficiency and equality results in a one-
sided immunization policy that disregards or, at worst, enlarges the gap of inequality in 
children’s immunization rate.  
In order to address this limitation, I incorporate efficiency measures and equality 
indicators within one framework. I believe that using quantitative indicators of inequality based 
                                                 
27
 The primary immunizing course of three doses of DTP (diphtheria-tetanus-pertussis) is given in the first month of 
life. For the full protection, at least three more doses of vaccine containing tetanus toxoid should be given to females 
before childbearing age (Galazka, 1993). The WHO considers the optimal time for boosting boys and girls to be at 
6, 7, and 8 years of age. School-based programs for administering booster doses of tetanus toxoid may be the best 
strategy against tetanus (WHO, 1995).  
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on parents’ level of education will help avoid immunization options that are dominated by 
efficiency at the expense of equality.  
There is another limitation to current immunization policy analysis that this paper seeks 
to address. It has been assumed that vaccination delivery costs through school systems might be 
cheaper than the costs through other delivery modes, but there are no data or studies to support 
such an assumption. Here I examine the rich experience and the data on school-based 
immunization in Indonesia to show that the delivery cost through school-based immunization is 
approximately two thirds that of other modes.   
The next section of this essay contains a brief review of the literature on equality in 
immunization. Section 3 discusses methods to measure inequality and efficiency. Then the three 
following sections explain the background of the study sites, 12 immunization schemes to be 
examined, and data sets used in the analysis. In section 7, I separately present the empirical 
results in terms of equality and efficiency as well as trade-offs between equality and efficiency 
according to different vaccination schemes; here I also conduct the Monte Carlo probabilistic 
sensitivity analysis in order to test the robustness of the results. In section 8, I present my 
conclusions. 
 
2. Literature Review 
Immunization is one of the most cost-effective interventions to prevent a series of major 
illnesses, particularly in environments where children are undernourished and many die from 
preventable diseases (World Bank, 1993). Immunization in developing countries, however, tends 
not to cover children from the poor in a society. Children in the poorest quintile are less likely to 
be fully immunized than those in the wealthiest quintile (Gwatkin, Nichter, 1995; WHO, 1999; 
Gwatkin and Deveshwar-Bahl, 2000; Gwatkin and Garima, 2001; Rutstein, Johnson, Pande, & 
Wagstaff, 2000; Vandemoortele, 2001; Pane and Yazbeck, 2002; and Delamonica, Minujin, and 
Gulaid, 2005).  
Gwatkin and Deveshwar-Bahl (2000) use household data collected by the Demographic 
and Health Survey program for 41 countries and overview the information about socioeconomic 
inequalities in full immunization coverage. They find that virtually everywhere full 
immunization rates (BCG, measles, DPT, and polio) are considerably higher among the rich than 
among the poor. On average, the rate is 25-75% greater in the richest than in the poorest quintile 
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of a country’s population. Since diseases that can be prevented through vaccines are generally 
thought to be concentrated primarily among the poor, Gwatkin and Deveshwar-Bahl conclude 
that there is a significant mismatch between the population groups that most need immunization 
and the population groups that immunization programs most frequently serve.  
Pande and Yazbeck (2003) use data from the India National Family Health Survey and 
analyze socioeconomic inequalities in immunization in India. They find that wealth and regional 
inequalities are correlated with overall levels of immunization. On one hand, there is a basic 
system failure that leaves even the wealthiest children with high levels of no immunization. On 
the other hand, any initial improvements in the degree of full immunization result in a significant 
increase in the immunization rate of wealthy children, causing wealth inequality to increase also. 
However, once performance has reached a critically good level (low no immunization and high 
full immunization), the immunization rate for the poor increases and inequalities decrease. 
Victoria et al. (2000, 2001) report similar patterns for immunization in Brazil.  
Schwartz and Bhushan (2004) examine immunization equity through a public-private 
partnership in rural areas of Cambodia. In the mid-1990s, the Cambodian primary health care 
system was not able to deliver an adequate level of services (Bhushan, Keller, and Schwartz, 
2002). Only 39% of children were fully immunized in 1998 (NIS, 2000). Thus, the Ministry of 
Health collaborates with international nongovernmental organizations (NGOs) to deliver primary 
health care services. Schwartz and Bhushan find that whether a child is fully immunized is 
affected by household wealth, as well as other factors such as whether the household lives in an 
urban or rural area, the mother’s level of education, the mother’s age, and the child’s sex. They 
also find that children in the poorest households in the districts served by NGOs are more likely 
to be fully immunized than poor children living in districts served by the government.  
Indonesia’s immunization program shares these characteristics. Nationally, the vaccine 
coverage rate for BCG, measles, DPT, and polio differs by income:  43% for the poorest 
population quintile vs. 72% for the richest quintile (Gwatkin and Deveshwar-Bahl, 2000; and 
Gwatkin and Garima, 2001).  
However, all of the existing studies were conducted after the mass immunization 
campaign (post-campaign studies). There are no studies that examine the expected effect of 
immunization programs on inequalities in vaccine coverage that are associated with pre-
campaign socioeconomic status (pre-campaign studies). 
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3. Methods 
3.1. Measuring socioeconomic status 
Immunization inequalities have been defined in socioeconomic terms, and the few studies 
examining inequalities in immunization rates have mostly used household income or 
consumption to measure socioeconomic status. However, several studies that examine 
inequalities in health but do not focus on immunization have used a variety of different measures 
of socioeconomic status, including income (van Doorslaer, Wagstaff, and Bleichrodt et al., 
1997), consumption (Wagstaff, 2000), size or ownership of household assets (Gwatkin, Rutstein, 
Johnson, Pande, & Wagstaff, 2000; and Koenig, Bishai, and Ali, 2001), as well as educational 
attainment (Kunst and Mackenbach, 1994; and Schwartz and Bhushan, 2004). Educational 
attainment and income are the most common proxy measures of human capital, 28 and a higher 
level of education ought to be correlated with increased earning power (Muller, 2002). In 
addition, more schooling, especially of mothers, seems to correlate with better health for 
families. In this study I use the level of parental education as an indicator of socioeconomic 
status in measuring immunization inequalities.  
 
3.2. Measuring inequalities by parents’ education  
There are several indexes of inequality in the literature on the measurement of inequality. 
They are the mean of the distribution, the coefficient of variation, the variance of logs, the Gini 
coefficient, the Theil index (1967), and the Atkinson index (1970, 1975) (see Levy et al., 2006 
for further details of each index). The Gini coefficient (G), a well-known measure for the 
magnitude of inequalities in health, is applied for the analysis, whose simple formula (Brown, 
1994) is shown below: 
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where X is the cumulative proportion of the population variable and Y is the cumulative 
proportion of cases expected or avoided. 
                                                 
28
 See Barro and Sala-i-Martin, 1995; Barro and Lee, 1996; Barro, 1998; and Kalaitzidakis, Manuneas, Savvides, 
and Stengos, 2001. 
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All children in the sample are ranked by the educational attainment of the household 
heads (usually their mother or father). The Gini coefficient ranges from 0 to 1, with 0 
representing perfect equality and 1 representing total inequality. The Gini coefficient is defined 
as twice the area between the Lorenz curve and the diagonal (area A of Figure 3.1).  
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Figure 3.1 An example of the Lorenz curve 
 
 
The Lorenz curve shows the percentage of immunized children (y-axis) against the 
cumulative proportion of children (x-axis, beginning with those whose parents have not finished 
elementary school and ending with those whose parents have more than a high school 
education). If immunization is distributed equally among children from all parental educational 
attainment levels, then the Lorenz curve meets the diagonal. In a perfectly equal society, the 18% 
of children with the least educated fathers would account for 18% of all immunized children. The 
55% of children whose fathers did not go to middle school would account for 55% of the total 
A 
Line of equality 
No schooling Elementary Middle High > High 
Lorenz curve 
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immunized cases, and so on. The further the curve is from the diagonal (area A), the greater is 
the degree of inequality in immunization.  
 
3.3. Measuring efficiency 
The results of economic analyses (e.g., cost-effectiveness analysis or cost-benefit 
analysis) will vary depending on the perspective assumed by the analyst (Drummond et al., 
2005), since that perspective determines which costs should be included and how they should be 
valued (Szucs, 2005). For example, a health care providers’ perspective focuses on the number 
of cases prevented by immunization programs. From a public-sector budgetary perspective, 
public-sector costs that are avoided or costs borne by healthcare providers are important criteria. 
From a comprehensive societal perspective, all costs and benefits should be identified, regardless 
of who incurs the costs and who receives the benefits (Szucs, 2005).   
 
Net benefits 
In justifying an immunization program, positive social net benefits would be one of the 
necessary conditions. Assuming that all or most benefits and costs of an immunization program 
can be quantified, the criterion of positive net benefits dictates that the benefits of introducing 
typhoid vaccines outweigh the costs. In the analysis I focus on two different measures of net 
benefits based on two different perspectives: a net public budgetary perspective and a net societal 
perspective.  
The first net benefit measure is taken from a public-sector budgetary perspective and 
subtracts the vaccine cost from the public-sector treatment cost savings,   
 
              Net public benefits = [Avoided public COIi]-[Total vaccine costi] 
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where ci is the number of cases prevented by an immunization program in group i and  r is a 
social discount rate, assumed as 3%. Qi denotes the number of individuals vaccinated by the 
program in group i and ScV  denotes the cost of the Vi vaccine per immunized child, including the 
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procurement and delivery cost, as well as the private cost of obtaining the vaccine (i.e., 
transportation cost and travel/waiting time).  
The second net benefit measure is taken from a societal perspective and adds willingness 
to pay (WTP) estimates to the first net benefit. WTP measures include pain, suffering, preventive 
expenditures associated with illness, and the value of reduced mortality risk, as well as actual 
costs associated with illness. 
 
         Net societal benefits = [WTPi + public COIi]-[Total vaccine costi]   
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Cost-effectiveness measures29 
While the cost-benefit analysis helps a decision-maker determine whether to pursue a 
particular goal, the cost-effectiveness analysis helps a decision-maker who has already decided 
to pursue the goal determine the lowest cost approach (Hinman, 1999). Assessing the cost-
effectiveness of a vaccination program can help guide decisions about introducing vaccines 
versus other health interventions.  
Since the early 1990s, standard cost-effectiveness methods have been developed by the 
Disease Control Priorities Project (Jamison et al., 2006) and WHO’s CHOICE project (WHO, 
2003b).30 It is useful to compare the “cost-effectiveness” (the cost per unit of effect) of a 
particular intervention either to those of alternative interventions that produce a similar effect or 
to a standard cut-off value (Evans and Hurley, 1995). If an intervention’s cost-per-unit effect is 
less than that of one or more alternative interventions, it will be judged the “more cost-effective.” 
If its cost-per-unit effect is less than a cut-off value, it may simply be judged “cost-effective.” 
Either result provides support for using the intervention as part of a health program, ensuring that 
the desirable effect is maximized subject to the constraint of a fixed budget (Bobadilla et al., 
1994).  
                                                 
29
 The basic analysis tool for cost-effectiveness measures is developed by the UNC-DOMI economic team.  
 
30
 For more information on the DCP, see http://www.dcp2.org; for CHOICE, see http://www.who.int/choice.  
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The third measure of efficiency in this study, the incremental cost-effectiveness ratio, is 
again taken from a public-sector budgetary perspective. It is the public dollars spent on 
vaccination minus the public-sector cost savings per disability-adjusted life years (DALY) 
averted: 
 
[ ]
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The DALY measure includes two components: years of life lost due to premature 
mortality (YLL) and years lived with disability (YLD). The DALY loss from mortality is 
calculated on the basis of the standardized life expectancy for children.   
In order to compare the “cost-effectiveness” of the Vi vaccination with the cut-off value, 
I use the common threshold, per capita gross domestic product (GDP). A “very cost-effective” 
intervention is one with a cost-effectiveness ratio less than the per capita GDP, while a “cost 
effective” intervention is one with a ratio less than three times the per capita GDP. To determine 
whether typhoid immunization competes with other important interventions, one would examine 
cost-effectiveness estimates (per DALY averted) of those other health interventions.   
 
4. Background 
Jakarta is the capital city of Indonesia and consists of five municipalities (South Jakarta, 
East Jakarta, Central Jakarta, West Jakarta, and North Jakarta). The total area is approximately 
662km2.  In 2001 the population of Jakarta was about 9.7 million, with a growth rate of 0.52% 
(Statistics DKI Jakarta, 2002, see Figure 3.2). But the population rises up to 11 million during 
the day, when people commute into the city from suburban areas for work. The monsoon-type 
climate is characterized by two seasons, with the dry season running from June to September and 
the rainy season from December to March. 
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Figure 3. 2. North Jakarta and Jakarta Bay, Indonesia 
 
 
In Indonesia, diarrhea is the third leading cause of overall morbidity and infant mortality 
(Nazir et al., 1985; Simanjuntak et al., 1998; UNDP, 2005). It is widely acknowledged that 
various diarrhea diseases are spread via fecal-oral routes, and that these routes are far more 
heavily traveled where water supplies and sanitary conditions are inadequate (McGranahan et al., 
1997).  
The sources of the existing water supply system in Jakarta are surface water, ground 
water, and spring water (Shofiani, 2003). In 2001 only about 25% of households in Jakarta had 
piped water supplied to the dwelling (Demographic and Health Survey, 2003). The average 
domestic water consumption is about 77l/capita/day for a household, which is lower than other 
mega-urban regions in Southeast Asia (ADB, 2005; Yulinawati 2005). The problem with 
drinking water in Jakarta is not only scarcity, but also inefficient allocation, inequitable pricing, 
and microbial contamination.  
The households with piped water connections are those of relatively high-income 
families, which spend 2% of their incomes on water (ADB, 2005). Another 25% of households, 
with neither house connections nor shallow wells, rely upon public wells and standpipes or have 
their water delivered by water vendors. Most of them are low-income families, and they spend 
7% of their incomes on water.31 The remaining population (half of the households) draws its 
                                                 
31
 The vendor water costs approximately USD3-5/m3, which is 10-25 times higher than the cost of piped water, 
USD0.3/m3 (ADB, 2005)-USD0.6/m3 (UN-HABITAT and Annan, 2003). Water vendors buy water at USD0.4/m3 
from public taps and sell at USD3-5/m3.   
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water supply from shallow wells. Groundwater is accessible within a few meters of the surface in 
most of Jakarta. However, most of this groundwater is not potable.  
Most urban dwellers rely on on-site sanitation rather than a sewer network to dispose of 
human waste. The on-site septic tank and cesspits are often connected to street drains with no 
waste treatment.  
Jakarta’s government attempted to solve the clean water supply problem by privatization. 
Despite this governmental intervention, however, safe water and better sanitation do not seem to 
be achievable in the near future in Jakarta. Therefore, the prevention of water-transmitted 
diseases through vaccines, as recommended by the WHO, is considered to be the second-best 
measure.  
 
New-generation typhoid vaccines 
There are two licensed and internationally available typhoid vaccines. The currently 
licensed liquid formulation of Ty21a has shown protective efficacy of 53-78% in children for at 
least five years. The Vi polysaccharide vaccine has efficacy of 64-72% in children and adults for 
at least three years (Ivanoff et al. 1994; Levine 1998; and Hessel et al. 1999). Both vaccines are 
licensed for use in persons two years and older, although data are limited on the clinical 
protection conferred by the vaccines to children under five years of age. These new-generation 
typhoid fever vaccines are licensed by the national Food and Drug Control Organization (POM) 
in Indonesia, too.   
Currently vaccines against typhoid fever (e.g. Vi polysaccharide and Ty21a) are available 
in Indonesia. However, they cost between USD6 and USD26 per dose. Since about 86% of 
Indonesians are not covered by any form of health insurance scheme (Thabrany, 2001);32 most of 
the typhoid vaccine cost is paid by clients out of pocket. With approximately 56% of Indonesians 
living on less than USD2 per day (WHO, 2006b), the vaccine is too expensive for anybody but 
the rich. 
 
Health sector financing and immunization 
                                                 
32
 Two main insurance companies, Askes and Jamsostek, cover 10% of the Indonesian population, while 
commercial insurance covers 4% (Thabrany, 2001, 2003; Hidayat et al., 2004; WHO, 2006b). 
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By the mid-1990s Indonesia had recorded high Expanded Program in Immunization 
(EPI) coverage, with at least 80% of all children receiving basic EPI vaccines before their first 
birthdays (WHO, 2007b). But in 1997 the Asian financial crisis, the end of the Soeharto 
government, and the decentralization of health services negatively affected the immunization 
program (USAID, 2008). During the crisis, only 52% of children were immunized against the six 
major vaccine-preventable diseases targeted by the EPI program (USAID, 2008). The formerly 
high-performing immunization program has fallen to dangerously low levels, leaving many 
infants and young children seriously exposed to the risk of disease and death (USAID, 2008).  
In addition, the government’s health care budget has been tight. During 2005, total 
expenditures for health were only 2.7% of gross domestic product, equivalent to USD34 per 
capita (WHO, 2006a). These are far below the average health expenditure for developing 
countries, 4.5% (WHO, 2006b). Out of the total health expenditures in Indonesia, 65% (USD22 
per capita) was spent by the private sector, whereas only 35% (USD12 per capita) was spent by 
the government (WHO, 2006a). Half of the total expenditure is out of pocket (USD17 out of 
USD34 per capita).33 The Ministry of Health (MOH) covered only 10% of the total health 
expenditure (USD3 per capita in 2005USD).  
However, Indonesia had recovered by 2000 from the economic crisis of 1997 
(Tjiptoherijanto and Remi, 2001; Cogneau and Grimm 2004; and Strauss et al., 2004). In 
addition, external donors have buffered the profound impacts of the crisis and the 
decentralization of the health sector by increasing funding targeted to the poor. Michaud (2005) 
tracked the external resource flows to the health sector in Indonesia and found that USD188 
million of external funds were spent in the health sector in 2002. There was no significant 
change in health sector spending before and after the economic crisis, according to the WHO 
(2006a). 
Recently the GAVI/Vaccine Fund committed USD40 million over five years (2002-2007) 
to support immunization services (USD16 million), injection safety (USD10.7 million), and 
Hepatitis B vaccines (USD13.2 million) (GOI, 2001, 2004, 2006; and Michaud, 2005). USAID 
also provided a USD20 million grant in order to increase the EPI immunization coverage for two 
years, beginning in 2007. Both projects have committed to building the capacity to sustain 
                                                 
33
 The author’s calculation using WHO (2006a). 
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immunization programs. These recent efforts may provide a better environment for the school-
based immunization project against typhoid fever that is considered here. 
 
5. Immunization scheme 
The school-based immunization program considered in this paper would be conducted in 
two impoverished sub-districts, Koja and Tanjung Priok, in North Jakarta with a combined 
population of 580,234.34 The Vi vaccine would be administered at schools. In the two sub-
districts, there are 204 primary schools and 90 junior high schools. Children who do not attend 
school are encouraged to go to the nearest school for immunization.  
Initial informational meetings would be held a couple of months before the immunization 
campaign. Posters and information leaflets on prevention of typhoid fever, the project’s aims, 
and immunization dates would be distributed to the puskesmas (community health center), 
schools, and households (through students). The vaccines would be delivered from a local cold 
room to the logistics office at NIHRD on daily basis, and then transported to the schools in 
project vehicles. Vi polysaccharide vaccine must be stored at a temperature of 2-8˚C (Agtini et 
al., 2006).  
The Vi polysaccharide vaccine is assumed to be locally produced. One vial contains 10-
20 doses. Given the Indonesian policy of discarding opened vials of vaccine at the end of a day, 
the vaccine wastage rate is assumed as 10%.35  
The immunization programs are categorized by vaccine delivery mode, the financing 
method, and target group. The vaccine would be delivered either by single injection or 
simultaneous administration. “Simultaneous vaccination” is when multiple vaccines are 
administered, usually in separate limbs (e.g., one in each arm). The single injection of the Vi 
vaccine is a baseline scenario in case administering it simultaneously with the TT booster turns 
out to be unsafe. However, there is usually no contraindication to simultaneous administration of 
any vaccines, except in the case of cholera and yellow fever or two live vaccines at the same 
                                                 
34
 The population figure from SUSENAS 2003 is updated to 2007 using the growth rate of population in Jakarta, 
0.52% (Statistics DKI Jakarta, 2002).  
 
35
 It is worth noting the opposite relationship between vial format and wastage rate. Multi-dose vials, in general, sell 
at a lower per-dose price and occupy less cold-chain capacity than single-dose formats. However, higher wastage 
rates of multi-dose vials may offset these benefits (for further details see Drain, Nelson, and Lloyd, 2003). In order 
to immunize more children at a minimum cost, the best strategy would be to use 20-dose vials and single-dose vials 
together. 
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time (Nafarrete, 2007). Giving a child several vaccines at the same time offers two practical 
advantages. First, more children can be immunized. Second, it means fewer visits to health care 
facilities, which saves both time and money for parents as well as for the public sector. 
It is worthwhile distinguishing “simultaneous vaccination” from “combination vaccine.” 
A combination vaccine consists of two or more separate vaccines that have been combined into a 
single shot. Examples of combination vaccines in current use are DTaP, trivalent IPV (three 
strains of inactivated polio vaccine), MMR (measles-mumps-rubella), DTaP-Hib, and Hib-
hepatitis B (Hep B). Individual vaccines should not be mixed in the same syringe unless they are 
licensed for mixing. The safety and immunogenicity of the Vi vaccine when given 
simultaneously with the TT booster in separate syringes or when combined in a single syringe is 
under study. The combination vaccine is not examined in this analysis because its licensing may 
take longer and there is a great degree of uncertainty as to the cost of manufacturing it.36  
There are two target groups. The first is only the students who attend primary or junior 
high schools, ages 5-14. The second is all children who are old enough to receive the vaccine 
safely (2 years) but under 15 years old.  
There are three financing schemes for the immunization. In the government scheme, the 
Indonesian government would pay all of the immunization costs. The procurement assistance 
scheme represents a cost-sharing arrangement. The vaccine procurement cost would be 
financed by external donors and the vaccine delivery cost by the Indonesian government. 
Indonesia is eligible for five-year (in most cases) time-limited grants from the GAVI Alliance 
(2006) to introduce new vaccines. 37 This cost-sharing scheme is the same as that of the 
ongoing DTP-Hepatitis B vaccination program. The last financing scheme is a user fee system. 
In this financial scheme, parents pay a user fee for their children’s vaccination against typhoid 
                                                 
36
 The price of a hypothetical combination vaccine depends on whether the cost of research and development is 
absorbed by the vaccine price. The information on the prices of combination vaccines is somehow contradictory. 
The experience of the PAHO revolving fund in procuring a pentavalent vaccine (DPT, HBV, Hib) shows that 
combination vaccines would have only a negligible effect on the overall cost of vaccination; that is, the cost of the 
combined vaccine was slightly more than the sum of the components (UN, 2002). However, the combined TT-
typhoid vaccine is new and plenty of research costs may be built into the vaccine procurement cost. Like Hep B, it 
may be costly. The price of DTP and Hep B was USD0.14 and USD0.28 in 2004, respectively. The sum of the two 
vaccine prices is only USD0.42, but at USD1.2 the price of the combination vaccine is 3.6 times higher. See 
http://www.who.int/immunization_delivery/new_vaccines/GAVI_Product_Menu.pdf. 
 
37
 All countries below the $1000 GNI/capita threshold and with immunization coverage of 50% or higher would be 
given equal access to grant resources (GAVI Alliances, 2006). 
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fever. The user fee is charged at the revenue-neutral point, i.e., at the point that the net program 
cost (total program cost−public COI−revenue) is zero.  
 
6. Data 
The Diseases of the Most Impoverished (DOMI) program conducted a series of 
epidemiological and economic studies in North Jakarta between 2002 and 2003. These include: 
1) a population-based surveillance study to measure the incidence of typhoid fever in two sub-
districts of Jakarta (Tanjung Priok and Koja); 2) a public and private cost-of-illness study of 
typhoid patients identified by blood culture in the surveillance study in Tanjung Priok and Koja;  
3) a survey carried out in the four other sub-districts of North Jakarta (Penjaringgan, Kelapa 
Gading, Cilincing, and Pademangan) on household willingness to pay for hypothetical typhoid 
vaccines using the contingent valuation method (855 respondents); and 4) vaccine cost studies.  
 
6.1. Burden of disease 
The Indonesian government has a surveillance system to detect diarrhea cases; however, 
public health data are likely inaccurate because of misdiagnosis, self-treatment, and the fact that 
only about 30% of provinces regularly provide disease reports to the central government (Malik 
et al., 2005). The DOMI research conducted the most recent study for measuring typhoid fever 
incidence in slum areas of North Jakarta from August 2002 to July 2003. Typhoid cases in the 
study area were identified through passive surveillance at participating government health 
facilities. During that year, 16,872 people presented at the health care facilities with three or 
more loose bowel movements within a 24-hour period and/or a fever (≥37.5˚C) for three or 
more days.  
One hundred thirty-one cases of typhoid fever were identified by blood culture, resulting 
in an estimated incidence of 1.6 per 1,000 (Ochiai et al., 2007).38  Children were at considerably 
higher risk of typhoid fever in the slum area of North Jakarta than adults, i.e., 3.5 per 1,000 
versus 1.0 per 1,000. Children aged five to fourteen years were at the highest risk of getting 
typhoid fever.  
                                                 
38
 Since several studies have shown blood cultures to be only around 50% sensitive as compared to bone marrow 
cultures, a multiplier of two is applied to the adjusted number of cases. 
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Still, laboratory data have fortunately shown that antibiotic resistance against S. typhi is 
not evident yet in Indonesia (Arjoso and Simanjuntak, 1998) 
 
6.2. Economic burden of typhoid fever 
Of 1,342 blood-culture-confirmed cases among children (aged 2-15 years), 72 were 
identified as typhoid fever in the DOMI surveillance study. These cases were enrolled in the 
DOMI cost-of-illness (COI) study to measure both the private and the public (or governmental) 
costs of a typhoid fever episode. The private COI includes both direct and indirect costs. The 
private direct COI consists of out-of-pocket costs incurred by patients for treatment, hospital 
stays, medicines, laboratory tests, transportation, and the food and lodging of patients and those 
accompanying them. The private indirect costs include lost wages of caretakers while looking 
after ill children as well as lost productivities of patients due to typhoid fever. The public COI 
measures the direct financial costs of providing treatment, the estimated depreciation cost of 
capital items (buildings and equipment), and a step-down allocation of indirect costs, such as 
administration and support.  
 
6.3. Willingness to pay (WTP) and predicted vaccine coverage rate 
Willingness to pay 
In the contingent valuation survey, 855 respondents were told about a hypothetical 
typhoid vaccine and asked if they would purchase the vaccines for their children at one of five 
randomized prices. The data of the contingent valuation survey include the level of parental 
education and whether each school-aged child attends school or not. First, the household’s WTP 
for young children aged 2-4.9 years, school-aged children (5-14 years) who attend school, and 
school-aged children who do not attend school are estimated by parental educational level if a 
70% effective/3-year typhoid vaccine were available (see the column of WTP before adjustment 
in Table 3.1 below).39  Second, the WTP estimates are adjusted for the time-to-think effect for 
each group of children (see the column of WTP after adjustment in Table 3.1). Several studies of 
private demand for typhoid or cholera vaccines find that respondents who were given more time 
to think about the hypothetical vaccine overnight indicated they were willing to pay 8-10% less 
                                                 
39
  The codes for estimating WTP developed by Cook, J., Maskery, B., and Jeuland, M. are adapted using 
information on school enrollment in the data of the contingent valuation survey.  
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than before they were given the extra time (see Cook et al., 2007; Lucas et al., 2007; Whittington 
et al., 2007; and Islam et al., 2008). 
 
Table 3.1. Vaccine coverage rate for free vaccine and WTP for children by age group and     
enrollment as well as parental education, with and without adjustment for time-to-think and  
uptake in TT booster project 
Before adjustment After adjustment 
Parental education 
Coverage rate WTP (2007 USD) Coverage rate WTP (2007 USD)  
Panel A: Young children (2-4.9 yrs) 
No schooling 38% $7 34% $6 
Elementary school 52% $9 46% $8 
Middle school 76% $11 68% $10 
High school 100% $13 89% $12 
> High School 100% $16 89% $15 
Panel B: School-aged children who do not attend school 
No schooling 36% $6 30% $6 
Elementary school 48% $8 40% $8 
Middle school 63% $9 53% $8 
High school 89% $14 75% $12 
> High School 100% $29 84% $26 
Panel C: School-aged children who attend school 
No schooling 53% $12 64% $11 
Elementary school 61% $13 74% $12 
Middle school 71% $15 86% $14 
High school 77% $18 93% $16 
> High School 88% $21 107% $19 
    Source: the data of the DOMI-contingent valuation survey. 
 
 
Predicted vaccine coverage rate 
The vaccine take-up rates (i.e., how many people would get vaccinated) for a free vaccine 
are also estimated for the same three groups of children according to parental education, using 
the data from the contingent valuation study. Then, for more accurate estimation the take-up 
rates are adjusted in two ways: the time-to-think effect for children who do not attend school and 
the school-delivery effect for children who attend school.  
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Panel A and B before adjustment in Table 3.1 present the predicted vaccine take-up rate 
for children who do not attend school (including young children). When the estimates of vaccine 
take-up at a zero price are adjusted to account for the effect of giving respondents time to think 
about their answers. Thus, the coverage level goes down 10-15%. The coverage rates of children 
who do not attend school are estimated to be, on average, 59% (2-4.9 years) and 50% (5-14 
years) for a free typhoid vaccine. In addition, 80% of people are assumed to have heard about the 
immunization campaign. In the sensitivity analysis these adjusted estimates are ranged by +/− 
20% of their base value.  
Next, the coverage rate for children from the contingent valuation survey who attend 
school is adjusted for the field evidence, that is, the coverage levels of the current school-based 
immunization programs in Indonesia. The coverage rate of the school-based TT booster program, 
which has been in operation for almost a decade in Indonesia, ranges by district from 80-89% at 
its highest to 50% at its lowest (WHO, 2007b). In Jakarta the BIAS program achieved a coverage 
rate of more than 90% between 2002 and 2004 (MOH, 2002). In addition, the DOMI Vi 
immunization project conducted in Jakarta in 2004 randomly selected 18 out of 105 public 
primary schools in Koja and Tanjung Priok (nine in each sub-district). The target population was 
5,303 students aged 5-11 years who attended the randomly selected schools. The demonstration 
project achieved an 84% coverage rate at the first visit. After additional contacts with 
unvaccinated children, the final coverage was 91% (Agtini et al., 2006). The immunization plan 
in this paper targets the same population in the same area through the same vaccine delivery 
strategy as the demonstration project. Therefore, based on the field evidence the coverage rates 
for children who attend school are adjusted 20% higher to 80% (see Panel C), compared to 50-
59% for children who do not attend school.  
 
6.4. Total vaccine cost 
Deriving the vaccination cost poses a significant challenge, as many studies have 
demonstrated. For example, Walker et al. (2000) and Pegurri et al. (2005) show that published 
cost studies lack information and transparency in the costs of currently available vaccines, 
making it more difficult to estimate the costs of a hypothetical vaccine. Within this limitation, I 
discuss two components of vaccination costs: the procurement cost and the delivery cost.  
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6.4.1. Vaccine procurement cost                                             
During the demonstration campaign, the Vi polysaccharide typhoid vaccine was supplied 
by GlaxoSmithKline from Belgium. However, if the vaccine were locally produced, the 
procurement cost would be lower. Vietnam has locally produced Vi at the price of USD0.54 per 
dose packaged in a 20-dose vial. Assuming 10% wastage and an estimated cost of USD0.04 per 
syringe, the cost of vaccine and syringe per vaccinated individual is hypothesized at USD0.60 
(Lauria and Stewart, 2007).  
 
6.4.2. Vaccine delivery cost                                                       
The incremental costs of adding a new vaccine vary depending on the vaccine delivery 
mode, the capacity of the current immunization system,40 the size of the immunization 
program,41 and the volume of the packages for the vaccine.42  
In order to derive vaccine delivery costs in Indonesia, I begin with the financial records 
of the demonstration project for typhoid immunization in North Jakarta as well as data on 94 
other immunization programs in Indonesia from the available literature (Anwar, 2001; Simbolon, 
2001; Malik et al., 2004; Mardiati et al., 2004; Stewart, 2005; and WHO, 2006c). Mardiati et al. 
(2004) use the richest data on vaccine cost in Indonesia. From 2001 through 2003, the vaccine 
costs per fully immunized child (FIC) for administering the traditional EPI6 vaccines (DTP, 
measles, polio, and BCG) were on average USD5.6 in four districts (Bangka, Belitung, 
Banjarnegara, and Pekalongan). In order to estimate the costs of delivering vaccines specifically 
in Indonesia, first, total vaccine costs per FIC and total vaccine costs per dose are calculated. 
Second, procurement costs of vaccines per dose are estimated based on certain assumptions and 
limited available vaccine price data. Finally, vaccine delivery costs are calculated by subtracting 
procurement costs from total vaccine costs per dose, since total vaccine costs per dose are the 
sum of procurement costs and delivery costs (see Appendix A for further details).  
                                                 
40
 For further details, see Martin, 1984; Creese, 1986; Shepard, Sanoh, and Coffi, 1986; Feilden, 1990; Brenzel, 
1990, 1994; Monath, 1993; Parent, Gessner, and da Silva, 2001; Waters et al., 2002, 2004; and WHO, 2004. 
 
41
 See Cook, 2007; and Lauria and Stewart, 2007.  
 
42
 See Hall et al., 1993; Edmunds et al., 2000; and Griffiths, Hutton, and das Dores, 2005. 
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After excluding the two extreme cases of typhoid Vi in North Jakarta and cholera in 
Aceh, I characterize the programs by (1) EPI versus non-EPI and (2) BIAS versus non-BIAS and 
present the average delivery cost with each program, as shown in Table 3.2.  
 
Table 3.2. Vaccine delivery costs per dose by delivery mode (2007USD) 
Category Characteristics of program Mean (Range) No. of observation 
EPI 0.9 (0.1-3.3) 69 EPI 
Non-EPI 0.7 (0.2-2.2) 24 
BIAS 0.6 (0.2-1.2) 12 BIAS 
Non-BIAS 0.9 (0.1-3.3) 81 
Note: BIAS includes only the TT booster. Non-BIAS includes all of EPI vaccines and TT.  
Source: Anwar (2001); Simbolon, (2001); Malik et al. (2004); Mardiati et al. (2004); and Stewart (2005). 
 
 
EPI versus non-EPI                                            
In Table 3.2 the category of non-EPI includes the administration of routine TT vaccines 
and the TT booster. There is a slight difference in the cost between EPI (USD0.9) and non-EPI 
(USD0.7) delivery.  
The EPI category includes the Hep B vaccines, which is delivered through the EPI 
program within seven days of birth to all newborns (MOH, 2002). Since most newborns in 
Indonesia are delivered at home (79% in the 1990s) (CBS, 1997), the Hep B vaccines are 
administered by midwives, making their delivery costs more expensive than other EPI vaccines, 
which are usually provided in health care facilities. The wastage rate of Hep B vaccines (31%) is 
also higher than the wastage rate of other EPI vaccines (5-10%) in Indonesia. Thus, the delivery 
cost of Hep B vaccines is on average USD1.4, higher than other EPI vaccines (USD0.7). If 
Hepatitis B programs are excluded from the category of EPI, the delivery cost of EPI vaccines is 
the same as non-EPI, on average. 
 
BIAS versus non-BIAS                                      
The BIAS category includes only TT booster vaccines, whereas the non-BIAS category 
includes all EPI and TT vaccines. The costs of delivering TT booster vaccines through the 
school-based platform (USD0.6) are lower than other vaccine delivery modes (USD0.9). The 
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range of delivery costs through the non-BIAS program is also wider than the one through the 
BIAS program, probably because the school-based program delivers the vaccines more 
efficiently and consistently.  
For the purpose of this paper, I make the conservative assumption that the average 
delivery cost is USD0.6 per dose for a vaccine administered singly (rather than simultaneously 
with other vaccines) through schools. Soendoro (2007), NIHRD staff, assumes the cost of 
typhoid vaccine delivery through the schools to be USD0.4 in Jakarta.  
This delivery cost is almost half of Lauria and Stewart (2007)’s recommendation for 
Indonesia. They review data from six vaccine cost studies (four single-country studies and two 
multi-country studies) and unpublished cost data from DOMI vaccine trials. They recommend 
USD1.0 for middle-income developing countries. However, they rely on the cost data from 
Chile, Israel, Argentina, South Africa, and others, rather than on data from Indonesia, which the 
present study uses exclusively. In addition, Lauria and Stewart do not distinguish between 
school-based and mass immunization programs. Indonesia has a rich experience with school-
based immunization, and the unique data from its programs clearly shows that the vaccine 
delivery cost of school-based immunization is lower.  
On the other hand, the data on the vaccine costs used in this study (Anwar, 2001; 
Simbolon, 2001; Malik et al., 2004; Mardiati et al., 2004; and Stewart, 2005) do not provide 
enough information on whether the costs include economic costs. Therefore, in order to account 
for the uncertainty, I allow the vaccine delivery cost to range from USD0.2 to USD1.2 per dose, 
which covers the range of the BIAS data in Table 3.2, as well as Lauria and Stewart (2007)’s 
recommendation. 
In the immunization schemes for North Jakarta that I propose in this study, the typhoid 
vaccine would also be simultaneously delivered along with TT vaccines through an existing 
BIAS program. Since the TT booster program is already established for the primary school 
students, the only additional costs of delivering the typhoid vaccine would be in the additional 
volume of typhoid vaccine and additional administration time. The simultaneous administration 
of vaccines is expected to be especially cost efficient in personnel costs, often the largest cost in 
immunization programs. Based on several studies (for further details, see Appendix B), the 
delivery cost through simultaneous administration is assumed to be USD0.45 for the primary 
school students. Table 3.3 summarizes the parameters and the data in detail.  
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Table 3.3. Description of model parameters with ranges of uncertainty, except for WTP and 
coverage rate 
Parameters Value Uncertainty rangea 
Site characteristics 
Child population1 325,261  
Minimum wage/month (2007USD)2 96 (72-120) 
Enrollment rate3: Primary school (5-11 yrs) 
                 Junior high school (12-14 yrs) 
93% 
72% 
(90-98) 
(70-83) 
Disease of burden 
Incidence(/1000)4: Young Children (2-4.9 yrs) 
                   School-aged Children (5-14 yrs) 
3.0 
3.8 
(1.8-5.0) 
(4.1-6.8) 
Average duration of case (days)5 16 (10-21) 
Assumed case fatality rate (CFR)6 (%) 1% (0.5-3) 
Vaccine characteristics and costs  
Vaccine effectiveness (%)  65% (55-75%) 
Vaccine duration (years) 3 (2-4) 
Delivery cost per dose (2007USD) 
Single administration. 
Simultaneous administration  
Primary school students  
Non-primary school students  
$0.6 
 
$0.45 
$0.6 
(0.4-1.5) 
 
(0.2-1.2) 
(0.4-1.5) 
Acquisition cost per dose (2007USD) $0.6 (0.4-0.8) 
Cost-of-illness (2007USD)5 
Public COI per case  $25 (19-32) 
Private COI per case: Young Children 
                        School-aged Children  
$66 
$55 
(50-83) 
(41-69) 
Total COI per case: Young Children  
                     School-aged Children 
$98 
$78 
(74-123) 
(59-98) 
Other parameters 
Discount rate 3%  
DALY weight7 0.27 (0.075-0.471) 
Note: a In the sensitivity analysis the base value is adjusted within a range of +/- 20%.  
Sources: 1 2003 Census population in N. Jakarta, Indonesia. 2 In 2006 the minimum wage per month in Jakarta was 
Rp 819,100 (USD95.5 in 2007 dollars). See http://www.indonesia-ottawa.org/economy/Economicissues/wage-
minimum-jkt-06.htm. 3 UNICEF fact sheet, http://www.unicef.org/indonesia/girls_education_fact_sheet_final_ENG_1_.pdf 
for Indonesia. 4 The DOMI epidemiology study. 5 The DOMI cost-of-illness data. 6 According to the WHO, the CFR 
for typhoid fever is about 1% assuming treatment with antibiotics. In Indonesia most people (84%) know how to 
treat typhoid fever and get antibiotics (Marlik et al., 2005). Several studies (Crump, Luby, and Mintz, 2004; and 
Parry et al., 2002) also assume 1% of CFR as a conservative estimate. Therefore, in the analysis CFR is assumed as 
1%, ranging from 0.5% to 3% in order to deal with uncertainty. 7 Available online at: 
http://www3.who.int/whosis/discussion_papers/pdf/paper54.pdf.  For general discussion of calculating DALYs see 
http://www.who.int/healthinfo/boddaly/en 
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7. Results 
7.1. Equality  
The educational level of a parent is used to examine inequality.  All of the DOMI data 
sets, including the epidemiology data, the cost-of-illness data, and the data using the contingent 
valuation method, have consistent information on the educational level of children’s care givers, 
usually parents.  
This section answers several questions below: 
  
(1) Are children with less educated parents more likely to suffer from typhoid fever?  
(2) Do households in which household heads have lower educational attainment incur a 
greater economic burden if their children have typhoid fever?  
(3) If the immunization program is launched, would the program reduce cases associated 
with typhoid fever equally across parents’ educational level?   
(4) Are the immunization rates of children the same whether or not there is a user fee? 
 
Are children with less educated parents more likely to suffer from typhoid fever?  
Panel A of Table 3.4 shows private COI for typhoid fever cases among children by 
parents’ educational attainment without the programs. Panel B represents the percentage 
vaccinated also by parental educational attainment.  
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Table 3.4. Number of cases and cost-of-illness estimates due to typhoid fever with/without an 
immunization program in North Jakarta 
Parameters No 
schooling 
Elementary 
school 
Middle 
school 
High 
school 
> High 
School 
% of Population a 18% 37% 21% 20% 4% 
Monthly household income 
(2007USD)b 124 153 174 219 360 
Panel A: Without a program 
Typhoid fever cases c 25% 26% 18% 23% 8% 
Private COI (2007 USD) c 44 79 57 55 57 
% of private COI out of income c 36% 51% 33% 25% 17% 
Panel B: With a program 
Without user fee 60% 65% 71% 79% 80% Percentage 
vaccinated b With user fee ($1) 35% 42% 53% 65% 71% 
Sources: a UNICEF fact sheet http://www.unicef.org/indonesia/girls_education_fact_sheet_final_ENG_1_.pdf for Indonesia. 
b
 The DOMI data of the contingent valuation study. c The DOMI cost-of-illness data. 
 
 
The first, fourth, and fifth columns of Panel A in Table 3.4 show that children with the 
least educated (≤ elementary school graduation) and more educated parents (high school) tend to 
have more typhoid fever cases, compared to the rest of the population by parental education. 
There is also clear evidence that children with the most educated parents (>high school) are least 
likely to suffer more from typhoid fever.  
 
Do households in which household heads have lower educational attainment incur a greater 
economic burden if their children have typhoid fever? 
With regard to the economic consequences of typhoid fever cases, the private economic 
burden associated with typhoid fever in children is in general heavy for any educational group. In 
Jakarta, typhoid illness costs a family, on average, the equivalent of between 17% (>high school) 
and 51% (elementary school) of monthly household income, according to the DOMI COI study 
and the DOMI contingent valuation study. Several studies assume that an economic burden of 
illness greater than 10% of household income is likely to be catastrophic for the household 
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economy.43 Thus, the economic burden associated with typhoid fever in children can be 
considered catastrophic for all Jakarta households. This is mainly because of the national health 
care financing structure. Poulos et al. (2008) find that the great majority of the total (public plus 
private) costs of typhoid illness were paid from private funds (60% for hospitalized patients and 
74% for outpatients), while according to the DOMI COI study the government paid only 40% of 
the costs for hospitalized patients and 26% for outpatients. The COI study shows that nearly all 
of these private direct costs were paid by families themselves (90%), and only a fraction were 
paid by insurance companies (1%), employers, or others.   
Nonetheless, it is clear that less educated groups (36-51%) bear significantly more 
economic burden than more educated groups (17-25%). At first glance, the proportion of private 
COI burden to household income does not look different across parental education level.44 
However, it is worth noting that the poor often live on a daily wage that is barely enough to meet 
minimum food requirements (Russell, 2003). In terms of coping with the budgetary shock or 
mobilizing assets to pay for treatment, 36 to 51% of household income spent on private COI may 
feel very different to the less educated groups than 17 to 25% will feel to the more educated 
groups (≥ high school graduation).  For hospitalized cases, families paid the equivalent of nearly 
two months of their household income (USD210), five times more than for non-hospitalized 
cases (USD41). It is hard to imagine how less educated groups or the poor (if one assumes that 
less educated people earn less and are poorer, as shown in the second row of Table 3.4) cope 
with the catastrophic burden of having their children hospitalized for typhoid fever. They would 
first cut their consumption of other minimum necessities, then sell productive assets or borrow 
money (Townsend, 1995; Morduch, 1995, 2002; Gerbtler and Gruber, 2002; and Russell, 2003). 
Twenty percent of the sample households in the cost-of-illness datasets sold assets or borrowed 
money in order to provide treatments for their children. Therefore, the private economic burden 
of hospitalized cases associated with typhoid fever might push less educated groups toward 
impoverishment. 
 
                                                 
43
 This 10% figure is somewhat arbitrary, because it may not be catastrophic for high-income households that can 
cut back on luxuries to pay for treatment (Russell, 1996). 
 
44
  The Kruskal-Wallis equality test was conducted. The null hypothesis is that the average percentage of household 
income spent on private COI burden is the same across parents’ educational level. The hypothesis is rejected at 10% 
of significance (p=.62). 
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If the immunization program is launched, would the program reduce cases associated with 
typhoid fever equally across parents’ educational level? 
If vaccines against typhoid fever were delivered without a user fee (Panel B), children 
with more educated parents would be more likely to be vaccinated, from 60% in the least 
educated group to 80% in the most educated group. If a user fee were charged at the revenue-
neutral point (i.e., when the net program cost is zero) of USD1, the percentage vaccinated would 
decrease most in less educated groups, while the percentage would not change significantly in 
more educated groups. In sum, less educated parents have lower demand for vaccines against 
typhoid fever and are more sensitive to the price of the vaccine than more educated parents.  
 
Are the immunization rates of children the same whether or not there is a user fee? 
Figures 3.3 and 3.4 show the vaccination rate of school-aged children who attend school 
and those who do not, according to parental educational level. The vaccine coverage rate is 
estimated using the data of the contingent valuation study regarding the enrollment of each 
school-aged child. The sum of percentages across parental educational attainments is 100% in 
each figure. In 2002 the enrollment rate of schools in Indonesia was approximately 93% for 
primary schools and 72% for junior high schools.45  
 
 
                                                 
45
 See UNICEF fact sheet http://www.unicef.org/indonesia/girls_education_fact_sheet_final_ENG_1_.pdf 
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Figure 3.3 Vaccination rate: school-aged children who enroll in school 
 
 
If one looks at Figure 3.3, 26% of children who attend school have parents who have not 
graduated from elementary school. Their vaccination rate is 20% if the vaccine is free but 10% if 
it costs USD1, i.e., the revenue neutral user fee. Children with more educated parents (>high 
school) comprise only 4% of children who attend school, and their vaccine take-up rate is the 
highest as well as not sensitive to price. The white area in Figure 3.3 shows the difference in 
coverage rate between a free vaccine program and one with a user fee. Thus, the larger the white 
area, the more the vaccine demand is sensitive to price.  
However, Figure 3.4 for school-aged children who do not attend school shows vaccine 
demand failure (Pande and Yazbeck, 2003). For children who do not attend school, there is 
significantly lower demand even for free vaccines against typhoid fever across any parental 
educational level. Also, their demand is not affected by vaccine price.  
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Figure 3.4 Vaccination rate: school-aged children who do not enroll in school 
 
 
Another way of answering the question is to look at the Lorenz curve of typhoid fever 
cases illustrated in Figures 3.5 and 3.6. Figure 3.5 shows the inequality of current typhoid fever 
cases and Figure 3.6 the inequality of avoided cases. The Lorenz curve represents the cumulative 
percentage of typhoid fever cases against the cumulative percentage of the population. The x-axis 
is ordered by the educational attainment of parents. If one focuses on the Lorenz curve for young 
children in Figure 3.5, the first 18% of children (whose parents have no schooling) have only 6% 
of the total typhoid fever cases. The next 37% and 21% of children have parents who have 
graduated from elementary and middle school, respectively. These cumulative 76% 
(=18+37+21) of young children have 44% of the total cases. This result runs counter to the 
expectation that children with less educated parents will have a higher rate of incidence.  
 
  
 
109 
 
0
10
20
30
40
50
60
70
80
90
100
0 10 20 30 40 50 60 70 80 90 100
Cumulative percentage of Population
ranked by parental education
Cu
m
u
la
tiv
e 
pe
rc
en
ta
ge
 
o
f e
x
pe
ct
ed
 
ca
se
s
Equality line Young children
School aged children
 
Figure 3.5 Lorenz curves: current typhoid fever cases of  
young children and school-aged children without the program 
 
 
In contrast to the Lorenz curve of young children, the curve of expected cases for school-
aged children shows a significant relationship between parents’ educational attainment and cases 
associated with typhoid fever. Children with less educated parents (up to 60% of the population) 
tend to have a higher incidence rate, which is located over the equality line. Children with more 
educated parents (the remaining 40%) tend to have a lower incidence rate, located below the 
equality line.  
Figure 3.6 compares typhoid fever cases with and without the immunization programs. 
Without the program, 45% of typhoid fever cases occur among the 45% of children whose 
fathers have not graduated from middle school.  
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Figure 3.6 Lorenz curves: typhoid fever cases 
of all children with/without the program 
 
 
This group would have almost the same cumulative percentage of cases avoided if the 
vaccine were delivered for free. Generally speaking, the area between the Lorenz curve and the 
equality line (area A in Figure 3.1) is bigger with the program than it is without the program. The 
greater the area A the greater the inequality. Even the free immunization program would increase 
inequality, therefore, because less educated parents would be less likely to have their children 
vaccinated in order to avoid typhoid fever. 
 Furthermore, the user fee would increase the area between the Lorenz curve and the 
equality line. If a user fee were charged, the gap in the area (area A) with and without the 
program increases mainly among the population located between 15% and 75% on the 
educational attainment axis (Figure 3.6). It means that less educated parents (elementary or 
middle school graduation) are more likely to be sensitive to the user fee. Therefore, a user fee 
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increases inequality even more by reducing the vaccine take-up rates among children with less 
educated parents.  
 
7.2. Efficiency 
Impact of immunization programs 
As Table 3.5 shows, a school-based immunization program targeting students only is more 
effective (80%) than one that targets all children (69%). If a user fee of USD1.1 and USD1.0 for 
the single and simultaneous administration, respectively, were charged, the vaccination rate 
would decrease to 49%, on average. 
 
 
Table 3.5. Program impacts of typhoid immunization programs for children 
Without user fee With user fee 
Parameters Students  
(5-14 yrs) 
All Children  
(2-14 yrs) 
Students  
(5-14 yrs) 
All Children  
(2-14 yrs) 
Percentage vaccinated 80% 69% 49% 49% 
Number of vaccinations         53K          75K  33K 54K 
Number of cases avoided † (763→) 397  (1174 →) 555 241 394 
Number of deaths avoided †  (7 →) 4 (11 →) 6 2 4 
YLL avoided ‡ (210 →) 109 (325 →) 153 66 109 
YLD avoided ‡ (9 →) 5 (14 →) 7 3 5 
DALY avoided ‡ (219 →) 114 (339→) 160 69 114 
Public COI avoided ‡ ($19K →) $10K  ($28K →) $13K  $6K $10K 
Private COI avoided ‡ ($41K →) $21K  ($66 →) $31K  $13K $22K 
Total COI avoided ‡ ($58K →) $30K  ($94K →) $44K  $18K $32K 
Note: † denotes an estimate over three years. ‡ denotes a discounted estimate over three years. Numbers in 
parentheses show the estimates without the program. 
 
 
If no typhoid vaccine is administered to students attending primary or junior high schools 
in Tanjung Priok and Koja, 763 cases and 7 deaths associated with typhoid fever are expected 
over three years. These illnesses impose the economic burden of USD18,521 on the public sector 
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and USD40,746 on families over three years. Assuming no herd protection46 and no user fee, 397 
cases and 4 deaths would be averted with the typhoid vaccine program for students only over the 
three years of the vaccine’s efficacy. Also, 47% of the economic burden would be avoided. 
However, the immunization program targeting students only misses 24% of children at 
the higher risk of typhoid fever. They are young children (2-4.9 years) and school-aged children 
who do not attend school. If the program expanded to all children aged 2-14 years in the target 
area, a total of 555 cases and 6 deaths would be averted. Without the immunization program for 
all children, typhoid fever cases would result in a loss of 325 life years due to premature 
mortality and 14 life years in disability over three years. The introduction of typhoid vaccines at 
zero price in two sub-districts of North Jakarta could avoid a loss of 179 (=339-160) disability-
adjusted life years due to typhoid fever.  That is, 53% of DALY would be saved. By the same 
token, 53% of the total economic burden (in other words, total COI) would also be avoided 
(USD50K out of USD94K).  
If a user fee were charged, all the parameters—the number of cases avoided, DALY 
avoided, and any cost of illness avoided—would be 61% and 71% less for students and all 
children, respectively, than if a user fee were not charged. The programs with a user fee are 
therefore clearly less effective than the programs without a user fee. 
 
Program cost                                              
Table 3.6 presents program costs for three different vaccine financing schemes and two 
different vaccine delivery modes.  
The total cost of implementing the vaccination program is approximately USD66,000 for 
students and USD93,000 for all children (Panel A), assuming a single administration. Without 
donors’ funding or a user fee, the government would be required to spend USD1.24 per 
vaccinated child. If the typhoid vaccines were simultaneously delivered through the TT booster 
program, the introduction of typhoid vaccines would cost the government 8% less than the single 
administration. There is, therefore, no great cost advantage to simultaneous administration. 
If the Vaccine Fund or another international institution helps purchase doses of typhoid 
vaccines, the total costs of the vaccination program are approximately half those of the 
                                                 
46
 Many studies find significant protection among those who do not receive at least one dose of a given vaccine (for 
Hib, see Broughton, 2007; for cholera, see Longini et al., 2007; Jeuland et al., 2007; and Cook, 2007; for meningitis, 
see McIntosh et al., 2005), but there is no study of indirect build-up of herd immunity from typhoid immunization. 
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governmental funding scheme (Panel B). The average cost per immunized child is USD0.6, since 
only the delivery cost would be covered by the government. Donors would be required to spend 
approximately USD34,000 for students and USD46,000 for all children to purchase the vaccines. 
Though there are the savings to the public COI, the government still has to pay USD24,000 for 
young children and USD33,000 for all children. If the typhoid vaccines are simultaneously 
delivered along with the TT booster vaccines, the government has to pay less, i.e., USD18,000 
and USD28,000 for students and all children, respectively. In general, the financial burden under 
the cost-sharing scheme seems affordable for the government. 
If a user fee is charged (Panel C), the number of children vaccinated decreases. Then the 
total program cost decreases, too, between USD38,000 and USD67,000, compared to the total 
program cost for a program fully funded by the government. The net program cost (=Total 
program cost−Public COI−Revenue) is zero or slightly positive for any delivery mode. 
  
 
114 
Table 3.6. Efficiency measures of typhoid immunization programs by vaccine delivery mode, 
financing scheme, and target group (2007USD) 
Single admin. Simultaneous admin. Parameters 
Students All children Students All children 
Panel A: Governmental funding 
Program costs 
Total program cost  66K 93K 61K 88K 
Average cost/immunized person 1.24 1.24 1.14 1.17 
Net Benefits 
Net public benefits (public COI 
avoided - total program costs) 
(57K) (80K) (51K) (75K) 
Net societal benefits (WTP benefits + 
public COI avoided  - total program 
costs) 
726K 940K 728K 942K 
Cost-Effectiveness 
Net program cost per case avoided 144 145 130 135 
Net program cost per DALY avoided 223 222 201 206 
Panel B: Donors’ funding 
Program costs 
Total program cost of the government 33K 47K 28K 41K 
Average cost/immunized person 0.62 0.62 0.52 0.55 
Net benefit measures 
Net public benefits  (24K) (33K) (18K) (28K) 
Net societal benefits 761K 989K 761K 989K 
Cost effectiveness 
Net program cost per case avoided 59 60 46 50 
Net program cost per DALY avoided 92 92 71 77 
Panel C: User fee 
Program costs 
Total program cost 41K 67K 38K 63K 
Net program cost  (5) (33) (1K) (9) 
User fee 1.06 1.06 1.0 1.0 
Average cost/immunized person 1.24 1.24 1.14 1.18 
Net Benefits 
Net public benefits  (35K) (57K) (32K) (54K) 
Net societal benefits 459K 663K 459K 663K 
Cost-Effectiveness 
Net program cost per case avoided 0 0 (5) 0 
Net program cost per DALY avoided (6) (25) (8) 0 
Note: Amounts in parentheses denote negative values 
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Net benefit measures                                    
From a public budgetary perspective, once the total program cost is subtracted from the 
public COI avoided, none of the programs offers positive net benefits. This is because currently 
75 percent of the cost of illness associated with typhoid fever is borne by the families of affected 
children. However, the net public benefit measure does not account for all the costs of illness 
avoided by the immunization programs. If pain and mortality risk, as well as the private 
economic burdens associated with typhoid fever, are taken into account, WTP + public COI net 
benefits for all programs would pass a social cost-benefit test. Programs with donor funding offer 
the highest net benefit (Panel A in Table 3.6), while programs with a user fee offer the lowest 
societal net benefit (Panel C). Simultaneous administration offers slightly more net benefits than 
single administration. With regard to target group, the immunization program targeting all 
children offers more positive net benefits than the program targeting students only.  
 
Cost-effectiveness ratio                                
The cost-effectiveness ratio ranges from USD201 to USD223 per DALY averted (see the 
last row of Panel A in Table 3.6) without external funding or a user fee. With donor funding, the 
cost-effectiveness ratio ranges from USD71 to USD92 (Panel B). If there is a user fee at cost 
recovery points, the net program cost is almost zero and so the net program cost per DALY 
averted is zero (Panel C). All of the typhoid immunization programs would be judged as “highly 
cost-effective” for any funding scheme, any target group, and any vaccine delivery modality, 
since the cost-effectiveness ratio of typhoid immunization program is much less than the 
standard cut-off value (USD1,812 for Indonesia in 2007)47.  
 
7.3. A trade-off between efficiency and equality 
Efficiency and equity are two standard criteria in policy analysis. If there are potential 
tradeoffs between efficiency and equity, prioritizing interventions solely on the basis of one 
criterion is unlikely to optimize the welfare of society because of people’s concerns for both 
(James, et al., 2005). When deciding between two or more immunization programs, a society 
would be better off by choosing the one that promises the lowest cost or the maximum net 
                                                 
47
 2007 national GDP per capita in Indonesia is obtained from the IMF’s World Economic Outlook. GDP is not 
adjusted for purchasing power parity. 
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benefit (efficiency), while also distributing the well-being gains — here, immunization coverage 
— across children from different socioeconomic strata (equity).48 
Figures 3.7 to 3.9 present trade-offs between equality and efficiency in different 
vaccination schemes. The y-axis in Figure 3.7 represents the Gini index of cases avoided in each 
immunization scenario, while the x-axis represents three efficiency measures. They are net 
program costs per DALY avoided (Figure 3.7), net public benefits (Figure 3.8), and net societal 
benefits (Figure 3.9). A lower Gini index (y-axis) presents less inequality and the right hand side 
of the x-axis presents more efficiency. Thus, the lower right-hand corner is best in the sense of 
maximizing efficiency and minimizing inequality. The upper right-hand corner and the lower 
left-hand corner are worse in the sense of maximizing efficiency and inequality and minimizing 
efficiency and inequality, respectively. 
Abbreviations for the various immunization scenarios are as follows:  
 
G Single administration without donor funding at price of $0 
g Simultaneous administration without donor funding at price of $0 
U Single administration without donor funding at price of $1 
u Simultaneous administration without donor funding at price of $1 
D Single administration with donor funding 
d Simultaneous administration with donor funding 
 
Figure 3.7 shows that the programs with a user fee (U and u) for any targeting group, 
whether students only or all children, offer the most efficiency in terms of net program cost per 
DALY avoided, as well as the most inequality in terms of cases avoided (a smaller net program 
cost/DALY means more efficiency, while a larger Gini coefficient means more inequality across 
parental educational levels).  
 
 
                                                 
48
 Williams and Cookson (2000) provide a good summary of two criteria of equity, i.e., horizontal and vertical 
equity. Horizontal equity means reduced inequalities in vaccine coverage rate between children, which is consistent 
with egalitarianism. The other, vertical equity, is consistent with Rawls’ theory of justice in terms of favoring the 
most disadvantaged. 
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Figure 3.7 Efficiency-equality trade-offs of typhoid immunization programs: 
          Gini coefficient against net program cost per DALY avoided 
 
 
The programs funded by the government are the least efficient in terms of the cost-
effectiveness ratio. Thus, the programs with both a user fee and government funding heavily 
favor one side in the efficiency/equality trade-off at the expense of the other. As for programs 
with donor funding, they do not improve equality, compared to the government-funded 
programs, but their efficiencies are improved. If the criterion is to avoid programs providing only 
efficiency or only equality, the programs with donor funding for either all children or for 
students only show better balance across both dimensions. With regard to simultaneous versus 
single administration, simultaneous administration (d, g, and u) offers more efficiency than 
single administration (D, G, and U), while holding equality steady. Typhoid immunization 
programs targeting students alone provide more equality to society than the programs targeting 
all children, but not greater efficiency in terms of cost-effectiveness ratios.  
Figure 3.8 presents the Gini coefficient of cases avoided through an immunization 
program against net public benefit.  
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Figure 3.8 Efficiency-equality trade-offs of typhoid immunization programs: 
          Gini coefficient against net public benefits 
 
 
If one seeks a trade-off between efficiency and equality from a public budgetary 
perspective, the programs with a user fee for all children and the programs with government 
funding for all children look less attractive. If a program charges a user fee, it maximizes 
inequality, while achieving efficiency at a medium level compared to other programs. If a 
government fully funds immunization against typhoid fever for all children, it minimizes 
efficiency, while achieving equality at a medium level. Thus, neither is a good option on the 
trade-off equality/efficiency front. The four programs with donor funding for any age group are 
more attractive because they minimize loss in net public benefits and maximize equality. The 
programs with a user fee for students look attractive, too.   
Figure 3.9 shows the trade-off between equality and net societal benefit. For the sake of 
simplicity, the points for simultaneous vaccine delivery are dropped in Figure 3.9 since they are 
same as the points for single vaccine delivery.  
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Figure 3.9 Efficiency-equality trade-offs of typhoid immunization programs: 
          Gini coefficient against net societal benefits 
 
 
If a society seeks to improve both health equality and efficiency in immunization 
programs from a societal perspective, the program with a user fee for both students and all 
children are not attractive. Compared to the other programs, the user fee program for all children 
accomplishes the least equality in terms of cases avoided through the program, while the one for 
students accomplishes the least net societal benefit. These options look the worst on the net 
societal benefit and equality dimension. Moreover, the user fee program for students is the least 
efficient because it reaches the fewest children. The program funded by both the government and 
donors represents more efficiency in terms of net societal benefits, as well as more equality, 
compared to the program with a user fee. On the equality/net societal benefit trade-off front, 
donor funding seems a better option than government funding.  
In sum, if one focuses on net program cost per DALY avoided as a measure of efficiency, 
user fee programs maximize the efficiency while minimizing the equality. From both the public 
budgetary and the societal perspective, a user fee decreases the equality the most without 
increasing efficiency the most because of its lower coverage rate. As we have seen from Table 
3.4, the vaccination rate of programs with a user fee is 49%, while the vaccination rate of 
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programs without a user fee is 69-80%. This finding is consistent with other studies (Evans, 
Barer, and Stoddart, 1993; Nolan, 1993; Van Doorslaer, Wagstaff, and Rutten, 1993; OECD, 
1994; Creese, 1997; and Kutzin, 1998). Therefore, if one prefers cost-effective programs while 
achieving equality across all three tradeoffs (Figures 3.7, 3.8, and 3.9), the programs with donor 
funding are the best, while the programs with a user fee are the worst option. 
 
7.4. Sensitivity analysis 
In order to test the robustness of the results, I varied the assumptions over the parameters 
and conducted the Monte Carlo probabilistic sensitivity analysis. In the Monte Carlo analysis, 
each assumption of each parameter is assigned a range of values with a frequency distribution 
instead of a point value, as shown in Table 3.7. Values for each assumption are randomly drawn 
from its uniform distribution and each model is run 10,000 times. 
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Table 3.7. Monte Carlo analysis results of total/net program cost and donor funding (2007USD) 
Single administration Simultaneous administration 
Parameters Students  
(5-14 yrs) 
All Children  
(2-14 yrs) 
Students  
(5-14 yrs) 
All Children 
(2-14 yrs) 
Panel A: Governmental funding 
Total program cost 32K-110K 45K-149K 21K-103K 34K-148K 
Net program cost per 
DALY avoided 
34 - 624 35 - 601 20 - 576 24 - 521 
Net public benefits (22K)-(100K) (34K)-(133K) (11K)-(96k) (19K)-(138K) 
Net societal benefits 498K - 980K 647K - 1,240K 500K - 974K 666K - 1,179K 
Gini coefficients 0.05-0.11 0.05-0.09 0.05-0.11 0.05-0.09 
Panel B: Donors’ funding 
Total program cost 25K-48K 35K-65K 19K-39K 29K-56K 
Donor funding 23K-39K 27K-68K 23K-38K 32K-52K 
Net program cost per 
DALY avoided 
24- 251 24 - 241 13- 196 16 - 210 
Net public benefits (39K)-(16K) (53K) - (22K) (30K)-(8K) (44K) - (15K) 
Net societal benefits 525K - 973K 731K - 1,205K 523K - 989K 716K - 1,220K 
Gini coefficients 0.05-0.11 0.05-0.09 0.05-0.11 0.05-0.09 
Panel C: User fee 
Total program cost 33K-109K 48K-150K 24K-104K 37K-143K 
Net program cost (35K)-43K (50K)-60K (44K)-40K (55K)-56K 
Net program cost per 
DALY avoided 
(176)- 301 (189) - 291 (241)- 213 (210) - 247 
Net public benefits (99K)-(24K) (136K) - (33K) (95K)-(15K) (131K) - (231K) 
Net societal benefits 500K - 987K 667K - 1,205K 475K - 1001K 665K - 1,220K 
Gini coefficients 0.01-0.05 0.15-0.21 0.01-0.05 0.15-0.21 
    Note: Amounts in parentheses denote negative values 
 
 
Program cost 
The first row of each panel in Table 3.7 shows the range of the total program cost while 
accounting for uncertainty. Without donor funding or a user fee, the government may be required 
to spend at least USD32,000 for the typhoid immunization program if the typhoid vaccines are 
delivered to the students separately from TT boosters. Under the worst scenario, it may cost as 
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much as USD110,000. However, if the vaccines are administered together with the TT vaccines, 
the program might cost the government less (USD21,000-USD103,000).   
With external funding, the cost to donors to purchase the single shot of typhoid vaccines 
for students may range from USD23,000 to USD39,000. In addition, the government must be 
prepared to spend a maximum of USD65,000 for the students. 
Because there is vaccine demand failure for school-aged children who do not attend 
school as shown in Figure 3.4, home delivery or a more intensive campaign should be considered 
as strategies for reaching this population. (Appendix C specifies the characteristics of this group, 
using the probit model).  
As Table 3.8 shows, these strategies incur higher vaccine delivery costs. In order to take 
into account uncertainty of vaccine delivery costs, I run a sensitivity analysis according to 
vaccine delivery costs at USD1, 2, and 3. This range corresponds to the home delivery costs of 
Hep B vaccines (see Table A.6 in Appendix A). 
 
 
Table 3.8. Sensitivity analysis for all children by applying various vaccine delivery costs for 
school-aged children who do not attend school (2007USD) 
 Single administration Simultaneous administration 
Vaccine delivery cost $1 $2 $3 $1 $2 $3 
Panel A: Governmental funding 
Total program cost  96K 101K 107K 91K 96K 102K 
Net public benefits  (83K) (88K) (93K) (78K) (83K) 88K 
Net societal benefits  937K 932K 927K 940K 934K 929K 
Net program cost per case avoided 150 159 169 140 149 159 
Net program cost/DALY avoided 229 244 259 214 229 243 
Panel B: Donors’ funding 
Total program cost  50K 55K 60K 45K 50K 55K 
Net public benefits  (36K) (42K) (47K) (31K) (36K) 42K 
Net societal benefits  986K 981K 976K 986K 981K 976K 
Net program cost per case avoided 66 75 85 56 65 75 
Net program cost/DALY avoided 100 115 129 86 100 115 
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Panel A of Table 3.8 shows that when applying the higher delivery costs to the school-
aged children who do not attend school, the program costs for a government-funded program 
increase from USD93,000 (at $0.6 of base delivery cost from Table 3.6) to USD107,000 (at $3 of 
delivery cost from Table 3.8) for single administration and from USD88,000 (at $0.45 of base 
delivery cost) to USD102,000 (at $2.7 of delivery cost) for simultaneous administration. The 
government would be expected to spend USD14,000 for either single or simultaneous 
administration in order to reach these disadvantaged children. 
Panel B of Table 3.8 shows that in the case of cost-sharing funding, the government 
would be required to spend USD13,000 more than the baseline scenario (60K at $3 of cost from 
Table 3.8−47K at base delivery cost from Table 3.6).  
As delivery costs increase once a program includes the disadvantaged children, net 
benefit measures decrease and cost-effectiveness ratios increase. However, the cost-effectiveness 
ratios of a program that reaches school-aged children who do not enroll in school are still highly 
favorable. 
 
Cost-effectiveness ratio 
We can see from Table 3.7 that the ranges of the cost-effectiveness ratios from the Monte 
Carlo analysis are not too wide and still fall below the standard cut-off value even in the worst-
case scenario, i.e., USD624 per DALY avoided (for a single administration program funded by 
the government for students). Therefore, the introduction of typhoid vaccines through schools is 
justified in North Jakarta using the cut-off value (USD1,812), regardless of funding source, 
vaccine delivery modes, and target groups. 
 
Net benefit measures 
Despite the impact of different factors on net benefit estimates, the sensitivity analysis of 
net benefit measures in Table 3.7 delivers a clear message: the net public benefit is almost 
always negative in the 10,000 simulations regardless of funding source, target group, and 
administration option, while the net societal benefit is always positive.  
The sensitivity analysis also highlights that, thanks to less variation in vaccine delivery 
costs, the ranges of the results are not very wide, which means less uncertainty, an important 
consideration for any policy decision maker. 
  
 
124 
 Table 3.9 shows the impact of each parameter, listed in Table 3.1 and 3.2, on net benefit 
estimates of the typhoid program.49 For both net benefit measures, public and societal, the most 
important factors in the probabilistic sensitivity analysis are vaccine take-up rates of students and 
enrollment rate, as well as vaccine costs, public COI, and WTP.  
 
 
Table 3.9. Effect of parameters on net benefits in the Monte Carlo analysis, ranked in order of 
significance to variation in results 
Net Benefit Most important 
Second Third Fourth 
Net public benefits 
(=public COI−total cost) 
Vaccine 
cost 
Take-up rate 
(students) 
Public COI Enrollment rate 
(junior high) 
Net societal benefits 
(=WTP + public COI−total cost) 
WTP  
(5-14 yrs) 
Vaccine cost Take-up rate 
(students) 
Enrollment rate 
(primary) 
 
 
As discussed earlier, the vaccine demands for school-aged children who do not attend 
school are significantly different from the demands for children in school. Therefore, in child 
immunization policy analysis it is important to account for whether children are in school or out 
of school. However, this aspect is often disregarded in child immunization policy analysis.  
 
7.5. Comparisons of cost-effectiveness ratios with other health interventions  
Do these highly cost-effective typhoid immunization programs compete with other 
important health interventions? In order to answer the question, I use the result of the sensitivity 
analysis from this study in terms of cost effectiveness ratio.  
Figure 3.10 compares cost-effectiveness estimates for the typhoid immunization program 
with those for other health interventions. They are the Haemophilus influenzae type b (Hib) 
vaccination in Indonesia (Broughton, 2007), the cholera immunization program in the same sub-
districts as this study (Jeuland et al., 2007), and other low-cost interventions in developing 
countries (Laxminarayan et al., 2006a, 2006b). 
 
 
                                                 
49
 The tornado chart tool of Crystal Ball provides this measure. 
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Figure 3.10 Comparison of cost-effectiveness ratios by health intervention program (2007USD) 
 
Note: The symbols * and ** indicate the results from Laxminarayan et al. (2006b) in low- and middle-income 
countries and from Broughton (2007) in Indonesia, respectively. 
For the purpose of presentation, the cost-effectiveness ratio of cholera vaccine is trimmed at 3,000. Its original range 
is reported as 1,076-8,963.  
 
 
The cost-effectiveness measures in Figure 3.10 require careful interpretation. 
Laxminarayan et al. (2006a, 2006b) warn that their final estimates are from published work or 
standardized resource costs adapted from the WHO’s CHOICE project. Also, the cost-
effectiveness ratio of the Hib vaccination is for all of Indonesia, not just North Jakarta. Though 
the cholera immunization program of Figure 3.10 targets the same area as this study, it is based 
on different assumptions from the ones guiding this analysis. Therefore, it is important to use the 
order of the estimates in Figure 3.10, rather than each estimate’s specific range, as an indicative 
guide for policy making.  
Figure 3.10 shows that the school-based typhoid immunization program with external 
funds is highly cost-effective, on a par with the HIV/AIDS prevention program. Immunization 
programs against typhoid fever are more cost-effective than those against cholera, Hib, and 
tuberculosis. The difference between the typhoid and cholera immunization programs requires 
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some explanation. Both target the same area and the same age group, but the typhoid program is 
more cost effective than the cholera program. This is mainly because the cost of the typhoid 
vaccine (USD0.6) is assumed as half the cost of the cholera vaccine (USD1). If we assume the 
same vaccine cost per dose for both the typhoid and the cholera program, the typhoid program 
would still be more cost effective because cholera immunization requires two doses of vaccines. 
The total cost of the cholera vaccine would be twice as much as the total cost of the typhoid 
vaccine, making the cholera program significantly less efficient.  
 
8. Discussion and Conclusion 
While the main purpose of this study is to demonstrate the impact of child immunization 
programs against typhoid fever in terms of both efficiency and equality, it has produced three 
additional findings that are key to any consideration of typhoid immunization programs. First, 
the vaccine delivery cost through schools to children is only two thirds of the cost through mass 
vaccine delivery. Second, targeting students only is more effective than targeting all children, 
mainly because of the higher vaccination rate of a school-based program. Third, if one focuses 
only on efficiency, all of the immunization strategies, whatever their funding source, delivery 
mode, or target group, would be considered “highly cost-effective.”  
With these findings in mind, I conclude that a program with a user fee, while clearly cost-
effective, would be regressive for lower-income families in North Jakarta. In order to examine 
whether children with lower socioeconomic status are either more likely to suffer from typhoid 
fever or less likely to get vaccinated against typhoid fever, I determine that status by using 
parents’ educational attainment from all of the available data sets (epidemiology data, cost-of-
illness data, and contingent valuation data) in the Koja and Tanjung Priok districts of North 
Jakarta.  
There is no clear evidence that children with less educated parents have higher incidence 
rates of typhoid fever. However, less educated parents are more likely to suffer from the 
catastrophic economic burden of having their children become sick or hospitalized with typhoid 
fever. In other words, the economic consequences of typhoid fever are regressive.  
Children with less educated parents are less likely to be vaccinated against typhoid fever, 
even when the vaccines are provided for free. Furthermore, the demand for free vaccines is the 
lowest for school-aged children who do not attend school. There may be a dead zone that 
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government information campaigns on immunization do not reach. Households with school-aged 
children who do not enroll may not fully know about the benefits of immunization. In order to 
reach these disadvantaged children, the government would be expected to spend at maximum 
USD14,000 more than the baseline scenario without intensive campaign strategies, regardless of 
which financial scheme is adopted.  
If a user fee is charged at the cost recovery point (USD1), expected vaccine coverage 
rates become clearly regressive. Children in North Jakarta suffer from chronic typhoid fever 
illnesses because of inadequate water supplies. Drinking water in Jakarta is scarce, and only 
relatively high-income families can afford piped water connections. Poor families must rely on 
vendor water, which costs 10 to 25 times as much as piped water. The absence of this public 
good imposes regressive water expenditures on the poor. Now, as an alternative to providing safe 
drinking water, the government is considering the introduction of immunization programs 
against a water-transmitted disease, typhoid fever. If, in turn, these programs favor children from 
highly educated parents at the expense of children with less educated parents, as a program with 
a user fee would, then the vicious circle never ends.  
A program with a user fee for all children, then, is the worst option if the government 
wants to both maximize efficiency and minimize inequality, because such a program decreases 
equality the most while not increasing efficiency the most. This finding corresponds with several 
studies that indicate that fees have rarely generated large amounts of revenue and are unlikely to 
improve (and might even have worsen) efficiency.50  
The programs with donor funding for any age group turn out to be the most attractive, 
followed by programs with government funding. One reason donor funding is the most attractive 
financing scheme for immunization in Indonesia is that with a limited health care budget, the 
government would not be able to introduce typhoid fever vaccines without cutting the budgets of 
other health interventions.  
With donor funding for the purchase of the vaccines, the net program cost for any 
immunization strategy seems affordable for the Indonesian government. Since a cost-sharing 
method is less expensive to the government than a use fee system, the government prefers donor 
funding for vaccine procurement cost to a user fee. The cost-effectiveness measures indicate that 
                                                 
50
 For further details see Fabricant, Kamara, and Mills, 1999; Arhin-Tenkorang, 2000; and James, Morris, Keith, and 
Taylor, 2005. 
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typhoid immunization with external funding is highly cost-effective (USD13-USD251 per 
DALY averted). The societal net benefit measures also pass a societal cost-benefit test, though 
the net public benefits using public COI do not.  
However, a cost-sharing scheme between the government and donors is usually limited to 
five years. Therefore, the government must make financial plans to sustain the immunization 
program once grants are ended (GAVI Alliance, 2006). In cases where the government is not 
able to make such plans, a partial subsidy program whereby user fees do not cover the costs of 
vaccination and the government pays the difference could be considered. Though I did not 
analyze this type of cost-sharing policy, we can expect that the vaccination rate of the partially 
subsidized program would be higher than the rate of a full user-fee program. The net program 
cost per DALY avoided for a partial subsidy program would be a little higher than the one in 
which a user fee is fully charged to parents, but it would still fall in a highly cost effective range. 
This type of partially subsidized program would minimize the inequality more than a full user-
fee program, while the government would bear the same financial burden as with the cost-
sharing program with donors.  
In sum, the results of this study suggest that to strike a fair balance between efficiency 
and equality, policy makers would be best advised to adopt a school-based typhoid fever 
immunization program, partially funded by donors (and with plans for sustaining it in the future), 
in which the typhoid vaccine was simultaneously delivered with the TT booster vaccines. 
 
If the typhoid programs for children from the two sub-districts of North Jakarta were 
expanded to the rest of North Jakarta, trade-off results in both the efficiency and the equality 
dimension might be similar. To reach this conclusion one has to examine such parameters as the 
distribution of population, incidence rate, costs, and benefits. The percentage of young children 
and school-aged children in the two sub-districts and the rest of North Jakarta are comparable, 
according to the 2004 population census in N. Jakarta. With regard to vaccine costs, Lauria and 
Stewart (2007) argue that in urban areas there may be economies of scale, though there is little 
evidence and there are conflicting opinions on whether economies of scale exist. Since North 
Jakarta is a part of the capital city of Indonesia, the vaccine delivery cost could decrease based 
on the economy of scale. The last parameters are net benefits and incidence rate. Though it is 
likely that there are differences in socioeconomic characteristics and incidence rate between the 
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two sub-districts and the rest of North Jakarta, we can assume that any cost-of-illness estimate, 
willingness-to-pay estimate, and incidence rate are the same in both areas. Finally, taking into 
consideration all the differences in the parameters, I find that there may be improvements in 
efficiency mainly because of the reduced vaccine delivery cost, as well as slight improvements in 
equality because of a slightly larger percentage of school-aged children in the rest of North 
Jakarta than in the smaller area. However, since all of the metrics increase at the same rate across 
all of the programs, the trade-off results on the efficiency-equality dimensions cannot 
definitively be said to change with the size of the vaccination program. The trade-off findings in 
the two sub-districts, therefore, may hold for the rest of North Jakarta, too. 
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Appendix A. Cost of vaccine delivery through single adminstration in Indonesia 
This section discusses and derives the delivery cost of typhoid vaccines based on several 
studies estimating the costs of delivering vaccines specifically in Indonesia. First, total vaccine 
costs per fully immunized child and total vaccine costs per dose are calculated. Second, 
procurement costs of vaccines per dose are estimated based on certain assumptions and limited 
available vaccine price data. Finally, vaccine delivery costs are calculated by subtracting 
procurement costs from total vaccine costs per dose, since total vaccine costs per dose are the 
sum of procurement costs and delivery costs.  
 
First step: estimating total vaccine cost per fully immunized child 
The basic data comes from Mardiati et al. (2004). It reports a unit cost of seven antigens 
per immunized person in Jawa Tengah and Bangka Belitung provinces from 2001 through 2003. 
The seven antigens consist of BCG, DPT, polio, measles, Hepatitis B, TT, and TT booster. The 
EPI vaccine costs per fully immunized child (FIC) are calculated by multiplying a unit cost by 
the number of shots recommended. This step is taken in order to ensure that the data is within the 
normal range. The total costs per FIC vary according to the definition of EPI vaccines, i.e., 
whether they are the traditional “EPI6” vaccines or include new and/or underused vaccines. 
Table A.1 summarizes the total vaccine costs per FIC in Indonesia.  
 
Table A.1 Total vaccine costs per fully immunized child (2007USD) 
Study Vaccines Mean S.D. Median Min. Max. 
EPI6 5.6 2.5 4.4 3.5 11.0 
EPI6, Hep B 12.0 4.2 12.2 6.3 21.5 
EPI6, Hep B, TT 14.3 4.5 12.9 7.6 23.1 
Mardiati et al. (2004) 
EPI6, Hep B, TT, BIAS 16.4 4.8 14.7 9.6 25.2 
REACH (1987) EPI6 20.0 NA NA 6.9 35.5 
WHO (1981) BCG, DPT, TT 7.1 1.3 7.0 5.5 9.3 
Barnum et al. (1980) BCG, DPT 8.3 0.5 8.3 7.9 8.7 
Creese et al. (1982) BCG, DPT 6.0 1.6 6.5 4.3 7.4 
 
 
Mardiati et al. (2004) use the richest data on vaccine cost in Indonesia. From 2001 
through 2003, the vaccine costs per FIC for administering the traditional EPI6 vaccines were on 
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average USD5.6 in four districts (Bangka, Belitung, Banjarnegara, and Pekalongan). If Hep B 
vaccines are included, the cost goes up to USD12.  
There were early costing studies conducted in the 1980s by the WHO and the USAID-
funded REACH project (Resources for Child Health). The results show that the average cost per 
FIC in 2007 dollars was approximately USD20 (Brenzel et al., 2006; GAVI, 2004; and Lydon, 
2007), with a range from USD7 to USD36.51 The country-specific studies commissioned by the 
WHO in the early 1980s (Barnum et al., 1980; WHO, 1981; and Creese et al., 1982) also found 
that the average cost per FIC was USD7-8 for BCG and DPT, and TT vaccines in Indonesia. 
Finally, the total costs per FIC in Indonesia fall into the lower boundary of the results from the 
REACH project, which focused on the traditional EPI vaccines.  
 
Second step: estimating unit vaccine cost per dose 
The goal of this section is to subtract the procurement costs from the total costs in order 
to derive the delivery costs of typhoid vaccines per dose. As the first step, the unit cost of each 
vaccine, i.e., the total cost divided by the number of vaccines, is estimated using Mardiati et al. 
(2004). The first panel of Table A.2 shows the unit cost of the traditional “EPI6” vaccines by 
district. Though there is variation across the districts, the average unit cost per dose is USD0.9 
(median USD0.6). If a hepatitis B vaccine is included, the total cost per dose goes up to on 
average USD1.4 (median USD0.8). Finally, when TT and TT booster vaccines are added, the 
total cost per dose goes down slightly to USD1.1, on average.  
                                                 
51
 The author’s calculation using Lydon (2007). 
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    Table A.2. Unit cost of vaccines per dose (2007USD) 
District Median S.D. Mean Min. Max. No. of 
observations 
EPI6 
Bangka 0.5 0.3 0.6 0.3 1.2 12 
Banjarnegara 0.6 0.4 0.6 0.2 1.3 12 
Belitung 1.1 1.2 1.4 0.4 4.0 12 
Pekalongan 0.6 0.6 0.8 0.2 1.9 12 
Sub-summary 0.6 0.8 0.9 0.2 4.0 48 
EPI6, Hep B 
Bangka 0.5 0.3 0.7 0.3 1.2 15 
Banjarnegara 0.8 1.0 1.0 0.2 2.8 15 
Belitung 1.1 1.1 1.4 0.4 4.0 15 
Pekalongan 0.7 1.4 1.4 0.2 4.9 15 
Sub-summary 0.8 1.4 1.4 0.2 4.9 15 
EPI6, Hep B, TT, and BIAS 
Bangka 0.7 0.4 0.8 0.3 1.5 21 
Banjarnegara 0.4 0.9 0.8 0.2 2.8 21 
Belitung 1.1 1.0 1.4 0.3 4.0 21 
Pekalongan 0.7 1.2 1.2 0.2 4.9 21 
Total summary 0.8 0.9 1.1 0.2 4.9 84 
     Source: Mardiati et al. (2004) 
 
 
Third step: estimating vaccine procurement cost per dose 
In order to estimate vaccine prices from the unit costs, two assumptions are made. First, 
for the traditional EPI6 vaccines, it is assumed, based on Lydon (2007), that vaccine 
procurement costs represent 20-30% of the average vaccine costs.  
Compared to the traditional EPI vaccines, the price of non-traditional EPI vaccines such 
as the hepatitis B vaccine is high. Table A.3 summarizes the procurement cost of the Hep B 
vaccine by vial format in Indonesia from several studies.  
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Table A.3. Price of Hep B vaccine and disposable syringe  
Study Vial format Price (2007USD) 
Vaccine 
GOI (2001) Multi-dose vial 0.4 
6-dose vial 0.9 
5-dose vial 1.6 
Levin et al. (2005) 
Uniject 2.3 
GOI (2004) Uniject 1.1-1.2 
Anwar (2001) Uniject 0.8 
Syringe 
Levin et al. (2005) Disposable 0.1-0.3 
 
 
Based on all of the data available, the procurement cost of Hep B vaccine ranges from 
USD0.4 to USD2.3. I assume a simple linear relationship between the unit cost and the 
procurement cost of Hep B vaccines and assign the procurement cost for each observation. Table 
A.4 shows the assumed procurement cost of Hep B vaccines in details. 
 
 
Table A.4 Estimates of the Hep B procurement cost (2007USD) 
Estimated procurement cost 
          Study         e   
District Admin. year Unit cost Lower bound Upper bound 
Mardiati et al. (2004) 
2001 1.0 0.4 0.5 
2002 1.2 0.4 0.5 
Bangka 
2003 0.8 0.4 0.5 
2001 1.5 0.4 0.5 
2002 1.4 0.4 0.5 
Belitung 
2003 0.9 0.4 0.5 
2001 2.8 0.8 1.6 
2002 2.8 0.8 1.6 
Banjarnegara 
2003 2.7 0.8 1.6 
2001 2.7 0.8 1.6 
2002 3.4 1.6 2.3 
Pekalongan 
2003 4.9 1.6 2.3 
Note: USD1= Indonesian Rupiah (Rp) 9,250 in 2000; USD1= Rp 10,000 in 2001; USD1= Rp 9,350 in 2002; and                             
USD1= Rp 8,550 in 2003. 
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Next, the procurement costs of all vaccines are summarized in Table A.5 based on the 
two assumptions above. In Indonesia the EPI vaccines are purchased from Bio Farma and so the 
domestic prices could be a little different from the international prices. The international prices 
of EPI vaccines reported by Lauria and Stewart (2007) are similar to the lower bound of the 
estimated prices under the assumptions discussed above. 
 
 
Table A.5 Comparison between international EPI prices and estimated prices (2007USD)   
Estimated price per dose 
Vaccine EPI price 
Lower bound Upper bound 
BCG 0.17 0.16 0.24 
DTP 0.12 0.12 0.18 
Measles 0.25 0.31 0.46 
Polio 0.15 0.07 0.10 
Hep B 0.84 0.79 1.17 
 
 
Fourth step: estimating vaccine delivery cost 
Finally, the vaccine delivery costs are estimated by subtracting the estimated procurement 
costs from the unit costs (see Table A.6). The third column (mean) shows that the average 
delivery costs range from USD0.2 to USD1.4. This finding is comparable to the vaccine delivery 
costs for seven GAVI-eligible countries. Their delivery costs, from country-level financial 
sustainability plans, range between USD0.3 and USD1.0 per dose in 2007 dollars (Sinha et al., 
2007). Since the price estimates using 20% of the unit cost are close to the international prices 
above, the upper bound of the estimated delivery costs is used in the main analysis.  
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Table A.6. Estimated delivery costs of vaccines per dose (2007USD) 
Vaccine Median S.D. Mean Min. Max. No. of 
observations 
Lower bound (=unit-cost vaccine price estimated at 30% of unit cost) 
BCG 0.54 0.22 0.56 0.27 0.95 12 
DPT 0.36 0.16 0.42 0.27 0.74 12 
Polio 0.20 0.10 0.23 0.12 0.43 12 
Measles 0.83 0.64 1.07 0.45 2.82 19 
Hep B 0.95 0.55 0.98 0.30 2.57 14 
TT 0.58 0.55 0.80 0.23 1.88 12 
TT booster 0.43 0.30 0.49 0.18 1.07 12 
Upper bound (=unit-cost vaccine price estimated at 20% of unit cost) 
BCG 0.61 0.25 0.63 0.31 1.08 12 
DPT 0.42 0.19 0.48 0.31 0.85 12 
Polio 0.23 0.11 0.26 0.14 0.49 12 
Measles 0.94 0.73 1.22 0.52 3.22 19 
Hep B 1.04 0.82 1.35 0.40 3.32 14 
TT 0.67 0.63 0.91 0.27 2.15 12 
TT booster 0.50 0.34 0.56 0.20 1.22 12 
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Appendix B. Cost of vaccine delivery through simultaneous administration 
In one of the scenarios, the typhoid vaccine would be simultaneously delivered with the 
TT vaccine through the existing BIAS program. Since the TT booster program is already 
established for primary school students, the only additional costs of delivering the typhoid 
vaccine would be the cost of the additional volume of typhoid vaccine and the cost of additional 
administration time. Personnel costs are often the single largest cost in immunization programs. 
Table B shows the contribution of personnel cost to the incremental costs from several studies.  
 
 
     Table B. Percent of personnel cost out of the incremental cost 
Country Type of 
vaccine 
Personnel 
cost 
Vaccination  
staff salary  
No. of 
immunizations 
Administration 
year 
Stewart (2005) 
Indonesia typhoid 81% 29% 4,828 2004 
India typhoid 62% 26% 37,686 2004 
Vietnam typhoid 92% 57% 32,267 2003 
Pakistan typhoid 41% 41% 12,830 2003 
Hutton and Tediosi (2006) 
Tanzania malaria 36% NA 1,438,000 2003 
WHO (1981) 
Indonesia EPI 53% NA 11,394 1979-1980 
Creese et al. (1982) 
Indonesia EPI 42% NA 1602 1979-1980 
Philippines EPI 60% NA 396 1979-1980 
Thailand EPI 55% NA 189 1979-1980 
 
 
In a recent and comprehensive study, Hutton and Tediosi (2006) estimate the incremental 
costs of adding a hypothetical malaria vaccine to the EPI schedule in Tanzania. They find that 
36% of the incremental costs are personnel costs. Two studies conducted in Indonesia and using 
data from the 1970s (WHO, 1981; and Creese et al., 1982) show personnel costs to be 42-60% of 
the incremental costs. Except for the DOMI projects (Stewart, 2005), the average contribution of 
personnel costs falls in the range of a finding from the GAVI Immunization Financing (IF) 
Database. The IF database collects the existing costing information across countries and 
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summarizes that personnel costs in general account for 50% to 75% of the incremental costs 
(Lydon, 2007). 
The DOMI projects (Stewart, 2005) provide detailed information for each of the average 
delivery cost components. Specifically, the salary of the vaccination team is reported as 26% to 
57% of the incremental costs. In order to remove the extra research expenses from the project 
costs, 50% is subtracted based on a careful review of the IF database and the DOMI projects. 
The salary of the vaccination team is therefore approximately equivalent to USD0.3 out of the 
delivery cost (USD0.6) for the single administration. If it is assumed that the vaccination time of 
the simultaneous administration is half that of the single shot, the delivery cost decreases to 
USD0.45 (=USD0.6-USD0.3×1/2). This is a conservative estimate since it does not reflect other 
potential savings in the vaccine delivery. In order to account for uncertainty, it ranges from 
USD0.2 to USD1.2.  
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Appendix C. Probit analysis of whether school-aged children attend school 
The probit model is based on the information provided by the contingent valuation survey 
on whether a school-aged child attends school. In order to specify the characteristics of this 
group, the probit model is used. The dependent variable, or indicator variable, is set to one for 
those who have school-aged children who do not go to school. Otherwise, it is zero. Table C 
presents two different specifications.  
 
 
Table C. School attendance of school-aged children using probit model, N=835 (t-statistics in 
parentheses) 
Independent variable Model 1 Model 2 
Income quintile II 
 (monthly household income is USD61-88) -0.041 (-0.26) -0.039 (-0.25) 
Income quintile III (USD88-138) -0.083 (-0.52) -0.079 (-0.5) 
Income quintile IV (USD138-): richest -0.011 (-0.08) -0.007 (-0.05) 
Respondent is 30-39 years old 0.202 (1.46) 0.206 (1.49) 
Respondent is 40-49 years 0.783*** (5.1) 0.788*** (5.18) 
Respondent is 50-59 years 0.517*** (2.62) 0.507*** (2.58) 
No schooling 0.420*** (2.72) 0.356*** (2.49) 
Primary school 0.301** (2.06) 0.287* (1.98) 
Middle school 0.141 (0.89) 0.131 (0.83) 
Respondent is a worker in formal sector† -0.242* (-1.69) -0.246* (-1.73) 
Number of children 0.456*** (11.25) 0.454*** (11.21) 
Travel time to nearest health facility > 15 min. 0.006 (0.05)  
Typhoid is common in neighborhood 0.224* (1.63) 0.213 (1.6) 
Respondent knows someone who has had typhoid 
fever -0.039 (-0.32)  
Respondent knows about EPI vaccines 0.009 (1.53) 0.008 (1.46) 
Religion is Muslim -0.145 (-0.62)  
Respondent fails effectiveness twice -0.185 (-1.23)  
Constant -2.028*** (-6.58) -2.195*** (-11.18) 
Pseudo R2 0.227 0.225 
Log likelihood -401.35 -402.35 
Note: † Formal sector is defined as civil servant, worker in public or private sector, sewage worker, service worker, 
or laboratory personnel 
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School-aged children are less likely to attend school if (1) their mothers or fathers are 30-
59 years old, as compared to parents younger than 30 years old; (2) their mothers or fathers have 
lower educational attainment (i.e., respondents did not complete middle school); (3) their 
mothers or fathers do not have formal jobs such as civil servant, worker in the public or private 
sector, sewage worker, service worker, or laboratory personnel, but rather are mostly street 
vendors, housewives, self-employed, unemployed, or retired; and (4) the number of children in 
their household is large.  
There is no clear evidence that the following have an effect on school enrollment: (1) 
monthly household income; (2) how far the nearest health care facility is located; (3) their 
mothers of fathers know someone who has had typhoid fever; (4) their mothers of fathers know 
about the EPI vaccines; (5) their families are Muslim; or (6) their mothers or fathers fail to 
understand the concept of vaccine effectiveness.  
 
